WO1994006296A1 - Iodine/resin disinfectant and a procedure for the preparation thereof - Google Patents

Iodine/resin disinfectant and a procedure for the preparation thereof Download PDF

Info

Publication number
WO1994006296A1
WO1994006296A1 PCT/CA1993/000378 CA9300378W WO9406296A1 WO 1994006296 A1 WO1994006296 A1 WO 1994006296A1 CA 9300378 W CA9300378 W CA 9300378W WO 9406296 A1 WO9406296 A1 WO 9406296A1
Authority
WO
WIPO (PCT)
Prior art keywords
εaid
reεin
anion exchange
elevated
resin
Prior art date
Application number
PCT/CA1993/000378
Other languages
French (fr)
Inventor
Pierre Jean Messier
Original Assignee
Pierre Jean Messier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020007014953A priority Critical patent/KR100316165B1/en
Priority to DK97108792T priority patent/DK0797917T3/en
Application filed by Pierre Jean Messier filed Critical Pierre Jean Messier
Priority to KR1019950701017A priority patent/KR100306886B1/en
Priority to AU49401/93A priority patent/AU688276B2/en
Priority to JP50762894A priority patent/JP3289831B2/en
Priority to DK93918858T priority patent/DK0660668T3/en
Priority to KR1020007014955A priority patent/KR100316167B1/en
Priority to EP93918858A priority patent/EP0660668B1/en
Priority to KR1020007014956A priority patent/KR100316168B1/en
Priority to KR1020007014954A priority patent/KR100316166B1/en
Priority to DE69320483T priority patent/DE69320483T2/en
Priority to CA002140639A priority patent/CA2140639C/en
Priority to US08/256,425 priority patent/US5639452A/en
Publication of WO1994006296A1 publication Critical patent/WO1994006296A1/en
Priority to US08/803,869 priority patent/US6045820A/en
Priority to HK98112325A priority patent/HK1011259A1/en
Priority to US09/267,056 priority patent/US6680050B1/en
Priority to US09/735,125 priority patent/US20010009661A1/en
Priority to US10/161,102 priority patent/US6899868B2/en
Priority to US10/166,465 priority patent/US6696055B2/en
Priority to US10/238,758 priority patent/US7261879B2/en
Priority to AU2002302053A priority patent/AU2002302053B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23Solid substances, e.g. granules, powders, blocks, tablets
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12Iodine, e.g. iodophors; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0085Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/12Apparatus, e.g. holders, therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/50Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/106Halogens or compounds thereof, e.g. iodine, chlorite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24FAIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR CURRENTS FOR SCREENING
    • F24F8/00Treatment, e.g. purification, of air supplied to human living or working spaces otherwise than by heating, cooling, humidifying or drying
    • F24F8/50Treatment, e.g. purification, of air supplied to human living or working spaces otherwise than by heating, cooling, humidifying or drying by odorisation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/20Air quality improvement or preservation, e.g. vehicle emission control or emission reduction by using catalytic converters

Definitions

  • the present invention relates to a disinfectant substance comprising an iodine (impregnated) resin and to a process for the preparation thereof.
  • the iodine/resin disinfectant may be used to sterilize a fluid such as, for example, water, air, as well as fluid exudate secreted at body lesions or traumas such as at cuts, burns , etc.; thus, the disinfectant may be used to devitalize microorganisms (e.g. bacteria, viruses, etc..) which may be present in the fluid (e.g. water, air, pus and the like) .
  • a fluid such as, for example, water, air, as well as fluid exudate secreted at body lesions or traumas such as at cuts, burns , etc.
  • the disinfectant may be used to devitalize microorganisms (e.g. bacteria, viruses, etc..) which may be present in the fluid (e.g. water, air, pus and the like) .
  • the treatment of fluid, such as water or air, with an iodine/resin disinfectant of the present invention may leave behind non-detectable (or acceptable) residual diatomic iodine in the fluid (e.g. water or air) .
  • the present invention in particular relates to a demand type broad spectrum resin-polyiodide (e.g. water, air, wound) disinfectant.
  • Diatomic halogen such as I 2 , Cl 2 , Br 2 , etc..
  • SUBSTITUTESHEET traditionally been used to disinfect water.
  • Diatomic chlorine for example, is a widely exploited disinfectant for controlling or eliminating micro-organisms which may be present in water.
  • a disadvantage of a sterilization regime which exploits diatomic halogen is that the regime may leave behind unacceptable (residual) levels of halogen in the water once sterilization is complete.
  • iodine/resin product has, however, been proposed for use as a demand disinfectant, namely a disinfectant wherein iodine is released almost entirely on a demand-action basis.
  • United States patent nos. 3,817,860, 3,923,665, 4,238,477 and 4,420,590 teach such a demand disinfectant wherein iodine is the active disinfectant agent; the entire contents of each of these patents is incorporated herein by reference.
  • the resin product may be used without fear of introducing unacceptable concentrations of diatomic iodine into the water to be sterilized.
  • U.S. patent nos. 3,817,860 and 3,923,665 teach an iodine/resin demand disinfectant which is the reaction product obtained by contacting a strong base anion exchange resin with a suitable source of triiodide ions.
  • the reaction product is taught as being very stable in the sense that the amount of iodine (e.g. I 2 ) released into water from the reaction product is sufficiently low that the water disinfected thereby is immediately ready for use, ie. as drinking water.
  • the procedure for preparing the iodine/resin comprises forming a triiodide ion (solution or sludge) by dissolving diatomic iodine in a water solution of a suitable alkali metal halide (e.g. KI, Nal,.).
  • a suitable alkali metal halide e.g. KI, Nal,.
  • the triiodide solution is in particular taught as being made with a minimal (i.e. minor) water content just sufficient to avoid causing the I 2 to crystallize out; see example 1 of U.S. patent no. 3,923,665.
  • the resulting (solution) containing the triiodide ion is then contacted with the starting resin (under ambient conditions with respect to temperature (i.e. 25 to 30° C) and pressure) , the triiodide ions exchanging with the anion of the resin (e.g. exchange with chlorine, sulfate, etc., ..).
  • the starting resin is taught as being a porous granular strong base anion exchange resin having strongly basic groups in a salt form wherein the anion thereof is exchangeable with triiodide ions.
  • contacting is continued until the desired amount of triiodide has reacted with the strongly basic groups such that bacterially contaminated water is disinfected when passed through a bed of the obtained resin. After a suitable contact time the iodine/resin is (water) washed to remove water-elutable iodine from the resin product.
  • U.S. patent no. 4,238,477 teaches an alternate process whereby the iodine/resin may be produced.
  • a suitable resin in the iodide form (I " ) is contacted with water comprising diatomic iodine (I 2 ) in solution, the water being recycled between a source of a predetermined amount of diatomic iodine and the resin.
  • the process as taught by this latter patent is a relatively complicated system of pumps, vessels, heaters, etc.; by exploiting a fluidized bed, it in particular may lead to a significant degree of resin bead attrition, i.e. particle breakup.
  • iodine tincture for sterilising wounds.
  • the sterilisation effect of iodine tincture is short lived; this means that the tincture must be reapplied on a regular basis to maintain the sterilisation effect.
  • such solutions may also damage or destroy the tissue around the wound if applied too liberally and too often.
  • the direct application of such solutions to a lesion or wound is usually accompanied by a painful sensation.
  • lesions such as for example wounds or burns
  • lesions may be treated in order to facilitate healing by devitalising microorganisms which may already be in the area of the lesion and further to prevent microorganisms from having access, to such lesion (i.e. a dressing), i.e. to inhibit access from any outside biovectors such as for example airborne, waterborne, spiral borne, blood borne, particulate borne microorganisms and the like.
  • the present invention provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described) ,
  • a demand disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described)
  • the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form with a sufficient amount of an iodine-substance absorbable by the anion exchange resin such that the anion exchange resin absorbs said iodine-substance so as to convert the anion exchange resin to the disinfectant-resin, said iodine-substance being selected from the group comprising I 2 (i.e. diatomic iodine) and polyiodide ions having a valence of
  • At least a portion of the absorption of iodine-substance is effected at elevated temperature and at elevated pressure, said elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C such as, for example, 102° C, 103° C, 104° C, 105° C, 110° C, 115° C, 150° C, etc.), said elevated pressure being greater than atmospheric pressure (e.g. a pressure greater than barometric pressure such as for example 2 psig, 3 psig, 4 psig, 5 psig, 15 psig, 25 psig, 35 psig, 100 psig, etc.).
  • elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C such as, for example, 102° C, 103° C, 104° C, 105° C, 110° C, 115° C, 150° C, etc.)
  • said elevated pressure being greater than atmospheric pressure (e.g. a pressure greater than barometric pressure such as
  • the disinfectant- resin may be one in which diatomic iodine is incorporated.
  • the disinfectant polyiodide-resin may in particular be triiodide-resin.
  • the iodine-substance may comprise triiodide ion of formula I 3 " , i.e. so as to form a disinfectant-resin which comprises (absorbed) triiodide ions of formula I 3 ⁇ .
  • triiodide refers to or characterize a substance or a complex as containing three iodine atoms and which has a valence of -1.
  • the triiodide ion herein therefore is a complex ion which may be considered as comprising molecular iodine (i.e. iodine as I 2 ) and an iodine ion (i.e. I " ).
  • polyiodide refers to or characterize a substance or a complex as containing three iodine atoms and which has a valence of -1.
  • the triiodide ion herein therefore is a complex ion which may be considered as comprising molecular iodine (i.e. iodine as I 2 ) and an iodine ion (i.e. I " ).
  • polyiodide refers to or characterize a substance or a complex as containing three iod
  • polyiodide ions and the like, refer to or characterize a substance or a complex as having three or more iodine atoms and which may be formed if more of the molecular iodine combines with the monovalent triiodide ion. These terms are more particularly described in the above referred to U.S. patents.
  • the present invention provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described) , the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form other than the iodide form I " , with a sufficient amount of an iodine-substance absorbable by the anion exchange resin such that the anion exchange resin absorbs said iodine-substance so as to convert the anion exchange resin to the disinfectant- resin, said iodine-substance being selected from the group comprising polyiodide ions having a valence of -1, characterized in that for the conversion step at least a portion of the absorption of iod
  • the strong base anion exchange resin may be in a salt form such as for example a chloride or hydroxyl form.
  • the conversion in accordance with the present invention may essentially or at least partially be effected at said elevated temperature and elevated pressure.
  • the conversion, in accordance with the present invention may, thus for example, be effected in one, two or more stages.
  • the elevated pressure/temperature conditions may be divided between two different pairs of elevated pressure/temperature conditions, e.g. an initial pressure of 15 psig and a temperature of 121° C and a subsequent pressure of 5 psig and a temperature of 115° C.
  • the conversion may for example, comprise a first stage followed by a second stage.
  • the first stage may, for example, be effected at low temperature conditions (e.g. at ambient temperature and ambient pressure conditions) whereas the second stage may be effected at elevated conditions such as described herein.
  • the present invention in accordance with another aspect provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e.
  • a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described)
  • the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form with a sufficient amount of an iodine-substance absorbable by the anion exchange resin such that the anion exchange resin absorbs said iodine-substance so as to convert the anion exchange resin to the demand disinfectant resin, said iodine- substance being selected from the group comprising I 2 and polyiodide ions having a valence of -1, characterized in that said conversion step comprises an initial conversion stage followed by a second conversion stage, in that said initial conversion stage comprises contacting the anion exchange resin with the iodine-substance at a temperature of 100° C or lower so as to obtain an intermediate composition, said intermediate composition comprising residual absorbable iodine-substance and an intermediate
  • said second conversion stage comprises subjecting the intermediate composition to elevated temperature and elevated pressure, said elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C) , said elevated pressure being greater than atmospheric pressure.
  • the present invention provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described) , the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form other than the iodide form
  • iodinated strong base anion exchange resin i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described
  • said conversion step comprises an initial conversion stage followed by a second conversion stage, in that said initial conversion stage comprises contacting the anion exchange resin with the iodine-substance at a temperature of 100° C or lower so as to obtain an intermediate composition, said intermediate composition comprising residual absorbable iodine-substance and an intermediate iodinated resin (i.e.
  • said second conversion stage comprises subjecting the intermediate composition to elevated temperature and elevated pressure, said elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C) , said elevated pressure being greater than atmospheric pressure.
  • the low temperature may, for example, be a non-boiling temperature of not more than 95° C; e.g. 15 to 60° C; e.g. ambient temperature or room temperature such as a temperature of from about 15° C to about 40° C, e.g. 20 to 30° C.
  • the pressure associated with the low temperature condition of the first stage may, for example, be a pressure of from 0 (zero) to less than 2 psig; the pressure may in particular be essentially ambient pressure (i.e. a pressure of less than 1 psig to 0 (zero) psig; 0 psig reflecting barometric or atmospheric pressure) .
  • the elevated temperature may, for example, be: a temperature of 102° C or higher; e.g. 105° C or higher; e.g. 110° C or higher; e.g. 115° C or higher; e.g. up to 150° C to 210° C; e.g. 115° C to 135° C.
  • the elevated pressure associated with the elevated temperature condition of the second stage may, for example, be: a pressure of 2 psig or greater; e.g. 5 psig or greater; e.g. 15 psig to 35 psig; e.g. up to 100 psig.
  • the present invention further relates to any demand disinfectant resin, the disinfectant resin being an iodinated strong base anion exchange resin which is the same as an iodinated strong base anion exchange resin prepared in accordance with a process as defined herein; an iodinated resin the same as a resin prepared in accordance with the (particular) process described herein i ⁇ one which has the same low iodine bleed characteristic, i.e. the iodine is (more) tenaciously associated with the resin than for previously known iodinated resins. It in particular relates to a demand disinfectant resin, the disinfectant resin being an iodinated strong base anion exchange resin whenever prepared in accordance with a process as defined herein.
  • the present invention also relates to the use of iodinated resins to disinfect fluids containing microorganisms, such fluids including air, water, pus, and the like.
  • the iodinated resin may for example be a known resin such as discussed herein, a resin in accordance with the present invention, nylon based resin beads impregnated with iodine (such as MCV resin from MCV Tech. Intn'l Inc.) , and the like.
  • the present invention also provides a method for disinfecting air containing airborne microorganisms, said method comprising passing said air over a disinfectant resin such that airborne microorganisms contact said resin and are devitalized thereby, said disinfectant resin comprising an iodinated resin.
  • the disinfectant resin may, for example, be a demand disinfectant resin.
  • the disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin.
  • the present invention further provides a system for disinfecting air containing airborne microorganisms, said system comprising means for providing an air path for the movement of air therethrough, and a disinfectant resin disposed in said air path such that airborne microorganisms in air passing through said air path are able to be brought into contact with said resin and be devitalized thereby, said disinfectant resin comprising an iodinated resin.
  • the disinfectant resin may, for example, be a demand disinfectant resin.
  • the disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin.
  • the present invention additionally provides a combination comprising a disinfectant component and a carrier component, said disinfectant component comprising particles of an iodinated resin, said particles of said disinfectant component being held (e.g. fixed) to said carrier component.
  • the disinfectant component may, for example, be a demand disinfectant component.
  • the disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin.
  • the combination may be used as a means for providing a barrier or shield for the body against microorganisms.
  • the combination may thus, for example, be incorporated into a textile or other wearing apparel starting material in the form of a layer (e.g. a liner layer) .
  • the obtained raw wearing apparel material may then be used to make a protective garment, glove, sock, footwear (e.g. shoe) , helmet, face mask and the like; the obtained wearing apparel may be worn in hazardous environments to protect the wearer from contact with viable microorganisms.
  • the combination as desired or as necessary may flexible or stiff; depending on the nature of the carrier component and also on the form of the resin (e.g. plate, particle, etc.).
  • the present invention in a more particular aspect provides a sterilisation dressing, for being applied to a lesion, (such as a sore, a wound (e.g. cut) , an ulcer, a boil, an abrasion, a burn or other lesion of the skin or internal organ) , said dressing comprising a disinfectant component and a carrier component, said disinfectant component comprising particles of an iodinated strong base anion exchange resin, said carrier component being configured so as to hold onto particles of said disinfectant component such that microorganisms are able to be brought into contact with said particles and be devitalised thereby, said carrier component being of a pharmaceutically acceptable material.
  • the disinfectant component may, for example, be a demand disinfectant.
  • the disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin.
  • the carrier component may be stiff or it may be flexible as desired.
  • the (sterilization) dressing may, for example, be applied over a wound or burn and be held in place over the time period needed for the body to repair the damaged area; the dressing during this time will act not only as a barrier or shield to prevent infectious microorganisms from contacting the lesion but also to sterilize the immediate area around the lesion including sterilising any fluid exudate such as pus which may exude from the lesion.
  • it has, for example, been found that even with relatively prolonged exposure of (guinea pig) skin to the active element of the dressing (i.e. the demand disinfectant) no irritation or inflammation was noted.
  • the dressing may effect infectious agents deep beneath the skin or dressing.
  • the healing process may thus be hastened by the application of a (sterilization) dressing in accordance with the present invention.
  • the demand disinfectant for the above mentioned method and system for treating air as well as for the combination and the dressing may be an iodinated resin produced in accordance with the present invention or it may be a known demand disinfectant iodinated resin such as for example as mentioned herein.
  • the demand disinfectant depending on the intended use may take on any desired form; it may be bulk form; it may be in sheet form; it may be in particulate or granular form (e.g. particles of resin of from 0.2 mm to 1 cm in size), etc..
  • any specified range or group is to be understood as a shorthand way of referring to each and every member of a range or group individually as well as each and every possible sub-ranges or sub-groups encompassed therein; and similarly with respect to any sub-ranges or sub-groups therein.
  • a time of 1 minute or more is to be understood as specifically incorporating herein each and every individual time, as well as sub-range, above 1 minute, such as for example 1 minute, 3 to 15 minutes, 1 minute to 20 hours, 1 to 3 hours, 16 hours, 3 hours to 20 hours etc.;
  • g or "girt” is a reference to the gram weight unit; that "C” is a reference to the celsius temperature unit; and “psig” is a reference to “pounds per square inch guage”.
  • Figure 1 is a graph of showing the ppm of Iodine in the effluent versus the total volume of water contacted with a disinfectant-resin bed of the prior art and an example disinfectant resin of the present invention
  • Figure 2 i ⁇ a graph of the number of microorganisms in effluent versus the total volume of contaminated water contacted with a disinfectant re ⁇ in of the prior art and an example di ⁇ infectant re ⁇ in of the present invention
  • Figure 3 i ⁇ a per ⁇ pective view of a cartridge which may be used to house an iodinated resin a ⁇ described herein for use for example in a ga ⁇ mask
  • Figure 4 is a cros ⁇ ⁇ ectional view 4-4 of the cartridge of figure 1
  • Figure 5 i ⁇ a ⁇ chematic illustration of a system for testing a cartridge containing an iodinated re ⁇ in
  • Figure 6 i ⁇ a ⁇ chematic illu ⁇ tration of
  • Figure 8 is a perspective view of a band-aid type sterlization dressing, wherein the iodinated resin particles are fixed to a central portion of an outer ⁇ urface of a flexible band-aid carrier;
  • Figure 9 i ⁇ a per ⁇ pective partially cut away view of a ⁇ terili ⁇ ation foam or ⁇ ponge type dre ⁇ ing compri ⁇ ing a flexible foam matrix having iodinated re ⁇ in particle ⁇ di ⁇ per ⁇ ed therein, the foam matrix having a relatively small pore size structure;
  • Figure 10 is a perspective partially cut away view of a sterili ⁇ ation foam or ⁇ ponge type dre ⁇ ing compri ⁇ ing a flexible foam matrix having iodinated re ⁇ in particles disper ⁇ ed therein, the foam matrix having a relatively large pore size structure; and
  • Figure 11 is a cro ⁇ ⁇ ectional view of a ⁇ andwich type of textile material for u ⁇ e in the preparation of protective clothing, the textile including a layer of a flexible foam matrix ⁇ uch a ⁇ is shown in figure 10.
  • the elevated temperature may a ⁇ mentioned above, for example, be in the range of from 105° C to 150° C; the elevated pressure may be 5 psig and up.
  • the anion exchange re ⁇ in may, for example, as described below, be a quaternary ammonium anion exchange resin; the anion exchange resin may be in the chloride form Cl " , in the hydroxyl form OH " ; etc.
  • the obtained iodide- resin may be treated prior to use to remove any water- elutable iodine from the iodide-resin.
  • the treatment e.g. washing
  • the treatment may be continued until no detectable iodine is found in wash water (the wash water initially being ion free water) .
  • Any suitable (known) iodine te ⁇ t procedure may be u ⁇ ed for iodine detection purpo ⁇ e ⁇ ( ⁇ ee for example the above mentioned U.S. patent ⁇ .
  • the ab ⁇ orbable iodine ⁇ ub ⁇ tance may, for example, be provided by a compo ⁇ ition con ⁇ i ⁇ ting of mixture of KI, I 2 and a minor amount of water, the mole ratio of KI to I 2 initially being about 1; the expre ⁇ ion "minor amount of water" a ⁇ u ⁇ ed herein ⁇ hall be under ⁇ tood a ⁇ characterizing the amount of water a ⁇ being sufficient to avoid I 2 crystallization.
  • the pre ⁇ ent invention in a further aspect provides an enhanced iodine/resin demand di ⁇ infectant product in which more iodine may be distributed throughout and be more tenaciously as ⁇ ociated with the re ⁇ in (e.g. bead ⁇ ) than with the previou ⁇ ly known or commercially available techniques, the disinfectant being produced by a proces ⁇ a ⁇ described herein.
  • the invention more particularly provides an enhanced triiodide-resin disinfectant.
  • the present invention can be practised with any (known) ⁇ trong ba ⁇ e anion exchange re ⁇ in (for example, with those such as are described in more detail in the above-mentioned United States patents such as United States patent no 3,923,665) .
  • a quaternary ammonium anion exchange resin is, however, preferred.
  • the expres ⁇ ion "strong base anion exchange re ⁇ in” de ⁇ ignate ⁇ a cla ⁇ of re ⁇ in ⁇ which either contain strongly basic "cationic" groups, such as quaternary ammonium groups or which have strongly ba ⁇ ic propertie ⁇ which are ⁇ ubstantially equivalent to quaternary ammonium exchange resin ⁇ .
  • United State ⁇ patent no ⁇ United State ⁇ patent no ⁇ .
  • 3,923,665 and 3,817,860 identify a number of commercially available quaternary ammonium re ⁇ in ⁇ , a ⁇ well a ⁇ other ⁇ trong base resin ⁇ including tertiary ⁇ ulphoniu re ⁇ in ⁇ , quaternary phosphonium resins, alkyl pyridinium resin ⁇ and the like.
  • quaternary ammonium anion exchange resins which can be used in accordance with the present invention include in particular, Amberlite IRA-401 S, Amberlite IR-400 (Cl “ ) , Amberlite IR-400 (OH “ ), Amberlite IR- 402 (Cl “ ) , etc., (from Rohm & Hass) which may be obtained in granular form.
  • These resins may for example, contain quaternary ammonium exchange groups which are bonded to styrene-divinyl benzene polymer chains.
  • the resin ⁇ which may be u ⁇ ed herein may be in a hydroxyl form, a chloride form or in another salt (e.g. sulphate) form provided that the anion is exchangeable with the iodine member (e.g. with triiodide ion) .
  • the starting resin may, for example, be granular (i.e. comprise a plurality of particles) ⁇ uch that the final product will likewise have a granular or particulate character; the granular form is advantageous due to the high surface area provided for contact with microorganisms.
  • the starting resin may, for example, comprise granule ⁇ having a size in the range of from 0.2 mm to 0.8 cm (e.g. of from 0.35 mm to 56 mm) .
  • resins are available in the salt form (e.g. as the chloride) and in the form of porous granular beads of various me ⁇ h sizes; the resin may of course be used in a bulk or massive form such a ⁇ a plate, ⁇ heet, etc..
  • a resin may be converted from a non-iodide form (e.g. a chloride form, a ⁇ ulphate form) to the I 3 " form.
  • Suitable halide ⁇ alt ⁇ include alkali metal halides (such as KI, Nal,...); potassium iodide is preferred.
  • an iodide form of the resin may be u ⁇ ed and the resin contacted with a source of diatomic iodine.
  • any material or substance capable of donating an iodine-member absorbable by the anion exchange resin so as to convert the anion exchange resin to the desired polyiodide-resin may be used, as long as the denotable iodine-member thereof is a polyiodide ion having a valence of -1 and/or diatomic iodine.
  • Examples of such materials in relation to iodine are shown in the above mentioned U.S. patents; e.g. compositions comprising iodine (I 2 ) and alkali metal halide (KI, Nal, etc., KI being preferred) in a ⁇ ociation with water.
  • the re ⁇ in is in an iodide ⁇ alt form (I '1 )
  • the material may compri ⁇ e the corre ⁇ ponding iodine in ga ⁇ eous form.
  • the re ⁇ in may be contacted with an alkali metal iodide/I 2 mix wherein the iodide and the diatomic iodine are present in more or less stoichiometric amount ⁇ (i.e. a mole ratio of 1) ; see the previously mentioned U.S. patents.
  • stoichiometric amounts of the iodine ion and iodine molecule i.e. one mole of I 2 per mole of I "1
  • the iodide sludge will compri ⁇ e ⁇ ub ⁇ tantially only the triiodide ions.
  • stoichiometric exces ⁇ quantities of I 2 are used some of the higher polyiodide ion ⁇ may be formed.
  • no more than the ⁇ toichiometric proportion ⁇ of I " and I 2 are u ⁇ ed in the initial aqueou ⁇ ⁇ tarting sludge so that sub ⁇ tantially only triiodided attache ⁇ to the re ⁇ in.
  • iodine may be combined with sodium, pota ⁇ ium or ammonium iodide and some water.
  • the composition will contain monovalent iodine ion which will combine with diatomic iodine (I 2 ) to form polyiodide ion.
  • I 2 diatomic iodine
  • the molar ratio of iodine ion to diatomic iodine will dictate the nature of the polyiodide ion present , i.e. triiodide ion, mixtures of triiodide ion and other higher polyiodides ion ⁇ , pentaiodide ion, etc....
  • the determination of the (total) amount of iodine to be contacted with the resin, re ⁇ idence time ⁇ etc., will depend upon such factors as the nature of the polyiodide it is desired to introduce into the structure of a resin; the nature of the ⁇ tarting re ⁇ in (i.e. porosity, grain ⁇ ize, equivalent exchange capacity of the re ⁇ in, etc.), etc.. Thu ⁇ , for example, to determine the amount of iodine required to prepare a polyiodide resin, the equivalent exchange capacity of the resin needs to be known. If necessary, this can be readily determined for example by the procedure de ⁇ cribed in U.S. patent no. 3,817,860 (column 9, lines 15 to 28) .
  • the components of the proce ⁇ may be cho ⁇ en ⁇ uch that the obtained iodinated ⁇ trong ba ⁇ e anion exchange resin may comprise a ⁇ trong base anion exchange resin component which repre ⁇ ents from 25 to 90 (preferably 45 to 65) percent by weight of the total weight of the obtained iodinated resin.
  • the conver ⁇ ion at elevated condition ⁇ in accordance with the present invention, may be effected in a reactor which is pressure sealable during conversion but which may be opened for recovery of the re ⁇ in product after a predetermined reaction time.
  • the proce ⁇ may thu ⁇ be a batch proce ⁇ s wherein conversion at elevated temperature and pres ⁇ ure i ⁇ effected once the reactor i ⁇ ⁇ ealed.
  • the reactor may be ⁇ ized and the amount of reactant ⁇ determined ⁇ o a ⁇ to provide a void space in the reactor during reaction.
  • the weight ratio of sludge to resin may be 1:1 or higher, eg. 1:1 to 5:1; a weight ratio of 1:1 (if Amberlite 401-S i ⁇ u ⁇ ed a ⁇ the re ⁇ in) i ⁇ preferred so a ⁇ to minimize the amount of unab ⁇ orbed iodine which mu ⁇ t be wa ⁇ hed from the iodine/re ⁇ in product.
  • the high temperature/pre ⁇ sure contact conditions may a ⁇ mentioned above be cho ⁇ en with a view to maximizing the iodine content of the obtained iodine (e.g. iodine) demand resin.
  • conversion of the resin to a polyhalide (e.g. I 3 " ) form may be effected at elevated temperature greater than 100° C, for example in the range of 105° C to 150° C (e.g. 110-115° C to 150° C) ; the upper limit of the temperature used will, for example, depend on the characteri ⁇ tics of the resin being used, i.e. the temperature should not be so high a ⁇ to degrade the re ⁇ in.
  • the conversion may take place in a clo ⁇ ed vessel or reactor.
  • the temperature of the system may therefore be used as a means of achieving or controlling the (desired) pres ⁇ ure in the vessel depending upon the makeup of the Iodine mix in the reactor.
  • a reaction mix di ⁇ po ⁇ ed in a pre ⁇ ure ⁇ ealed reactor may be, for example, ⁇ ubjected to a temperature of 105° C and a pressure of 200 mmHg, the pres ⁇ ure being induced by steam.
  • a relatively inert gas may be used to induce and ⁇ or augment the pressure in the reactor.
  • a pres ⁇ urized relatively inert ga ⁇ may be injected into a sealed reactor.
  • the chosen ga ⁇ mu ⁇ t not unduly interfer with the production of a ⁇ uitable iodinated re ⁇ in.
  • the high temperature/pressure treatment may be conducted in a clo ⁇ ed reactor in the pre ⁇ ence of (trapped air) , a non-interfering ga ⁇ ⁇ uch a ⁇ iodine it ⁇ elf or of ⁇ ome other relatively inert (noble) ga ⁇ ; the pressure as mentioned above may be augmented by the pres ⁇ uring gas.
  • Air, carbon dioxide, nitrogen or the like may also be u ⁇ ed as a pres ⁇ uring ga ⁇ , if de ⁇ ired, keeping in mind, however, that the u ⁇ e thereof must not unduly interfer with the production of a suitable iodinated resin. If pressure is to be induced by steam then as mentioned below ⁇ teps should be taken to isolate the reaction mix from (exce ⁇ s) water.
  • the elevated pressure is any pre ⁇ ure above ambient.
  • the pre ⁇ sure may, for example, be 1 psig or higher, e.g in the range from 5 to 50 psig; the upper limit of the pres ⁇ ure u ⁇ ed will also, for example, depend on the characteristics of the resin being used, i.e. the pres ⁇ ure ⁇ hould not be ⁇ o high a ⁇ to degrade the re ⁇ in.
  • the residence or contact time at the elevated conditions is variable depending upon the starting materials, contact conditions and amount of (tenaciou ⁇ ly held) iodine it i ⁇ de ⁇ ired to be ab ⁇ orbed by the anion exchange re ⁇ in.
  • the contact time may thu ⁇ take on any value; u ⁇ ually, however, it i ⁇ to be expected that it will be desired that the contact time (under the conditions used) be sufficient to maximize the amount of (tenaciously held) iodine absorbed from the material containing the absorbable iodine moiety.
  • the re ⁇ idence time may for example be a ⁇ little a ⁇ 5 to 15 minute ⁇ (in the ca ⁇ e where a preimpregnation ⁇ tep i ⁇ u ⁇ ed a ⁇ ⁇ hall be described below) or several hour ⁇ or more ( up to 8 or 9 hours or more) .
  • the residence time exploited for elevated the conditions, in any event, will a ⁇ mentioned above depend on the ⁇ tarting material, temperature and pre ⁇ ure conditions, etc... ; it may vary from several minutes to 8 or 9 hours or more; the upper time limit will in any event also, for example, depend on the characteristics of the resin being used, i.e. the residence time should not be so high as to degrade the resin.
  • the contact at high temperature/pres ⁇ ure i ⁇ preceded by an initial impregnation or absorption step may be carried out for only a few minutes (e.g. for from 1 to 10 minutes or more) or for up to 24 hour ⁇ or more (e.g. for from one hour or more i.e. for from three to twenty-four hour ⁇ ) .
  • the time period of the initial stage may be relatively short. The time period, for example, may be a few minutes or ⁇ o and may correpond to the time necessary to just mix the reactant ⁇ together; in thi ⁇ ca ⁇ e the conver ⁇ ion may be considered to be essentially carried out in a single stage at elevated conditions.
  • the residence time of the first stage will also be predetermined with a view to the end product resin desired.
  • a water containing sludge of triiodide ions can be contacted with a salt form of the starting resin at ambient (i.e. room) temperature and pressure conditions to obtain an intermediate iodide-re ⁇ in reaction product including residual iodine- substance.
  • This step is preferably carried out in a batch reactor; the obtained intermediate compo ⁇ ition comprising an intermediate iodide-re ⁇ in may then be ⁇ ubjected to the higher temperature and pre ⁇ ure in accordance with the present invention in batch fashion as well.
  • Such a first stage may be used to initiate buildup of iodine within the resin matrix.
  • an iodide-resin demand disinfectant may, for example, be obtained by a) bringing a porou ⁇ , granular, ⁇ tarting re ⁇ in into contact with an aqueous sludge of iodine and potas ⁇ ium iodide ⁇ o a ⁇ to obtain a pa ⁇ te mixture, iodine being pre ⁇ ent in the ⁇ ludge e ⁇ entially as triiodide ions, ⁇ aid ⁇ tarting resin being a strong base anion exchange resin having strongly basic groups thereof in a salt form the anion of which is exchangeable with triiodide ions, b) subjecting the paste mixture to elevated temperature and pressure conditions in an enclosed container or reactor (e.g.
  • deioni ⁇ ed water R/O water (at 45° C) , etc.) to remove water elutable iodine ⁇ uch a ⁇ KI from the surface of the resin so that on drying no iodine (KI) crystal ⁇ will form on the surface of the iodine/resin;
  • R/O water is water obtained using double rever ⁇ e o ⁇ mo ⁇ i ⁇ . R/O water is defined below.
  • iodide/resin demand di ⁇ infectant may be obtained using the following sequence of step ⁇ :
  • the resin is admixed with the above-minimal water slurry in small aliquats so as to obtain a predetermined weight ratio of slurry to re ⁇ in (e.g. a 50:50 weight ratio) ;
  • the re ⁇ in-slurry mixture is then placed in a ⁇ haking bath at atmo ⁇ pheric pressure in a closed, air- tight container (if nece ⁇ ary the container being provided with a ⁇ mall pre ⁇ ure relea ⁇ e valve or opening the purpo ⁇ e of which will be hereinafter explained) for a predetermined time period (e.g. for up to, for example, ⁇ ixteen to twenty-four hour ⁇ or more [e.g. a week if de ⁇ ired]) to form an intermediate re ⁇ in compo ⁇ ition;
  • a predetermined time period e.g. for up to, for example, ⁇ ixteen to twenty-four hour ⁇ or more [e.g. a week if de ⁇ ired]
  • high temperature e.g. 120° C
  • a small hole is neces ⁇ ary when a container such as a glass flask is used in order to avoid a too great pre ⁇ sure difference being built up between the interior of the flask and the interior of the autoclave which might cause the flask to collapse.
  • the hole in any event is ju ⁇ t large enough to more or le ⁇ allow for the equalization of pre ⁇ ure and to maintain a po ⁇ itive pres ⁇ ure in the flask relative to the interior of the autoclave such that any foreign material such a ⁇ water vapour is inhibited from flowing into the flask.
  • a more ⁇ turdy pre ⁇ ure re ⁇ istant container could of course be used such that, depending on the construction of the container and the temperature/pre ⁇ ure condition ⁇ prevailing in the autoclave, the hole may be avoided.
  • a single autoclave/container may be u ⁇ ed serving to hold and heat the reaction mix under pres ⁇ ure; such a container mu ⁇ t of course be constructed so as to be able to resist the predetermined reaction conditions.
  • the iodide-resin compound formed as described herein can be used as a demand disinfectant to di ⁇ infect water by batch contacting the contaminated water with the re ⁇ in; continuou ⁇ proce ⁇ ing as mentioned in United States patent no 3,923,665 is also possible.
  • water containing viable bacteria (to be killed) may be pa ⁇ ed through a fixed bed of porous granular iodine/resin material.
  • the maximum permis ⁇ ible flow rate ⁇ for total bacterial ⁇ terilization may vary with the concentration of the polyiodide (e.g. triiodide) group ⁇ in the resin, bed depth, bacterial count, etc...
  • the disinfection process may be monitored by taking sample ⁇ of water after pa ⁇ sage through the bed.
  • Potable innocuous water may thus be readily produced in accordance with the present invention without the incorporation of objectionable amount ⁇ of free iodine therein as a result.
  • the resin may be used with any (known) water treating devices such as for example those shown in U.S. patent nos. 4,749,484 and 4,978,449.
  • the present invention also provide ⁇ a method for disinfecting air containing airborne microorganism ⁇ .
  • the method may comprise pas ⁇ ing the air over a demand di ⁇ infectant resin such that airborne microorganisms contact said resin and are devitalized thereby, the demand disinfectant re ⁇ in comprising an iodinated strong ba ⁇ e anion exchange re ⁇ in.
  • the method may, for example, include passing the air through a bed of granules of iodinated resin so that the air course ⁇ over the granules (in a serpentine manner) a ⁇ the air make ⁇ it ⁇ way through the bed.
  • the maximum permissible flow rates for total bacterial sterilization may vary with the concentration of the polyiodide groups in the resin, bed depth, bacterial count, etc...
  • the iodinated strong base anion exchange resin may comprise a strong ba ⁇ e anion exchange re ⁇ in component which repre ⁇ ents from 25 to 90 (preferably 45 to 65) percent by weight of the total weight of the iodinated resin.
  • the pre ⁇ ent invention provide ⁇ a system for disinfecting air containing airborne microorganisms, said ⁇ y ⁇ tem, for example, comprising means for providing an air path for the movement of air therethrough, and a demand di ⁇ infectant re ⁇ in di ⁇ po ⁇ ed in ⁇ aid air path ⁇ uch that airborne microorgani ⁇ ms in air passing through said air path are able to be brought into contact with ⁇ aid resin and be devitalized thereby, said demand disinfectant comprising an iodinated strong ba ⁇ e anion exchange re ⁇ in.
  • An air path means may define an air inlet and an air outlet.
  • the resin may be dispo ⁇ ed between said inlet and outlet or be dispo ⁇ ed at the inlet or outlet.
  • the air path mean ⁇ may take any form. It may take the form of ductwork in a forced air ventilation system with the demand disinfectant comprising a bed of re ⁇ in granule ⁇ through which the air i ⁇ made to pa ⁇ , the bed otherwi ⁇ e blocking off the air path.
  • the air path mean ⁇ may be defined by a cartridge u ⁇ ed for a gas mask, the cartridge having an inlet and an outlet for air; the iodinated re ⁇ in for the cartridge may, if de ⁇ ired, be pre ⁇ ent a ⁇ a bed of granule ⁇ , granule ⁇ incorporated into a (fluid) porou ⁇ carrier (e.g. tissue, polyurethane foam, etc.) or alternatively take a more mas ⁇ ive form such as a plate( ⁇ ), a tube(s), a block(s), etc.
  • Cartridge type gas mask ⁇ are known; ⁇ uch ga ⁇ ma ⁇ k ⁇ may be obtained for example from Eastern Safety Equipment Co., Mosport, New York, USA.
  • the C-50 cartridge from a gas mask may for example be adapted to hold a bed of re ⁇ in of granules of the present invention.
  • the cartridge 1 compri ⁇ e ⁇ an a hollow, open ended, thi-walled, tubular body of circular cro ⁇ ⁇ ection.
  • the wall 2 may for example be of nylon.
  • the open end ⁇ of the cartridge are each blocked off by some suitable me ⁇ h like support material 3 (e.g. 10 micron polypropylene mesh) which is held in place in any suitable known manner such a ⁇ by glues, spring clip, etc.
  • the iodinated granular resin bed 4 occupies the entire space between the me ⁇ h supports 3 and 3 * ; although the granular resin is more or less tightly packed between the mesh ⁇ upport ⁇ 3 and 3 ' , there are ⁇ till air spaces between the granules for the passage of air through the granular bed.
  • the mesh support ⁇ each have opening ⁇ ⁇ mall enough to retain the iodinated resin in place while allowing air to pass therethrough into the and through the supported resin bed 4.
  • the cartridge as shown in figure 4 may include a downstream bed 5 of granules of activated carbon, catalyst, or iodine absorbent resins, to scavenge any iodine liberated from the iodinated resin 4.
  • the activated carbon bed 5 i ⁇ held in place by a me ⁇ h support 3' and an additional mesh 6.
  • the bed depth of the resin and carbon is shown as about 2.5 cm; wheras the bed diameter is about 8 cm.
  • the carbon bed may be omitted, i.e. only the iodinated resin bed 4 may be present in the cartridge as the active component (in the examples below, unless the contrary is indicated, the cartridge ⁇ do not include any carbon bed) ; in thi ⁇ ca ⁇ e the bed depth may, for example, be le ⁇ s 2.5 cm, e.g. 0.1 cm, 0.25 cm, 0.5 cm, 0.85 cm, 1.15 cm, etc..
  • Such a cartridge may be disposed in an air path as shown for example in figure ⁇ 5 and 6 which will be di ⁇ cu ⁇ ed below.
  • the re ⁇ in di ⁇ posed in the air path could of course take on any form other than granule ⁇ ⁇ uch as blocks, plates, tubes etc.
  • the iodinated demand disinfectant resin for air treatment may be any (known) iodinated resin so long as the iodinated re ⁇ in i ⁇ capable of devitalizing airborne microorganisms (i.e. microorganism ⁇ tran ⁇ ported by air) coming into contact therewith. It may, for example, be a re ⁇ in as proposed in U.S. patent nos.
  • the iodine scavenging material may be an activated carbon material or an un-iodinated strong ba ⁇ e anion exchange re ⁇ in a ⁇ de ⁇ cribed herein.
  • iodinated resin may advantageously be a resin made in accordance with the pre ⁇ ent invention; in thi ⁇ ca ⁇ e the re ⁇ in need not be u ⁇ ed in conjunction with an iodine ⁇ cavenging material ⁇ uch as a (known) exchange resin, activated carbon, catalyst, etc. , since an iodinated resin made in accordance with the proces ⁇ of the pre ⁇ ent invention may liberate iodine into the air in an amount below acceptable thre ⁇ hold limits for breathing by human beings.
  • the iodinated re ⁇ in for the treatment of air or water may be ⁇ ome type of mixture of iodinated re ⁇ in ⁇ , e.g. a mixture of a known iodinated re ⁇ in and an iodinated re ⁇ in prepared in accordance herewith.
  • the pre ⁇ ent invention in a further a ⁇ pect provides a combination which may act as a sterilization barrier with respect to microorgani ⁇ ms.
  • the sterilization combination may, for example, be incorporated into protective wearing apparel or be configured a ⁇ a ⁇ terilization dre ⁇ ing for le ⁇ ions such as for example, wounds and burns; the ⁇ terilisation barrier combination can be configured to be or not to be air breathable.
  • a sterilization dressing of the present invention advantageously may take the form of a flexible porou ⁇ cellular polymeric foam ⁇ heet having a spongy aspect and having dispersed within the polymeric matrix thereof particles of a demand disinfectant comprising a (known) iodinated re ⁇ in or an iodinated resin as de ⁇ cribed herein.
  • the ⁇ terilization ⁇ heet may be placed over a burn area to maintain the burn area in a ⁇ terilized ⁇ tate during the healing proce ⁇ .
  • the di ⁇ infectant particle ⁇ are di ⁇ tributed throughout the polymeric matrix and have ⁇ urface ⁇ projecting into the open pore ⁇ of the ⁇ pongy matrix; the ⁇ pongy matrix acts as a sponge so that on the body side thereof it can soak up fluid ⁇ uch a ⁇ pu ⁇ which exude from the burn le ⁇ ion.
  • any microorganisms in the fluid or pus can contact the di ⁇ infectant re ⁇ in particle ⁇ and become devitalized a ⁇ a re ⁇ ult.
  • any microorgani ⁇ ms on the opposite side of the sterilization barrier which attempt to pass through the barrier are also subject to being contacted with the di ⁇ infectant and are also devitalised.
  • a (flexible) phamaceutically acceptable hydrophilic foam matrix may be obtained by reacting water with HYPOL foamable hydrophilic polyurethane polymer; the HYPOL polymer starting material may be obtained from .R. Grace & Co. Lexintington Mass. U.S.A.. Water reacts to cross link the HYPOL polymer; if water is added quickly or at relatively high temperature foaming occurs and a foam product is obtained.
  • the carrier component may, as necessary, also be oil or fat loving, e.g. for dealing with individuals with high cholesterol levels.
  • the iodinated resin for the sterili ⁇ ation combination may be some type known iodinated resin, a resin prepared in accordance herewith, or a mixture of iodinated resins, e.g. a mixture of a known iodinated resin and an iodinated re ⁇ in prepared in accordance herewith.
  • the ⁇ tarting materials may have to be treated to remove components which may interfer with the absorption of the halide into the resin.
  • Water if present in the initial reaction mix should be free of interfering elements such as interfering ions. Distilled or ion free water is preferably used for washing.
  • Iodine method mercuric chloride added to aqueous elemental iodine ⁇ olutions causes complete hydrolysis of iodine and the stoichiometric production of hypoiodou ⁇ acid.
  • the compound 4, 4', 4" methylidynetri ⁇ (leuco crystal violet) reacts with the hypoiodous acid to form cry ⁇ tal violet dye.
  • the maximum absorbance of the crystal violet dye ⁇ olution i ⁇ produced in the Ph range 3.5-4.0 and mea ⁇ ured at a wavelength of 592 nm.
  • the ab ⁇ orbance follows beers' law over a wide range of iodine concentration. Iodine can be mea ⁇ ured in the pre ⁇ ence of max. 50 PPM iodide ion ⁇ without interference.
  • Iodide method iodide is selectively oxidized to iodine by the addition of potas ⁇ ium peroxymono ⁇ ulfate. The iodine produced react ⁇ in ⁇ tantaneously with the indicator reagent leuco crystal violet over the same conditions described previously for iodine methods. Total iodine + iodide results from this procedure and iodide is calculated from substraction of iodine concentration.
  • Readings were performed on a lkb spectrophotometer with a lightpath of 1 cm and selected at 592 nm.
  • the resin is water wa ⁇ hed to remove unde ⁇ irable element ⁇ such as material in ionic form. Thu ⁇ , 100.00 grams of Amberlite 401 S and 200 ml of R/O water are placed in an erlenmyer of 1000 ml. The mixture is shaken for about 3 minute ⁇ and the water i ⁇ then ⁇ eparated from the re ⁇ in by drip filtration u ⁇ ing a wathman filter paper and funnel. The re ⁇ in i ⁇ water wa ⁇ hed in the ⁇ ame fa ⁇ hion two more time ⁇ . After the la ⁇ t water wa ⁇ h the resin is drip dried (i.e. again using a wathman filter paper and funnel) for 15 minutes.
  • the ⁇ o recovered water washed resin is subjected to an alcohol wash to dis ⁇ olve unde ⁇ irable organic material which may be stuck on the resin. Thu ⁇ , the water washed resin is immersed in 300.00 ml of ethanol. The re ⁇ in alcohol mixture i ⁇ ⁇ haken in an ultrasonic bath (Crest ultrasonic:1000 Watts - 20 liter capacity) for 5 minute ⁇ . The alcohol washed resin is drip dried, again using a wathman filter paper and funnel. The "fi ⁇ h" smell i ⁇ removed from the alcohol wa ⁇ hed resin by a final water washing stage wherein the wash R/O water is preheated to 40 degree ⁇ cel ⁇ ius.
  • the alcohol washed resin is placed in an erlenmyer fla ⁇ k (1000 ml) and 250 ml of R/O water at 40 degree ⁇ cel ⁇ ius is added thereto.
  • the water-resin mixture is shaken in a shaking bath (Yamata shaking bath - 1 impulse per ⁇ econd/water at 32 degrees celsius) for 5 minutes; the water is then removed from the resin by drip drying a ⁇ mentioned above.
  • the water wash is repeated once more and the resin is drip dried (for 1 hour) as mentioned above.
  • a mixture of iodine (I 2 ) and pota ⁇ sium iodide (KI) i ⁇ prepared by mixing together, in an erlenmyer fla ⁇ k, 60.00 grams of iodine and 40.00 grams of potassium iodide (in both case ⁇ on a dry weight ba ⁇ i ⁇ ) . Thereafter R/O water is admixed slowly drop by drop with the mixture until a metallic looking sludge i ⁇ obtained (e.g. with the addition of about 5.00 grams of water). The obtained iodine/potassium iodide sludge i ⁇ then ready for use in example 2 hereinbelow.
  • aqueous iodine sludge as obtained above, is placed in a 500.00 ml Erlenmyer flask and is slowly heated to, and maintained at 40 degrees celsius for a few minute ⁇ . Once the temperature of the sludge reaches 40° C, the washed resin, obtained a ⁇ above, i ⁇ slowly admixed with the iodine sludge in 10.00 gram portions every 8 minutes until all of the washed resin is within the erlenmyer flask.
  • the temperature of the water in the shaking bath is maintained at about 20 degrees celsiu ⁇ during thi ⁇ time period.
  • the Erlenmyer flask is ⁇ ized ⁇ uch that at the end of this (initial) impregnation step, it is only 50% filled with the in proces ⁇ resin, etc, i.e. there is a void volume above the impregnation mix.
  • EXAMPLE 3 ELEVATED PRESSURE/TEMPERATURE TREATMENT
  • the Erlenmyer flask i ⁇ disposed within a (steam pressure) autoclave along with a suitable amount of water.
  • the autoclave (pre ⁇ ure) ⁇ ealed about the fla ⁇ k, the autoclave i ⁇ heated.
  • the (raw) disinfectant of Example 3 is removed from the autoclave Erlenmyer flask and placed in another 2000 ml Erlenmyer fla ⁇ k. 1400 ml of R/O water at 20 degree ⁇ Cel ⁇ ius is admixed with the resin in the flask and the slurry is shaken manually for 3 minutes. The wash water is thereafter removed from the flask by decantation. This wash step is repeated 7 more time ⁇ . The entire wa ⁇ h cycle i ⁇ repeated twice (i.e. eight water washes per cycle) but using water at 45 degrees Cel ⁇ ius for the next wash cycle and then with water at 20 degrees Celsiu ⁇ for the last wash cycle. The washed iodine- resin i ⁇ then ready to use.
  • Iodinated resin manufactured in accordance with the present invention i.e. as obtained from example 4 above.
  • Iodinated resin manufactured in accordance with teachings of the prior art i.e. U.S. patent no. 3,923,665
  • namely as obtained from example 2 above after suitable washing to remove elutable iodine.
  • the re ⁇ in ⁇ were examined in a drip dried ⁇ tate, i.e. the re ⁇ in ⁇ were u ⁇ ed after being drip dried u ⁇ ing wathman filter paper and a funnel (for a 5 minute dry period) .
  • the resin in accordance with the present invention i.e resin I-A
  • Re ⁇ in Size (ie. approximate effective diameter size) - lowest to highest
  • the re ⁇ pective test solution ⁇ were allowed to pa ⁇ downwardly through each of the resins in the same fashion and at the ⁇ ame flow rate (i.e. the te ⁇ t condition ⁇ were the same for each resin) .
  • the test ⁇ were carried out at ambient condition ⁇ of temperature and pre ⁇ ure.
  • the microorgani ⁇ m ⁇ and te ⁇ t re ⁇ ult ⁇ were a ⁇ follow ⁇ : a) A lyophilized ⁇ train of KLEBSIELLA TERRIGENA
  • a test solution containing KLEBSIELLA TERRIGENA (A.T.C.C. 33257) at an initial concentration of 4.8 X 10 7 per 100 ml was pas ⁇ ed through the fixed bed of each re ⁇ in at a flow rate of 125 ml/min to 200 ml/min.
  • the treated volume of solution for each resin was 150 liters in total. Sampling of the effluent or treated ⁇ olution wa ⁇ effected at interval ⁇ corre ⁇ ponding with a predetermined percentage of the te ⁇ t portion ⁇ having pa ⁇ ed through the re ⁇ in ⁇ .
  • the re ⁇ ults are shown in Table 6a below:
  • the assay technique consi ⁇ ted of inoculating healthy BGM cell ⁇ with a ⁇ mall amount of filtered water at regular interval ⁇ . If a viru ⁇ particle were pre ⁇ ent, a plaque would be observed on the cellular bed thru the gellified maintenance media which contained a vital stain.
  • the re ⁇ ult ⁇ are ⁇ hown in Table 6b below:
  • the a ⁇ ay technique ⁇ were ⁇ imilar to tho ⁇ e u ⁇ ed for polioviru ⁇ , only the cell type and vital ⁇ tain changed ⁇ ince they are ⁇ pecific for each type of virus. The same sampling strategy was applied.
  • a test solution containing Rotavirus (A.T.C.C VR-59) at an initial concentration of 1 X 10 7 per 100 ml was passed through the fixed bed of each resin at a flow rate of 125 ml/min to 200 ml/min.
  • the treated volume of solution for each resin was 150 liter ⁇ in total. Sampling of the effluent or treated ⁇ olution wa ⁇ effected at interval ⁇ corre ⁇ ponding with a predetermined percentage of the te ⁇ t portions having passed through the resins.
  • Table 6c The results are shown in Table 6c below:
  • the bacteriocidal longevity of the Resin I-A and Resin I-D were determined for purpose ⁇ of compari ⁇ on.
  • Two fixed resin bed devices were provided, one device loaded with one of the resins and the other device loaded with the other resin; each device was loaded with 75.00 grams of a respective resin.
  • the tests for each resin bed were conducted simultaneously.
  • the ⁇ olution to be treated was passed therethrough at a flow rate of 2.0 litres per minute, with an initial concentration of Kleb ⁇ iella Terrigena 1 X 10 7 cfu/100 ml.
  • the volume of contaminated solution at which bacteria start to pas ⁇ through the prior art re ⁇ in i.e. Re ⁇ in I-D
  • the breakthrough volume for the resin of the pre ⁇ ent invention i.e. Resin I-A
  • the bacteriocidal activity of the disinfectant resin of the present invention is superior to that of the known resin (Resin I-D), i.e. the Resin I-A has about a 16% ⁇ uperior antimicrobial activity in relation to the amount of water treatable by a given amount of disinfectant resin.
  • Resin I-A' An iodinated re ⁇ in (Resin I-A') wa ⁇ prepared following the procedure ⁇ of examples 1 to 4 except that for the resin, Amberlite IR-400 (OH " ) (wa ⁇ u ⁇ ed and for the procedure of example 3 the elevated temperature and pre ⁇ ure condition ⁇ were ⁇ et at 121° C and 15 p ⁇ ig re ⁇ pectively.
  • EXAMPLE 10 COMPARATIVE IODINE CONTENT IN EFFLUENT AIR
  • Each cartridge contained 50.0 grammes of dry (granular) resin (i.e. and no activated carbon bed) .
  • One cartridge contained Resin I-A' and the other contained Re ⁇ in I-D.
  • the cartridge ⁇ were each disposed in a sy ⁇ tem as illustrated in figure 5 but which did not contain any atomizer indicated generally by the reference number 7.
  • the system included a housing 8 for defining an air path and had an air inlet 9.
  • the resin cartridge 1 wa ⁇ disposed at the outlet of the air path.
  • the air leaving the cartridge 1 was directed by appropriate tubing to a collector station 10.
  • the sy ⁇ tem included a vacuum pump 11 (but not the air sterilizer sy ⁇ tem 12) for drawing air from inlet 9 through the ⁇ y ⁇ tem. In operation a cartridge 1 wa ⁇ releasably placed in position
  • each, cartridge was ⁇ ubmitted to an air velocity therethrough of 0.7 Liter/per minute for a period of 50 minute ⁇ .
  • the collector ⁇ tation 10 included 50 ml purified R/O water (the water was then subjected to standard optical coloration technique ⁇ (i.e. the Leuco violet technique a ⁇ referred to in example 5.4 above), to determine the total iodine content) .
  • T.L.V. threshold limit value
  • the iodine T.L.V. is 1.0 Mg/m 3 for air analysis for human breathing during a period of 8 hrs.
  • the Re ⁇ in I-A' (of the pre ⁇ ent invention) relea ⁇ e ⁇ iodine at a level well below the T.L.V.
  • the Resin I-A 1 could thus be used without an iodine scavenger; thi ⁇ would, for example, simplify the construction of a ga ⁇ ma ⁇ k cartridge.
  • the known Re ⁇ in I-D on the other hand could also be used but it would require some sort of iodine scavenger (e.g. activated carbon) to obtain the necessary iodine T.V.L. level.
  • EXAMPLE 11 The Resin I-A 1 was tested with different micro-organisms under different conditions for the sterilization of air.
  • Re ⁇ in I-A' wa ⁇ evaluated for it ⁇ biocidal capacity on direct contact with Kleb ⁇ iella Terrigena in relation to a time reference and a humidity content variation; namely water content variation ⁇ of 110%, 50% & 0% (relative to the weight of dry re ⁇ in) and time variations of 2, 5, 10, and 15 second ⁇ .
  • the testing proceeded as follows with respect to the dry re ⁇ in.
  • a gla ⁇ rod wa ⁇ immer ⁇ ed in the inoculum and then immer ⁇ ed in the dry re ⁇ in for 2 ⁇ econds.
  • the glas ⁇ rod was then washed in 100 ml phosphate buffer to wash out the microorganisms.
  • the collected ⁇ ample wa ⁇ then plated and incubated.
  • Thi ⁇ procedure wa ⁇ then repeated for 5, 10 and 15 seconds.
  • EXAMPLE 11.2 KLEBSIELLA TERRIGENA ERADICATION STUDY: AIR FLOW.
  • the system used was the ⁇ y ⁇ tem illustrated in figure 5.
  • the system included an atomizer 7 (of known construction) di ⁇ po ⁇ ed in a hou ⁇ ing 8 provided with an air opening 9.
  • the ⁇ ystem had a vacuum pump 11 for the displacement of air through the system.
  • the system included an air sterilizer 12 comprising a hollow hou ⁇ ing 10 inches high by about 2.5 inches in inner diameter and filled with about 1.5 kilograms of Resin I-A'; the sterilizer has an air inlet and outlet.
  • the air path through the cartridge 1 is designated by teh arrows 14.
  • the atomizer 7 contained an inoculum 16 (Kleb ⁇ iella Terrigena: 10 7 x 100 ml) .
  • the air flow at arrow 13 wa ⁇ ⁇ et at 30 liters per minute and the air inflow at arrow 17 for the atomizer was set at 8 liters per minute; the atomizer 7 injected mi ⁇ t or ⁇ pray 18 of inoculum into the air in the air path and the inoculated air then pa ⁇ ed through cartridge 1 a ⁇ ⁇ hown by the arrows 14.
  • a cartridge 1 as illustrated in figures 3 and 4 was prepared using dry Resin I-A' (65.0 gm giving a bed depth of 1.15 cm) .
  • the cartridge 1 was submitted to an injection of a total of 10 ml of inoculum over a time period of 15 minute. Sampling was done at 0 minutes, 7.5 minutes and at 15 minutes. The samples were collected in a standard impinger a ⁇ ⁇ hown in figure 5. After, proce ⁇ ing 100 ml of the water from the impinger on microbiological paper filter and incubation, the re ⁇ ult ⁇ ⁇ how total eradication of Kleb ⁇ iella Terrigena.
  • EXAMPLE 11.3 BACILLUS PUMILUS ERADICATION: AIR CONTACT.
  • members of the sy ⁇ tem are the ⁇ ame as those used in the system illustrated in figure 5, the same reference numerals are u ⁇ ed to identify the same parts.
  • thermophilic bacteria Bacillus Pumilus was prepared and injected at a concentration of 10 3 /litre of influent air.
  • a cartridge mask containing 65.00 gm of Re ⁇ in I-A 1 wa ⁇ prepared a ⁇ for the previou ⁇ example. The te ⁇ t ran for 30 minute ⁇ .
  • EXAMPLE 11.4 BACILLUS SUBTILIS STERILIZATION IN AIR FLOW.
  • the millepore filter paper wa ⁇ collected, lain on T.S.A. (after neutrali ⁇ ation of potential iodine with ⁇ odium thio ⁇ ulfate 5%) and incubated for 48 hours at 37 degree celsius. The result ⁇ ⁇ how a total eradication of micro-organi ⁇ m ⁇ .
  • EXAMPLE 11.5 BACILLUS SUBTILIS: Re ⁇ in I-A" versus glas ⁇ bead ⁇ in air flow.
  • Resin I-A' cartridge 10 micron polypropylene upstream mesh (filter) ;
  • the two cartridges were, once in ⁇ erted in their re ⁇ pective testing chamber, submitted to a velocity of 23 litre per minute ⁇ for 40 minute ⁇ with a microbiological load of 40 bacteria per litre in the influent.
  • upstream mesh 2 cfu tnc * cfu Resin ⁇ beads: 0 cfu tnc cfu
  • microbiological filter paper 0 cfu 86 cfu
  • the Glass beads on the other hand have a mechanical filtering capacity in regards to the biological vector but migration occurs rapidly thus obtaining "tnc" results (too numerous to count) on the upstream mesh and the beads themselves.
  • the migration keeps on going through the filter until it reaches the microbiological paper filter in large number.
  • the glas ⁇ beads filter become ⁇ ⁇ everely contaminated, cau ⁇ ing a disposal problem.
  • EXAMPLE 11.6 BACILLUS SUBTILIS: Resin bed depth comparison This test was performed to establish the biocidal effectiveness of the Resin I-A' in regards to the microbiological eradication of Bacillus Subtili ⁇ . The ⁇ y ⁇ tem of figure 6 wa ⁇ used.
  • a positive control yielded a concentration of 275 cfu/litre of air at the microbiological sampling site.
  • Re ⁇ in I-A 1 , Re ⁇ in I-B 1 , Re ⁇ in I-B" and Re ⁇ in I-A were prepared a ⁇ follow ⁇ :
  • Re ⁇ in I-A' wa ⁇ prepared as described in example 9.
  • Resin I-B' was prepared following the procedures of examples 1 and 2 except that for the resin, Amberlite IR-400 (OH " ) (from Rohm & Has ⁇ ) wa ⁇ used.
  • Re ⁇ in I-B" was prepared following the procedure ⁇ of example ⁇ 1 and 2 (u ⁇ ing Amberlite 401-S) except that the amount of the I 2 /KI mixture wa ⁇ adju ⁇ ted ⁇ o a ⁇ to provide a re ⁇ in compri ⁇ ing about 30 percent iodine at the end of the procedure in example 2; the mixture obtained at the end of the procedure of example 2 wa ⁇ divided into two equal part ⁇ and one part wa ⁇ subjected to a wash to provide the iodinated resin obtained as at the end of the procedure in example 2; and Resin I-A" wa ⁇ prepared by taking the remaining one half part of the intermediate mixture obtained in the preparation of Re ⁇ in I-B" (mentioned above) and ⁇ ubjecting the mixture to the
  • the iodine content of the above iodinated re ⁇ in ⁇ was determined in accordance with the procedure outlined in example 5.3.
  • the resin ⁇ were also subjected to an iodine bleed te ⁇ t a ⁇ outlined in example 7.
  • the re ⁇ ult ⁇ are ⁇ hown in table 12 below:
  • a ⁇ may be ⁇ een from table 12, ⁇ ubjecting the re ⁇ in to a high temperature/pre ⁇ ure treatment re ⁇ ults in the iodine being more tenaciously fixed to the resin at different iodine concentration ⁇ .
  • Re ⁇ in IA, Re ⁇ in 2B, Re ⁇ in 3A and Re ⁇ in 4B were prepared a ⁇ follows:
  • the 200 gm re ⁇ in portion ⁇ were each iodinated using a respective iodine sludge as follows:
  • Resin IA was prepared, using an above mentioned 200 gm resin portion and a respective iodine ⁇ ludge, following the procedure ⁇ of example ⁇ 2 to 4 except that for the procedure of example 3 the elevated temperature and pre ⁇ ure condition ⁇ were set at 121° C and 15 psig respectively (while the reaction time at the elevated conditions remained at 15 minutes) ;
  • Resin 2B was prepared, using an above mentioned 200 gm resin portion and a respective iodine sludge, following the procedure of example 2 except that the temperature of the ⁇ haking bath wa ⁇ maintained at 40° C;
  • Re ⁇ in 3A wa ⁇ prepared, u ⁇ ing an above mentioned 200 gm resin portion and a respective iodine sludge, following the procedures of examples 2 to 4 except that for the procedure of example 3 the elevated temperature and pres ⁇ ure condition ⁇ were set at 121° C and 15 psig respectively while the reaction time at these elevated conditions wa ⁇ set at 1.5 hours rather than at 15 minutes;
  • EXAMPLE 15 Sterili ⁇ ation barrier combination ⁇ for u ⁇ e a ⁇ wound ( ⁇ terili ⁇ ation) dre ⁇ ing ⁇
  • re ⁇ in compri ⁇ ing particle ⁇ or bead ⁇ of about 0.3 mm to about 0.7 mm;
  • HYPOL foamable hydrophilic polyurethane polymer (code : # FHP2002) from W.R. Grace & Co. , Organic Chemicals Division, Lexington, Massachu ⁇ ett ⁇ 02173.
  • the obtained foam was set or cured in about 7 minutes; the resin particles were disper ⁇ ed throughout the matrix of the foam which wa ⁇ of porou ⁇ cellular ⁇ tructure (i.e. sponge like) .
  • the obtained flexible foam had a semi-sphere like form (see for example figure 9) ; ⁇ lice ⁇ of thi ⁇ foam material were taken so as to provide a foam dres ⁇ ing having an e ⁇ entially flat face for being applied against a wound.
  • the obtained sterili ⁇ ation foam wa ⁇ flexible and sponge like in that it could absorb liquids ⁇ uch a ⁇ water, pu ⁇ and the like.
  • the ⁇ terili ⁇ ation strip barrier was prepared as follows:
  • An open ended ring funnel was dispo ⁇ ed over a central area of the ⁇ trip on the adhesive face thereof. Resin bead ⁇ were placed in the stem of the ring funnel ⁇ o a ⁇ to e ⁇ entialy cover the central portion of the adhe ⁇ ive face defined by the ring; a plunger wa ⁇ ⁇ hoved into the ring and a mild pre ⁇ ure was applied to the resin bead ⁇ therein.
  • the ring wa ⁇ removed along with exce ⁇ resin beads ⁇ o a ⁇ to leave behind a ⁇ ingle layer of re ⁇ in bead ⁇ fixed to the adhe ⁇ ive face of the ⁇ trip; the re ⁇ in bead ⁇ in the layer e ⁇ entialy abutted each other.
  • the ⁇ trip barrier had a form as ⁇ hown in figure 8; if de ⁇ ired the beads do not have to abut but could be spaced apart.
  • guinea pigs Eight male guinea pigs were shaved so as to expo ⁇ e e ⁇ sentially the same ⁇ kin area.
  • the guinea pig ⁇ each weighed about 500 to 550 gm and were obtained from Charle ⁇ River, Quebec, Canada, a ⁇ ub-divi ⁇ ion of Bausch & Lomb; the guinea pigs were quarantined for a period of 48 hours before being prepared for and subjected to the te ⁇ t ⁇ .
  • the guinea pigs were prepared for the tests a ⁇ follows:
  • An inoculum compri ⁇ ing a mixture of Staphillococu ⁇
  • a cruciform structured scalpel cut (#) wa ⁇ made above the inoculum injection area of each of the animal ⁇ ; i.e. the cuts were 1.0 to 4.0 cm long and 1.0 to 4.0 mm deep. Additional inoculum was dabbed onto the ⁇ urface cut ⁇ .
  • the animal ⁇ were divided into two groups of four animals each, one group to be used a ⁇ a control group and the other group a ⁇ a te ⁇ t group.
  • a foam ⁇ terili ⁇ ation dressing was applied over the wound for each of the animals of the test group, i.e. the foam dres ⁇ ing was placed in contact with the wounded skin area and maintained in place during the period of the test.
  • the foam dre ⁇ ing ⁇ were maintained in place over the wound area by mean ⁇ of an adhe ⁇ ive ⁇ trip which wa ⁇ provided with an opening or window by mean ⁇ of which a portion of the foam dre ⁇ ing wa ⁇ left uncovered and exposed to the air.
  • the four animals of the te ⁇ t group with dre ⁇ ing ⁇ developed no infection and the scaring process was initiated after 16 hour ⁇ .
  • the four control animal ⁇ developed infection and the infection wa ⁇ ⁇ till ⁇ preading after 72 hour ⁇ .
  • EXAMPLE 15.4 Animal infection study: burns The same ⁇ tudie ⁇ a ⁇ de ⁇ cribed in example 15.3 were carried out except that the le ⁇ ion wa ⁇ a burn created with a 1.0 cm red hot rod; the hot rod wa ⁇ firmly held again ⁇ t the ⁇ kin for about 3 to 4 seconds. The same Inoculum as in example 15.3 was injected beneath the burn area and al ⁇ o dabbed onto the ⁇ urface of the burned ⁇ kin. Exactly the same result ⁇ were obtained for the two type ⁇ of dre ⁇ sings as were obtained for the te ⁇ t ⁇ of example 15.3.
  • guinea pig ⁇ Four male guinea pig ⁇ were ⁇ haved ⁇ o a ⁇ to expo ⁇ e e ⁇ entially the ⁇ ame ⁇ kin area.
  • the guinea pig ⁇ each weighed about 500 to 550 gm and were obtained from Charle ⁇ River, Quebc, Canada; the guinea pig ⁇ were quarantined for a period of 48 hour ⁇ before being prepared for and ⁇ ubjected to the te ⁇ t ⁇ .
  • the guinea pig ⁇ were prepared for the te ⁇ t ⁇ a ⁇ follow ⁇ :
  • the animal ⁇ were divided into two group ⁇ of two animal ⁇ each, one group to be u ⁇ ed a ⁇ a control group and the other group a ⁇ a te ⁇ t group.
  • a foam ⁇ terilisation dressing was applied over the wound for each of the animal ⁇ of the te ⁇ t group, i.e. the foam dre ⁇ ing wa ⁇ placed in contact with the wounded skin area and maintained in place during the period of the test.
  • the foam dre ⁇ sings were maintained in place over the wound area by mean ⁇ of an adhesive strip which was provided with an opening or window by means of which a portion of the foam dre ⁇ ing was left uncovered and exposed. No dres ⁇ ing or ⁇ terili ⁇ ation material was applied to the wounds of the animal ⁇ of the control group.
  • An inoculum compri ⁇ ing a mixture of Staphillococus Aureus and Pseudomona ⁇ Aerigino ⁇ a wa ⁇ prepared at 10 7 cfu/ 100ml; the ratio of Staphillococu ⁇ Aureus to Pseudomonas Aeriginosa was 1:1.
  • Sufficient inoculum wa ⁇ prepared such that each of the animals of the test and control group could be bathed in the inoculum such that the bath liquid was in continual contact with the wound area, i.e. the bath liquid covered the dressing ⁇ . The animals of each group were kept in the bath inoculum for a period of 72 hours.
  • the two animals of the test group with dres ⁇ ing ⁇ developed no infection and the ⁇ caring proce ⁇ wa ⁇ in full process.
  • the two control animals each had developed infection.
  • Three male guinea pig ⁇ were ⁇ haved ⁇ o a ⁇ to expo ⁇ e e ⁇ entially the same skin area.
  • the guinea pig ⁇ each weighed about 500 to 550 gm and were obtained from Charle ⁇ River, Quebec, Canada; the guinea pig ⁇ were quarantined for a period of 48 hour ⁇ before being prepared for and ⁇ ubjected to the te ⁇ t ⁇ .
  • the guinea pig ⁇ were prepared for the te ⁇ t ⁇ a ⁇ follow ⁇ :
  • An inoculum comprising a mixture of staphillococus Aureus and Pseudomonas Aeriginosa was prepared at 10 9 cfu/ml; the ratio of Staphillococu ⁇ Aureu ⁇ to Pseudomonas Aeriginosa wa ⁇ 1:1.
  • the inoculum was only dabbed onto the surface of the wounds of each of the animals (no injection of inoculum under the skin) . It wa ⁇ found that a 5% iodine tincture locally applied on the wound ⁇ would neutrali ⁇ e infection provided that the iodine tincture was applied at 0.1 ml directly after infection and every 2 hours thereafter for 10 hours; the iodine tincture was from Jean Coutu, Quebec, Canada - 5% iodine, 3.3% KI and 75% ethanol. However, it was noted that the skin in the periphery of the wound wa ⁇ ⁇ eriou ⁇ ly devitalised becau ⁇ e of the burning effect of the tincture i.e. of the iodine.
  • the guinea pigs were shaved so as to expo ⁇ e e ⁇ entially the ⁇ ame ⁇ kin area.
  • the guinea pigs each weighed about 500 to 550 gm and were obtained from Charles River, Quebec, Canada; the guinea pigs were quarantined for a period of 48 hour ⁇ before being subjected to the test ⁇ .
  • a foam ⁇ terili ⁇ ation dressing of example 15.1 was applied over a ⁇ have skin area of each of the animals, i.e. the foam dressing was placed in contact with the shaved ⁇ kin area and maintained in place during the period of the test.
  • the foam dressings were maintained in place over the skin area by mean ⁇ of an adhe ⁇ ive ⁇ trip which wa ⁇ provided with an opening or window by mean ⁇ of which a portion of the foam dre ⁇ ing wa ⁇ left uncovered and expo ⁇ ed to the air.
  • the dre ⁇ ing wa ⁇ maintained in place for a period of 3 week ⁇ .
  • the covered skin area was examined every two day ⁇ . No redness, rash, inflammation, or any other reaction wa ⁇ noted; the covered ⁇ kin remained healthy.
  • Figure ⁇ 7 to 11 illustrate a number of example embodiements of sterili ⁇ ation barrier combination ⁇ of the pre ⁇ ent invention; ⁇ ome of the ⁇ e combination ⁇ are also described in example 15 above.
  • Figure 7 show ⁇ a partially cut away perspective view of a sterilisation barrier dressing of tea-bag type construction wherein the iodinated resin particles or beads (one of which is designated by the reference numeral 30) are free flowing but are held together by being enveloped by a fluid (e.g. air-liquid) permeable envelope 31 of (known) pharmaceutically acceptable paper or gauze (e.g. a ⁇ uitable ⁇ terile gauze from John ⁇ on & John ⁇ on, Canada) .
  • a fluid e.g. air-liquid
  • gauze e.g. a ⁇ uitable ⁇ terile gauze from John ⁇ on & John ⁇ on, Canada
  • the paper or gauze i ⁇ permeable to fluid ⁇ ⁇ uch a ⁇ air and water but is able to hold onto the particles of iodinated resin enveloped thereby ⁇ ince any hole ⁇ in the paper gauze are ⁇ ized to be ⁇ maller than the particle ⁇ of resin.
  • This type of dressing may be made relatively small or relatively large keeping in mind the ⁇ ize of the le ⁇ ion that it i ⁇ intended to cover.
  • the dre ⁇ ing may be made by providing a ⁇ heet of paper or gauze, placing the desired amount of resin particle ⁇ thereon and then folding one ⁇ ide edge of the paper or gauze over the re ⁇ in particle ⁇ 30 ⁇ o as to overlay and abut the opposite side; these abuting side edge ⁇ 32 and 33 a ⁇ well a ⁇ each of the re ⁇ pective ⁇ ide edges of the two pairs of adjacent side edges indicated generally at 34 and 35 may be fixed together in any known manner, for example by compre ⁇ ion, ⁇ titching or by the use of any known phamaceutically acceptable adhesive.
  • fixation of the sides is ⁇ uch that they will tend to maintain their integrity in the face of water , body fluid ⁇ or body exudate ⁇ (e.g. pu ⁇ ) .
  • the embodiment ⁇ hown in figure 7 i ⁇ ⁇ hown may be considered as e ⁇ entially having a plurality of resin bead layers; it could of course have only a single ⁇ uch layer.
  • the sterilisation barrier may take on a band- aid type aspect as shown in figure 8.
  • the combination ⁇ hown ha ⁇ a flexible carrier component 36.
  • a central portion of one ⁇ ide of the carrier component 36 ha ⁇ fixed thereto a plurality of beads or particles (one of which is de ⁇ ignated by the reference numeral 37) of demand disinfectant iodinated resin.
  • the resin bead ⁇ 37 are fixed to the ⁇ urface by a ⁇ uitable adhesive which is phar acetically acceptable and which will maintain the beads on the carrier component even if exposed to water or body fluids or exudate ⁇ .
  • the portion of the band surface 38 which surrounds the centrally dispo ⁇ ed bead ⁇ 36 may al ⁇ o be provided with any (known) adhesive which may for example be able to releasably stick the combination to the skin (e.g. a latex based adhe ⁇ ive) .
  • the carrier component 36 may, a ⁇ desired be permeable or impermeable to fluid ⁇ such as air, water, pu ⁇ ; prefereably, the carrier i ⁇ permeable to ga ⁇ such as air, water vapour, etc. at least in the region of the re ⁇ in bead ⁇ fixed thereto, i.e. thi ⁇ region i ⁇ air breathable.
  • the carrier component 36 may be of any suitable pharmaceutically acceptable (plastic ⁇ ) material (e.g.
  • the carrier component may be a porou ⁇ hydrophobic material permeable to air and water vapour ⁇ uch a ⁇ de ⁇ cribed in U.S. patent nos. 3,953,566 and 4,194,041 - Gore-Tex) .
  • the carrier component complete with an adhe ⁇ ive face may be obtained from Peco Marketing ltd. , Montreal, Quebec under the name "Compeed”.
  • Figure ⁇ 9, 10 and 11 how a number of further embodiment ⁇ of the sterilisation barrier combination.
  • Figure 9 ⁇ how ⁇ a flexible sterilisation foam or ⁇ ponge type dre ⁇ sing 39 for wounds.
  • the dre ⁇ ing compri ⁇ e ⁇ a flexible pharmaceutically acceptable foam matrix 40 having iodinated resin particles (one of which i ⁇ de ⁇ ignated with the reference numeral 41) dispersed therein.
  • the foam matrix 40 has a porous open cell structure such that it is permeable to fluids such a ⁇ air and water and can absorb body liquid ⁇ in the manner of a ⁇ ponge (e.g. the foam is hydrophilic and/or oil loving) ; the foam barrier is air breathable.
  • the foam matrix 40 as shown has cells of relatively small ⁇ ize ⁇ o a ⁇ to facilitate the ab ⁇ orption of liquids such as pu ⁇ .
  • the re ⁇ in particles 41 making up the resin disinfectant component are distributed throughout and held or fixed in place by the polymeric matrix 40 ⁇ uch that ⁇ urface portion ⁇ of the re ⁇ in particles are exposed within the cells of the matrix 40.
  • the exposed surface ⁇ of the re ⁇ in are available for contact with any microorganisms which may find their way into the cells of the body of the barrier combination; contact with the re ⁇ in devitali ⁇ es the microorganism ⁇ .
  • the foam ⁇ terili ⁇ ation barrier or dre ⁇ ing 39 a ⁇ shown in figure 9 has a ⁇ emi-spherical like shape.
  • the flat surface 42 may be applied to a wound or cut.
  • the dres ⁇ ing may be held in place by any ⁇ uitable mean ⁇ ⁇ uch a ⁇ for example any suitable strapping or by adhe ⁇ ive tape means.
  • the ⁇ terilisation foam dressing 39 is held in place such that at least a portion of it is exposed (e.g. exposed to the air) ; thus the means for holding the foam in place may be an adhe ⁇ ive ⁇ trip which ha ⁇ a central opening exposing at least a portion of the foam when the foam i ⁇ held in place.
  • the flexible foam ⁇ terili ⁇ ation barrier will ⁇ terilise the immediate area of the wound which it covers and also prevent other infectious microorgani ⁇ m ⁇ from contacting the wound from outside the body. Surpri ⁇ ingly, however, it ha ⁇ been found that the ⁇ terilisation barrier is also effective not only again ⁇ t microorgani ⁇ m ⁇ at the immediate ⁇ urface of a wound but also against tho ⁇ e deeper within the body in the area of a cut.
  • Figure 10 illu ⁇ trate ⁇ another type of flexible foam ⁇ terilisation barrier 43. It differs from the sterili ⁇ ation barrier shown in figure 9 in that the size of the cells (one of which i ⁇ de ⁇ ignated with the reference numeral 44) is significantly larger than those for the foam shown in figure 9; this type of foam may be used a ⁇ a liner material for wearing apparel to provide the apparel with the ability to protect the wearer from ( ⁇ kin) contact with viable microorgani ⁇ m ⁇ .
  • the re ⁇ in bead ⁇ , ⁇ pheres or particles are, a ⁇ in the ca ⁇ e of the re ⁇ in spheres 41 for the foam barrier 39 of figure 9, dispersed in the foam matrix and are held or fixed in place thereby such that exposed surfaces of the resin are available for contact with any microorgani ⁇ m ⁇ which may find their way into the cell ⁇ of the body of the barrier combination; contact with the resin devitalises the microorganisms.
  • the foam matrix for the sterili ⁇ ation barrier ⁇ of figures 9 and 10 may be made by admixing (known) starting reactants in (known) manner to make (known) foam ⁇ which are pharmaceutically acceptable.
  • known polyurethane foam ⁇ may for example be u ⁇ ed.
  • the di ⁇ infectant re ⁇ in particle ⁇ may be admixed with and di ⁇ per ⁇ ed (e.g. more or le ⁇ homogeneou ⁇ ly) in the ⁇ tarting reactant ⁇ at the beginning of the foam producing reaction.
  • the foam barrier may be set in molds or else cut to the de ⁇ ired ⁇ hape.
  • the foam ⁇ terili ⁇ ation barrier may take any de ⁇ ired form such as sheet ⁇ , film ⁇ , plug ⁇ , and the like; it may, for example, be molded ⁇ o a ⁇ to conform to the ⁇ hape of portion of the body to which it i ⁇ to be applied.
  • a (flexible) phamaceutically acceptable hydrophilic foam matrix may be obtained u ⁇ ing water and HYPOL foamable hydrophilic polyurethane polymer ⁇ tarting material from W.R. Grace & Co. Lexintington Ma ⁇ . U.S.A..
  • the pore or cell ⁇ ize of the foam barrier may be adju ⁇ ted in known manner; for example by altering the reaction temperature.
  • a temperature of about 50 to 70° C may be u ⁇ ed to obtain small pore sizes and a lower temperature of about 35 to 45° C may be used to obtainer larger ⁇ ized pore ⁇ .
  • Figure 11 ⁇ how ⁇ a cross ⁇ ectional portion of a ⁇ andwich type textile material 46 which incorporate ⁇ a flexible large cell ⁇ ize sterilisation foam layer 47.
  • the sandwich comprise ⁇ two outer flexible clothe type layer ⁇ 48 and 49 which are fixed to the central ⁇ terili ⁇ ation foam barrier 46 in any ⁇ uitable manner (e.g. by an adhe ⁇ ive, melt fu ⁇ ion, etc.).
  • the two outer layer ⁇ 48 and 49 may be of any desired material; they may be permeable or impermeable to fluids such a ⁇ air, water vapour, water and the like. They may for example be of cotton, polypropylene, etc.; or a Gore-tex type material mentioned above.
  • a sheet of textile material as shown may cut into pieces of variou ⁇ ⁇ hape ⁇ needed to form such protective wearing apparel as may be de ⁇ ired, e.g. coat ⁇ , pant ⁇ , ⁇ ock ⁇ , face masks (e.g. full face mask ⁇ or ma ⁇ k ⁇ covering only the mouth and no ⁇ e) and the like.
  • face masks e.g. full face mask ⁇ or ma ⁇ k ⁇ covering only the mouth and no ⁇ e
  • the flexible foam layer 47 can be made in any known manner provided that di ⁇ infectant resin particles are disper ⁇ ed in the reaction mixture during the reaction ⁇ uch that the end product foam also has the re ⁇ in particle ⁇ di ⁇ per ⁇ ed in the foam matrix and any microorgani ⁇ m able to penetrate into an interior cell of the foam may be able to contact a re ⁇ in particle expo ⁇ ed into the cell and be devitalised thereby.
  • the foam barrier as in the ca ⁇ e of the foam dre ⁇ ing ⁇ mentioned may be configured to be permeable to fluids such a ⁇ air, water, etc..
  • the textile material 46 may be formed by first forming a sheet of the sterilisation foam; by providing sheet ⁇ of the desired outer layers; and then gluing the elements together such that the foam is sandwiched between the two other outer layer ⁇ .
  • a mold may be used wherein opposed ⁇ urface ⁇ of the mold are provided with a re ⁇ pective outer layer; the foam ⁇ tarting material ⁇ are introduced between the layers; and foaming activated such that the foam layer is produced in situ.
  • figure 11 may of course have only one ⁇ uch clothe like layer. Additionally if the outer layer or layers are permeable to fluids such as air, water, pus and the like, the wearing apparel made therefrom could as needed double as a kind of ⁇ terili ⁇ ation dressing; the textile may thus for example be air breathable.
  • foam sterilisation barrier has been described in relation to a flexible foam it may be a stiff foam depending upon the application; again the stiff foam matrix may be prepared in known manner.
  • An alternate embodiement of the ⁇ andwich type textile may be made wherein the foam matrix i ⁇ omitted; in thi ⁇ ca ⁇ e the bead ⁇ may be placed between the outer layer ⁇ and the beads may be fixed in place for example by an adhesive or by melt fusion depending on the nature of the layers (e.g. melt fusion may be considered if the layers are of thermoplastics material; the textile may of course be so made a ⁇ to pre ⁇ erve the flexibility of the combination.

Abstract

The present invention relates to iodine demand disinfectants. It relates in particular to a process for preparing a polyiodide-resin for use as a iodine demand disinfectant wherein a porous strong base anion exchange resin in a salt form, is contacted with a material capable of donating a member absorbable by the resin so as to convert the resin to the polyiodide-resin. The adsorbable member is selected from the group comprising I2 and polyiodide ion having a valence of -1. The process is characterized in that conversion of the anion exchange resin to the polyiodide-resin is effected at elevated temperature and elevated pressure, the elevated temperature being 100 °C or higher, the elevated pressure being greater than atmospheric pressure. The present invention also relates to a disinfectant substance comprising an iodine (impregnated) resin as produced by the above process.

Description

IODINE/RESIN DISINFECTANT AND A PROCEDURE FOR THE PREPARATION THEREOF
The present application is a continuation-in-part of U.S. patent application no. 07/957,307 filed September 16, 1992 and of U.S. patent application no. 08/047,535 filed on April 19, 1993.
The present invention relates to a disinfectant substance comprising an iodine (impregnated) resin and to a process for the preparation thereof. The iodine/resin disinfectant may be used to sterilize a fluid such as, for example, water, air, as well as fluid exudate secreted at body lesions or traumas such as at cuts, burns , etc.; thus, the disinfectant may be used to devitalize microorganisms (e.g. bacteria, viruses, etc..) which may be present in the fluid (e.g. water, air, pus and the like) . The treatment of fluid, such as water or air, with an iodine/resin disinfectant of the present invention may leave behind non-detectable (or acceptable) residual diatomic iodine in the fluid (e.g. water or air) . The present invention in particular relates to a demand type broad spectrum resin-polyiodide (e.g. water, air, wound) disinfectant.
Diatomic halogen (such as I2, Cl2, Br2, etc..) has
SUBSTITUTESHEET traditionally been used to disinfect water. Diatomic chlorine, for example, is a widely exploited disinfectant for controlling or eliminating micro-organisms which may be present in water. A disadvantage of a sterilization regime which exploits diatomic halogen is that the regime may leave behind unacceptable (residual) levels of halogen in the water once sterilization is complete.
An iodine/resin product has, however, been proposed for use as a demand disinfectant, namely a disinfectant wherein iodine is released almost entirely on a demand-action basis. United States patent nos. 3,817,860, 3,923,665, 4,238,477 and 4,420,590 teach such a demand disinfectant wherein iodine is the active disinfectant agent; the entire contents of each of these patents is incorporated herein by reference. In accordance with the teachings of these patents the resin product may be used without fear of introducing unacceptable concentrations of diatomic iodine into the water to be sterilized.
U.S. patent nos. 3,817,860 and 3,923,665 teach an iodine/resin demand disinfectant which is the reaction product obtained by contacting a strong base anion exchange resin with a suitable source of triiodide ions. The reaction product is taught as being very stable in the sense that the amount of iodine (e.g. I2) released into water from the reaction product is sufficiently low that the water disinfected thereby is immediately ready for use, ie. as drinking water.
In accordance with the teachings of U.S. patent nos. 3,817,860 and 3,923,665 the procedure for preparing the iodine/resin comprises forming a triiodide ion (solution or sludge) by dissolving diatomic iodine in a water solution of a suitable alkali metal halide (e.g. KI, Nal,....). The triiodide solution is in particular taught as being made with a minimal (i.e. minor) water content just sufficient to avoid causing the I2 to crystallize out; see example 1 of U.S. patent no. 3,923,665. The resulting (solution) containing the triiodide ion is then contacted with the starting resin (under ambient conditions with respect to temperature (i.e. 25 to 30° C) and pressure) , the triiodide ions exchanging with the anion of the resin (e.g. exchange with chlorine, sulfate, etc., ..). The starting resin is taught as being a porous granular strong base anion exchange resin having strongly basic groups in a salt form wherein the anion thereof is exchangeable with triiodide ions. In accordance with the teachings of the above prior art references contacting is continued until the desired amount of triiodide has reacted with the strongly basic groups such that bacterially contaminated water is disinfected when passed through a bed of the obtained resin. After a suitable contact time the iodine/resin is (water) washed to remove water-elutable iodine from the resin product.
However, as indicated in U.S. patent no. 4,238,477, it is difficult to use the procedures outlined in the two previously mentioned U.S. patents so as to obtain a homogeneous iodine/resin product containing only triiodide anions and wherein all of the active sites of the resin have been converted to triiodide ions.
Accordingly, U.S. patent no. 4,238,477 teaches an alternate process whereby the iodine/resin may be produced. In accordance with this alternate impregnation/contact process, a suitable resin in the iodide form (I") is contacted with water comprising diatomic iodine (I2) in solution, the water being recycled between a source of a predetermined amount of diatomic iodine and the resin. The process as taught by this latter patent, however, is a relatively complicated system of pumps, vessels, heaters, etc.; by exploiting a fluidized bed, it in particular may lead to a significant degree of resin bead attrition, i.e. particle breakup.
The processes as taught in U.S. patent nos. 3,817,860 and 3,923,665 are carried out at ambient temperature and ambient pressure conditions. The U.S. patent 4,238,477 teaches that the contact may occur at a higher temperature such as 60 to 95° C but that the temperature must be a non-boiling temperature (with respect to water) ; see column 3 lines 55 to 66.
The above referred to U.S. patents teach the use of the demand disinfectant iodinated resins for treating water; see also U.S. patent nos. 4,298,475 and 4,995,976 which teach water purification devices or systems which exploit iodinated resins. None of these patents teaches the use of the iodinated resins for the purpose of sterilizing air.
It is also known to use iodine tincture for sterilising wounds. The sterilisation effect of iodine tincture is short lived; this means that the tincture must be reapplied on a regular basis to maintain the sterilisation effect. However, such solutions may also damage or destroy the tissue around the wound if applied too liberally and too often. Additionally, the direct application of such solutions to a lesion or wound is usually accompanied by a painful sensation.
Accordingly it would be advantageous to have a iodine/resin product which has improved characteristics over known or commercially available iodine/resin disinfectant products.
It would also be advantageous to have an alternate process for the preparation of a iodine/resin product (which has improved characteristics over the previously known iodine/resin) .
It would be advantageous to have an alternative effective demand disinfectant (e.g. bactericidal) resin and an effective technique for the manufacture thereof. It would, in particular, be advantageous to have an iodine/resin demand disinfectant having a relatively low level of iodine bleed into a fluid (such as water or air) being treated as well as an iodine impregnation process for obtaining such iodinated resin.
It would also be advantageous to have a means whereby lesions, such as for example wounds or burns, may be treated in order to facilitate healing by devitalising microorganisms which may already be in the area of the lesion and further to prevent microorganisms from having access, to such lesion (i.e. a dressing), i.e. to inhibit access from any outside biovectors such as for example airborne, waterborne, spital borne, blood borne, particulate borne microorganisms and the like.
It would additionally be advantageous to have a means for inhibiting or preventing microorganisms from contacting predetermined areas of the body such as the skin (e.g. a protective textile for making protective clothing) .
In accordance with a general aspect, the present invention provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described) ,
the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form with a sufficient amount of an iodine-substance absorbable by the anion exchange resin such that the anion exchange resin absorbs said iodine-substance so as to convert the anion exchange resin to the disinfectant-resin, said iodine-substance being selected from the group comprising I2 (i.e. diatomic iodine) and polyiodide ions having a valence of
characterized in that for the conversion step at least a portion of the absorption of iodine-substance is effected at elevated temperature and at elevated pressure, said elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C such as, for example, 102° C, 103° C, 104° C, 105° C, 110° C, 115° C, 150° C, etc.), said elevated pressure being greater than atmospheric pressure (e.g. a pressure greater than barometric pressure such as for example 2 psig, 3 psig, 4 psig, 5 psig, 15 psig, 25 psig, 35 psig, 100 psig, etc.).
In accordance with the present invention the disinfectant- resin may be one in which diatomic iodine is incorporated. The disinfectant polyiodide-resin may in particular be triiodide-resin. Thus, for example, the iodine-substance may comprise triiodide ion of formula I3 ", i.e. so as to form a disinfectant-resin which comprises (absorbed) triiodide ions of formula I3 ~.
The terms "triiodide", "triiodide ion" and the like, as used in the context herein, refer to or characterize a substance or a complex as containing three iodine atoms and which has a valence of -1. The triiodide ion herein therefore is a complex ion which may be considered as comprising molecular iodine (i.e. iodine as I2) and an iodine ion (i.e. I"). Similarly the terms "polyiodide". "polyiodide ions" and the like, refer to or characterize a substance or a complex as having three or more iodine atoms and which may be formed if more of the molecular iodine combines with the monovalent triiodide ion. These terms are more particularly described in the above referred to U.S. patents.
In accordance with a further aspect, the present invention provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described) , the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form other than the iodide form I", with a sufficient amount of an iodine-substance absorbable by the anion exchange resin such that the anion exchange resin absorbs said iodine-substance so as to convert the anion exchange resin to the disinfectant- resin, said iodine-substance being selected from the group comprising polyiodide ions having a valence of -1, characterized in that for the conversion step at least a portion of the absorption of iodine-substance is effected at elevated temperature and at elevated pressure, said elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C) , said elevated pressure being greater than atmospheric pressure (e.g. a pressure greater than barometric pressure) .
The strong base anion exchange resin may be in a salt form such as for example a chloride or hydroxyl form.
The conversion in accordance with the present invention may essentially or at least partially be effected at said elevated temperature and elevated pressure. The conversion, in accordance with the present invention, may, thus for example, be effected in one, two or more stages. For example, the elevated pressure/temperature conditions may be divided between two different pairs of elevated pressure/temperature conditions, e.g. an initial pressure of 15 psig and a temperature of 121° C and a subsequent pressure of 5 psig and a temperature of 115° C.
If the conversion is to be carried out in two stages, it may for example, comprise a first stage followed by a second stage. The first stage may, for example, be effected at low temperature conditions (e.g. at ambient temperature and ambient pressure conditions) whereas the second stage may be effected at elevated conditions such as described herein. Thus, the present invention, in accordance with another aspect provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described) , the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form with a sufficient amount of an iodine-substance absorbable by the anion exchange resin such that the anion exchange resin absorbs said iodine-substance so as to convert the anion exchange resin to the demand disinfectant resin, said iodine- substance being selected from the group comprising I2 and polyiodide ions having a valence of -1, characterized in that said conversion step comprises an initial conversion stage followed by a second conversion stage, in that said initial conversion stage comprises contacting the anion exchange resin with the iodine-substance at a temperature of 100° C or lower so as to obtain an intermediate composition, said intermediate composition comprising residual absorbable iodine-substance and an intermediate iodinated resin, (i.e. a resin comprising absorbed polyiodide ions having a valence of -1) , and in that said second conversion stage comprises subjecting the intermediate composition to elevated temperature and elevated pressure, said elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C) , said elevated pressure being greater than atmospheric pressure.
In accordance with a further particular aspect, the present invention provides a process for preparing a demand disinfectant resin, said disinfectant resin being an iodinated strong base anion exchange resin, (i.e. a demand disinfectant-resin comprising polyiodide ions, having a valence of -1, the ions being absorbed or impregnated into the resin as herein described) , the process comprising a conversion step, the conversion step comprising contacting a porous strong base anion exchange resin in a salt form other than the iodide form
I" with a sufficient amount of an iodine-substance absorbable by the anion exchange resin such that the anion exchange resin absorbs said iodine-substance so as to convert the anion exchange resin to the disinfectant- resin, said iodine-substance being selected from the group comprising polyiodide ions having a valence of -1, characterized in that said conversion step comprises an initial conversion stage followed by a second conversion stage, in that said initial conversion stage comprises contacting the anion exchange resin with the iodine-substance at a temperature of 100° C or lower so as to obtain an intermediate composition, said intermediate composition comprising residual absorbable iodine-substance and an intermediate iodinated resin (i.e. a resin comprising absorbed polyiodide ions having a valence of -1) , and in that said second conversion stage comprises subjecting the intermediate composition to elevated temperature and elevated pressure, said elevated temperature being 100° C or higher (e.g. a temperature higher than 100° C) , said elevated pressure being greater than atmospheric pressure.
In accordance with the present invention, for the first stage, the low temperature may, for example, be a non-boiling temperature of not more than 95° C; e.g. 15 to 60° C; e.g. ambient temperature or room temperature such as a temperature of from about 15° C to about 40° C, e.g. 20 to 30° C. The pressure associated with the low temperature condition of the first stage may, for example, be a pressure of from 0 (zero) to less than 2 psig; the pressure may in particular be essentially ambient pressure (i.e. a pressure of less than 1 psig to 0 (zero) psig; 0 psig reflecting barometric or atmospheric pressure) .
In accordance with the present invention, for the second stage, the elevated temperature may, for example, be: a temperature of 102° C or higher; e.g. 105° C or higher; e.g. 110° C or higher; e.g. 115° C or higher; e.g. up to 150° C to 210° C; e.g. 115° C to 135° C. The elevated pressure associated with the elevated temperature condition of the second stage may, for example, be: a pressure of 2 psig or greater; e.g. 5 psig or greater; e.g. 15 psig to 35 psig; e.g. up to 100 psig.
The present invention further relates to any demand disinfectant resin, the disinfectant resin being an iodinated strong base anion exchange resin which is the same as an iodinated strong base anion exchange resin prepared in accordance with a process as defined herein; an iodinated resin the same as a resin prepared in accordance with the (particular) process described herein iε one which has the same low iodine bleed characteristic, i.e. the iodine is (more) tenaciously associated with the resin than for previously known iodinated resins. It in particular relates to a demand disinfectant resin, the disinfectant resin being an iodinated strong base anion exchange resin whenever prepared in accordance with a process as defined herein.
The present invention also relates to the use of iodinated resins to disinfect fluids containing microorganisms, such fluids including air, water, pus, and the like. The iodinated resin may for example be a known resin such as discussed herein, a resin in accordance with the present invention, nylon based resin beads impregnated with iodine (such as MCV resin from MCV Tech. Intn'l Inc.) , and the like.
Thus the present invention also provides a method for disinfecting air containing airborne microorganisms, said method comprising passing said air over a disinfectant resin such that airborne microorganisms contact said resin and are devitalized thereby, said disinfectant resin comprising an iodinated resin. The disinfectant resin may, for example, be a demand disinfectant resin. The disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin.
The present invention further provides a system for disinfecting air containing airborne microorganisms, said system comprising means for providing an air path for the movement of air therethrough, and a disinfectant resin disposed in said air path such that airborne microorganisms in air passing through said air path are able to be brought into contact with said resin and be devitalized thereby, said disinfectant resin comprising an iodinated resin. The disinfectant resin may, for example, be a demand disinfectant resin. The disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin.
The present invention additionally provides a combination comprising a disinfectant component and a carrier component, said disinfectant component comprising particles of an iodinated resin, said particles of said disinfectant component being held (e.g. fixed) to said carrier component. The disinfectant component may, for example, be a demand disinfectant component. The disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin. The combination may be used as a means for providing a barrier or shield for the body against microorganisms. The combination may thus, for example, be incorporated into a textile or other wearing apparel starting material in the form of a layer (e.g. a liner layer) . The obtained raw wearing apparel material may then be used to make a protective garment, glove, sock, footwear (e.g. shoe) , helmet, face mask and the like; the obtained wearing apparel may be worn in hazardous environments to protect the wearer from contact with viable microorganisms. The combination as desired or as necessary may flexible or stiff; depending on the nature of the carrier component and also on the form of the resin (e.g. plate, particle, etc.).
The present invention in a more particular aspect provides a sterilisation dressing, for being applied to a lesion, (such as a sore, a wound (e.g. cut) , an ulcer, a boil, an abrasion, a burn or other lesion of the skin or internal organ) , said dressing comprising a disinfectant component and a carrier component, said disinfectant component comprising particles of an iodinated strong base anion exchange resin, said carrier component being configured so as to hold onto particles of said disinfectant component such that microorganisms are able to be brought into contact with said particles and be devitalised thereby, said carrier component being of a pharmaceutically acceptable material. The disinfectant component may, for example, be a demand disinfectant. The disinfectant resin may, for example, comprise an iodinated strong base anion exchange resin. The carrier component may be stiff or it may be flexible as desired. The (sterilization) dressing may, for example, be applied over a wound or burn and be held in place over the time period needed for the body to repair the damaged area; the dressing during this time will act not only as a barrier or shield to prevent infectious microorganisms from contacting the lesion but also to sterilize the immediate area around the lesion including sterilising any fluid exudate such as pus which may exude from the lesion. Surprisingly, it has, for example, been found that even with relatively prolonged exposure of (guinea pig) skin to the active element of the dressing (i.e. the demand disinfectant) no irritation or inflammation was noted. It has also surprisingly been found that the dressing may effect infectious agents deep beneath the skin or dressing. The healing process may thus be hastened by the application of a (sterilization) dressing in accordance with the present invention.
The demand disinfectant for the above mentioned method and system for treating air as well as for the combination and the dressing may be an iodinated resin produced in accordance with the present invention or it may be a known demand disinfectant iodinated resin such as for example as mentioned herein.
The demand disinfectant depending on the intended use may take on any desired form; it may be bulk form; it may be in sheet form; it may be in particulate or granular form (e.g. particles of resin of from 0.2 mm to 1 cm in size), etc..
It is to be understood herein, that if a "range" or "group of substances" is mentioned with respect to a particular characteristic (e.g. temperature, presssure, time and the like) of the present invention, the present invention relates to and explicitly incorporates herein each and every specific member and combination of sub-ranges or sub-groups therein whatsoever. Thus, any specified range or group is to be understood as a shorthand way of referring to each and every member of a range or group individually as well as each and every possible sub-ranges or sub-groups encompassed therein; and similarly with respect to any sub-ranges or sub-groups therein. Thus, for example,
- with respect to a pressure greater than atmospheric, this is to be understood as specifically incorporating herein each and every individual pressure state, as well as sub-range, above atmospheric, such as for example 2 psig, 5 psig, 20 psig, 35.5 psig, 5 to 8 psig, 5 to 35, psig 10 to 25 psig, 20 to 40 psig, 35 to 50 psig, 2 to 100 psig, etc.. ;
- with respect to a temperature greater than 100° C, this is to be understood as specifically incorporating herein each and every individual temperature state, as well as sub-range, above 100° C, such as for example 101° C, 105° C and up, 110° C and up, 115° C and up, 110 to 135° C, 115° c to 135° C, 102° C to 150° C, up to 210°
- with respect to a temperature lower than 100° C, this is to be understood as specifically incorporating herein each and every individual temperature state, as well as sub-range, below 100° C, such as for example 15° C and up, 15° C to 40° C, 65° C to 95° C, 95° C and lower, etc.;
- with respect to residence or reaction time, a time of 1 minute or more is to be understood as specifically incorporating herein each and every individual time, as well as sub-range, above 1 minute, such as for example 1 minute, 3 to 15 minutes, 1 minute to 20 hours, 1 to 3 hours, 16 hours, 3 hours to 20 hours etc.;
- and similarly with respect to other parameters such as low pressures, concentrations, elements, etc...
It is also to be understood herein that "g" or "girt" is a reference to the gram weight unit; that "C" is a reference to the celsius temperature unit; and "psig" is a reference to "pounds per square inch guage".
In drawings which illustrate example embodiments of the present invention: Figure 1 is a graph of showing the ppm of Iodine in the effluent versus the total volume of water contacted with a disinfectant-resin bed of the prior art and an example disinfectant resin of the present invention; Figure 2 iε a graph of the number of microorganisms in effluent versus the total volume of contaminated water contacted with a disinfectant reεin of the prior art and an example diεinfectant reεin of the present invention; Figure 3 iε a perεpective view of a cartridge which may be used to house an iodinated resin aε described herein for use for example in a gaε mask; Figure 4 is a crosε εectional view 4-4 of the cartridge of figure 1; Figure 5 iε a εchematic illustration of a system for testing a cartridge containing an iodinated reεin; Figure 6 iε a εchematic illuεtration of another type of εyεtem for teεting a cartridge containing an iodinated reεin; Figure 7 iε a partially cut away perεpective view of a εteriliεation dreεεing of tea-bag type conεtruction wherein the iodinated resin particles are free flowing but are held together by being enveloped by a fluid (e.g. air-liquid) permeable envelope of paper, gauze, plaεticε material, etc.;
Figure 8 is a perspective view of a band-aid type sterlization dressing, wherein the iodinated resin particles are fixed to a central portion of an outer εurface of a flexible band-aid carrier;
Figure 9 iε a perεpective partially cut away view of a εteriliεation foam or εponge type dreεεing compriεing a flexible foam matrix having iodinated reεin particleε diεperεed therein, the foam matrix having a relatively small pore size structure;
Figure 10 is a perspective partially cut away view of a steriliεation foam or εponge type dreεεing compriεing a flexible foam matrix having iodinated reεin particles disperεed therein, the foam matrix having a relatively large pore size structure; and
Figure 11 is a croεε εectional view of a εandwich type of textile material for uεe in the preparation of protective clothing, the textile including a layer of a flexible foam matrix εuch aε is shown in figure 10.
In accordance with the present invention, the elevated temperature may aε mentioned above, for example, be in the range of from 105° C to 150° C; the elevated pressure may be 5 psig and up.
In accordance with the process of the present invention the anion exchange reεin may, for example, as described below, be a quaternary ammonium anion exchange resin; the anion exchange resin may be in the chloride form Cl", in the hydroxyl form OH"; etc....
In accordance with the present invention the obtained iodide- resin may be treated prior to use to remove any water- elutable iodine from the iodide-resin. The treatment (e.g. washing) may be continued until no detectable iodine is found in wash water (the wash water initially being ion free water) . Any suitable (known) iodine teεt procedure may be uεed for iodine detection purpoεeε (εee for example the above mentioned U.S. patentε.
In accordance with the preεent invention, the abεorbable iodine εubεtance may, for example, be provided by a compoεition conεiεting of mixture of KI, I2 and a minor amount of water, the mole ratio of KI to I2 initially being about 1; the expreεεion "minor amount of water" aε uεed herein εhall be underεtood aε characterizing the amount of water aε being sufficient to avoid I2 crystallization.
The preεent invention in a further aspect provides an enhanced iodine/resin demand diεinfectant product in which more iodine may be distributed throughout and be more tenaciously asεociated with the reεin (e.g. beadε) than with the previouεly known or commercially available techniques, the disinfectant being produced by a procesε aε described herein. The invention more particularly provides an enhanced triiodide-resin disinfectant.
The present invention can be practised with any (known) εtrong baεe anion exchange reεin (for example, with those such as are described in more detail in the above-mentioned United States patents such as United States patent no 3,923,665) . A quaternary ammonium anion exchange resin is, however, preferred. As used herein, it is to be understood that the expresεion "strong base anion exchange reεin" deεignateε a claεε of reεinε which either contain strongly basic "cationic" groups, such as quaternary ammonium groups or which have strongly baεic propertieε which are εubstantially equivalent to quaternary ammonium exchange resinε. United Stateε patent noε. 3,923,665 and 3,817,860 identify a number of commercially available quaternary ammonium reεinε, aε well aε other εtrong base resinε including tertiary εulphoniu reεinε, quaternary phosphonium resins, alkyl pyridinium resinε and the like.
Commercially available quaternary ammonium anion exchange resins which can be used in accordance with the present invention include in particular, Amberlite IRA-401 S, Amberlite IR-400 (Cl") , Amberlite IR-400 (OH"), Amberlite IR- 402 (Cl") , etc., (from Rohm & Hass) which may be obtained in granular form. These resins may for example, contain quaternary ammonium exchange groups which are bonded to styrene-divinyl benzene polymer chains. The resinε which may be uεed herein may be in a hydroxyl form, a chloride form or in another salt (e.g. sulphate) form provided that the anion is exchangeable with the iodine member (e.g. with triiodide ion) .
The starting resin may, for example, be granular (i.e. comprise a plurality of particles) εuch that the final product will likewise have a granular or particulate character; the granular form is advantageous due to the high surface area provided for contact with microorganisms. The starting resin may, for example, comprise granuleε having a size in the range of from 0.2 mm to 0.8 cm (e.g. of from 0.35 mm to 56 mm) .
Commercially available resins εuch as those mentioned above are available in the salt form (e.g. as the chloride) and in the form of porous granular beads of various meεh sizes; the resin may of course be used in a bulk or massive form such aε a plate, εheet, etc..
In accordance with the present invention, for example, a resin may be converted from a non-iodide form (e.g. a chloride form, a εulphate form) to the I3 " form. Suitable halide εaltε include alkali metal halides (such as KI, Nal,...); potassium iodide is preferred. Alternatively, an iodide form of the resin may be uεed and the resin contacted with a source of diatomic iodine. In accordance with the present invention any material or substance capable of donating an iodine-member absorbable by the anion exchange resin so as to convert the anion exchange resin to the desired polyiodide-resin may be used, as long as the denotable iodine-member thereof is a polyiodide ion having a valence of -1 and/or diatomic iodine. Examples of such materials in relation to iodine are shown in the above mentioned U.S. patents; e.g. compositions comprising iodine (I2) and alkali metal halide (KI, Nal, etc., KI being preferred) in aεεociation with water. Alternatively, if the reεin is in an iodide εalt form (I'1) , the material may compriεe the correεponding iodine in gaεeous form.
Thus, for example, if a triiodide-resin iε deεired the reεin may be contacted with an alkali metal iodide/I2 mix wherein the iodide and the diatomic iodine are present in more or less stoichiometric amountε (i.e. a mole ratio of 1) ; see the previously mentioned U.S. patents. By applying stoichiometric amounts of the iodine ion and iodine molecule (i.e. one mole of I2 per mole of I"1) , the iodide sludge will compriεe εubεtantially only the triiodide ions. If stoichiometric excesε quantities of I2 are used some of the higher polyiodide ionε may be formed. Preferably, no more than the εtoichiometric proportionε of I" and I2 are uεed in the initial aqueouε εtarting sludge so that subεtantially only triiodided attacheε to the reεin.
For example iodine may be combined with sodium, potaεεium or ammonium iodide and some water. The composition will contain monovalent iodine ion which will combine with diatomic iodine (I2) to form polyiodide ion. The molar ratio of iodine ion to diatomic iodine will dictate the nature of the polyiodide ion present , i.e. triiodide ion, mixtures of triiodide ion and other higher polyiodides ionε, pentaiodide ion, etc.... Uεing about 1 mole of iodine ion per mole of diatomic iodine the formation of triiodide ion will be favoured. If stiochiometric exceεε of diatomic iodine iε used this will favour the formation of higher polyiodides.
The determination of the (total) amount of iodine to be contacted with the resin, reεidence timeε etc., will depend upon such factors as the nature of the polyiodide it is desired to introduce into the structure of a resin; the nature of the εtarting reεin (i.e. porosity, grain εize, equivalent exchange capacity of the reεin, etc.), etc.. Thuε, for example, to determine the amount of iodine required to prepare a polyiodide resin, the equivalent exchange capacity of the resin needs to be known. If necessary, this can be readily determined for example by the procedure deεcribed in U.S. patent no. 3,817,860 (column 9, lines 15 to 28) . The components of the proceεε may be choεen εuch that the obtained iodinated εtrong baεe anion exchange resin may comprise a εtrong base anion exchange resin component which repreεents from 25 to 90 (preferably 45 to 65) percent by weight of the total weight of the obtained iodinated resin. The converεion at elevated conditionε, in accordance with the present invention, may be effected in a reactor which is pressure sealable during conversion but which may be opened for recovery of the reεin product after a predetermined reaction time. The proceεε may thuε be a batch proceεs wherein conversion at elevated temperature and presεure iε effected once the reactor iε εealed. In accordance with the preεent invention the reactor may be εized and the amount of reactantε determined εo aε to provide a void space in the reactor during reaction. In the case, for example, wherein the material having the denotable iodine-member is a εludge of alkali metal/I2 and water, the weight ratio of sludge to resin may be 1:1 or higher, eg. 1:1 to 5:1; a weight ratio of 1:1 (if Amberlite 401-S iε uεed aε the reεin) iε preferred so aε to minimize the amount of unabεorbed iodine which muεt be waεhed from the iodine/reεin product.
The high temperature/preεsure contact conditions may aε mentioned above be choεen with a view to maximizing the iodine content of the obtained iodine (e.g. iodine) demand resin.
In accordance with the present invention conversion of the resin to a polyhalide (e.g. I3 ") form may be effected at elevated temperature greater than 100° C, for example in the range of 105° C to 150° C (e.g. 110-115° C to 150° C) ; the upper limit of the temperature used will, for example, depend on the characteriεtics of the resin being used, i.e. the temperature should not be so high aε to degrade the reεin.
Aε mentioned in order to effect the converεion at elevated preεsure, the conversion may take place in a cloεed vessel or reactor. The presεure in εuch caεe may be a function of the temperature such that the presεure may vary with the temperature approximately in accordance with the well known gas equation PV = nRT, wherein V = the constant (free) volume of the reactor, n = moles of material in the reactor, R is the universal gaε conεtant, T is the temperature and P is the pressure. In a closed vessel, the temperature of the system may therefore be used as a means of achieving or controlling the (desired) presεure in the vessel depending upon the makeup of the Iodine mix in the reactor. Thus in accordance with the present invention, a reaction mix diεpoεed in a preεεure εealed reactor may be, for example, εubjected to a temperature of 105° C and a pressure of 200 mmHg, the presεure being induced by steam.
Alternatively, a relatively inert gas may be used to induce and\or augment the pressure in the reactor. Thus, a presεurized relatively inert gaε may be injected into a sealed reactor. The chosen gaε muεt not unduly interfer with the production of a εuitable iodinated reεin. The high temperature/pressure treatment may be conducted in a cloεed reactor in the preεence of (trapped air) , a non-interfering gaε εuch aε iodine itεelf or of εome other relatively inert (noble) gaε; the pressure as mentioned above may be augmented by the presεuring gas. Air, carbon dioxide, nitrogen or the like may also be uεed as a presεuring gaε, if deεired, keeping in mind, however, that the uεe thereof must not unduly interfer with the production of a suitable iodinated resin. If pressure is to be induced by steam then as mentioned below εteps should be taken to isolate the reaction mix from (exceεs) water.
In accordance with the present invention, the elevated pressure is any preεεure above ambient. The preεsure may, for example, be 1 psig or higher, e.g in the range from 5 to 50 psig; the upper limit of the presεure uεed will also, for example, depend on the characteristics of the resin being used, i.e. the presεure εhould not be εo high aε to degrade the reεin.
The residence or contact time at the elevated conditions is variable depending upon the starting materials, contact conditions and amount of (tenaciouεly held) iodine it iε deεired to be abεorbed by the anion exchange reεin. The contact time may thuε take on any value; uεually, however, it iε to be expected that it will be desired that the contact time (under the conditions used) be sufficient to maximize the amount of (tenaciously held) iodine absorbed from the material containing the absorbable iodine moiety. The reεidence time may for example be aε little aε 5 to 15 minuteε (in the caεe where a preimpregnation εtep iε uεed aε εhall be described below) or several hourε or more ( up to 8 or 9 hours or more) . The residence time exploited for elevated the conditions, in any event, will aε mentioned above depend on the εtarting material, temperature and preεεure conditions, etc... ; it may vary from several minutes to 8 or 9 hours or more; the upper time limit will in any event also, for example, depend on the characteristics of the resin being used, i.e. the residence time should not be so high as to degrade the resin.
Preferably, the contact at high temperature/presεure iε preceded by an initial impregnation or absorption step (first stage) . Such first stage may be carried out for only a few minutes (e.g. for from 1 to 10 minutes or more) or for up to 24 hourε or more (e.g. for from one hour or more i.e. for from three to twenty-four hourε) . The time period of the initial stage may be relatively short. The time period, for example, may be a few minutes or εo and may correpond to the time necessary to just mix the reactantε together; in thiε caεe the converεion may be considered to be essentially carried out in a single stage at elevated conditions. The residence time of the first stage will also be predetermined with a view to the end product resin desired. For example, a water containing sludge of triiodide ions can be contacted with a salt form of the starting resin at ambient (i.e. room) temperature and pressure conditions to obtain an intermediate iodide-reεin reaction product including residual iodine- substance. This step is preferably carried out in a batch reactor; the obtained intermediate compoεition comprising an intermediate iodide-reεin may then be εubjected to the higher temperature and preεεure in accordance with the present invention in batch fashion as well. Such a first stage may be used to initiate buildup of iodine within the resin matrix.
In accordance with the present invention an iodide-resin demand disinfectant may, for example, be obtained by a) bringing a porouε, granular, εtarting reεin into contact with an aqueous sludge of iodine and potasεium iodide εo aε to obtain a paεte mixture, iodine being preεent in the εludge eεεentially as triiodide ions, εaid εtarting resin being a strong base anion exchange resin having strongly basic groups thereof in a salt form the anion of which is exchangeable with triiodide ions, b) subjecting the paste mixture to elevated temperature and pressure conditions in an enclosed container or reactor (e.g. autoclave) for a predetermined impregnating duration of time, a void space being provided in the reactor such that contact occurε under an (eεεentially) iodine (rich) atmoεphere, and c) washing the obtained iodide-resin product (with a suitable (i.e. purity) washing liquid, (e.g. deioniεed water, R/O water (at 45° C) , etc.) to remove water elutable iodine εuch aε KI from the surface of the resin so that on drying no iodine (KI) crystalε will form on the surface of the iodine/resin; R/O water, is water obtained using double reverεe oεmoεiε. R/O water is defined below.
More particularly an iodide/resin demand diεinfectant may be obtained using the following sequence of stepε:
1. The reεin iε purified by triple passage of water and then dispoεed in ethanol in an electroεonic bath and flushed with water and drip dried; 2. (Esεentially) εtoichiometric amounts of I2 and potassium iodide are admixed with a minimum amount of water which is just sufficient to obtain an I3- slurry or sludge (with, if desired, very low heating) ;
3. The resin is admixed with the above-minimal water slurry in small aliquats so as to obtain a predetermined weight ratio of slurry to reεin (e.g. a 50:50 weight ratio) ;
4. The reεin-slurry mixture is then placed in a εhaking bath at atmoεpheric pressure in a closed, air- tight container (if neceεεary the container being provided with a εmall preεεure releaεe valve or opening the purpoεe of which will be hereinafter explained) for a predetermined time period (e.g. for up to, for example, εixteen to twenty-four hourε or more [e.g. a week if deεired]) to form an intermediate reεin compoεition;
5. The container containing the reaction mixture iε then diεpoεed in a (εteam) autoclave and heated at high temperature, (e.g. 120° C) to provide a εuper atmoεpheric preεεure therein (with the ε all valve open if the container walls would not be able to resist the pressure to be exerted within the autoclave) for a predetermined residence time (e.g. a residence time of about fifteen minuteε) calculated from the time the mixture reacheε the predetermined high temperature (e.g. 120° C) .
6. The autoclave iε removed from the heat and aε εoon aε the preεsure is equalized to atmospheric, the internal container is removed and the resin product is washed (e.g. six times) with R/O water until the wash water comes out with a total iodine content of less than 0.1 parts per million.
A small hole is necesεary when a container such as a glass flask is used in order to avoid a too great preεsure difference being built up between the interior of the flask and the interior of the autoclave which might cause the flask to collapse. The hole in any event is juεt large enough to more or leεε allow for the equalization of preεεure and to maintain a poεitive presεure in the flask relative to the interior of the autoclave such that any foreign material such aε water vapour is inhibited from flowing into the flask. A more εturdy preεεure reεistant container could of course be used such that, depending on the construction of the container and the temperature/preεεure conditionε prevailing in the autoclave, the hole may be avoided. Alternatively, instead of using a separate container to hold the reaction mix and placing it in a separate autoclave, a single autoclave/container may be uεed serving to hold and heat the reaction mix under presεure; such a container muεt of course be constructed so as to be able to resist the predetermined reaction conditions.
The iodide-resin compound formed as described herein can be used as a demand disinfectant to diεinfect water by batch contacting the contaminated water with the reεin; continuouε proceεεing as mentioned in United States patent no 3,923,665 is also possible. Thus water containing viable bacteria (to be killed) may be paεεed through a fixed bed of porous granular iodine/resin material. The maximum permisεible flow rateε for total bacterial εterilization may vary with the concentration of the polyiodide (e.g. triiodide) groupε in the resin, bed depth, bacterial count, etc... The disinfection process may be monitored by taking sampleε of water after paεsage through the bed. Potable innocuous water may thus be readily produced in accordance with the present invention without the incorporation of objectionable amountε of free iodine therein as a result. The resin may be used with any (known) water treating devices such as for example those shown in U.S. patent nos. 4,749,484 and 4,978,449.
In accordance with a further aspect, however, as mentioned above, the present invention also provideε a method for disinfecting air containing airborne microorganismε. The method may comprise pasεing the air over a demand diεinfectant resin such that airborne microorganisms contact said resin and are devitalized thereby, the demand disinfectant reεin comprising an iodinated strong baεe anion exchange reεin. The method may, for example, include passing the air through a bed of granules of iodinated resin so that the air courseε over the granules (in a serpentine manner) aε the air makeε itε way through the bed. The maximum permissible flow rates for total bacterial sterilization may vary with the concentration of the polyiodide groups in the resin, bed depth, bacterial count, etc... The iodinated strong base anion exchange resin may comprise a strong baεe anion exchange reεin component which repreεents from 25 to 90 (preferably 45 to 65) percent by weight of the total weight of the iodinated resin.
In accordance with an additional aspect, the preεent invention provideε a system for disinfecting air containing airborne microorganisms, said εyεtem, for example, comprising means for providing an air path for the movement of air therethrough, and a demand diεinfectant reεin diεpoεed in εaid air path εuch that airborne microorganiεms in air passing through said air path are able to be brought into contact with εaid resin and be devitalized thereby, said demand disinfectant comprising an iodinated strong baεe anion exchange reεin. An air path means may define an air inlet and an air outlet. The resin may be dispoεed between said inlet and outlet or be dispoεed at the inlet or outlet. The air path meanε may take any form. It may take the form of ductwork in a forced air ventilation system with the demand disinfectant comprising a bed of reεin granuleε through which the air iε made to paεε, the bed otherwiεe blocking off the air path. Alternatively the air path meanε may be defined by a cartridge uεed for a gas mask, the cartridge having an inlet and an outlet for air; the iodinated reεin for the cartridge may, if deεired, be preεent aε a bed of granuleε, granuleε incorporated into a (fluid) porouε carrier (e.g. tissue, polyurethane foam, etc.) or alternatively take a more masεive form such as a plate(ε), a tube(s), a block(s), etc.. Cartridge type gas maskε are known; εuch gaε maεkε may be obtained for example from Eastern Safety Equipment Co., Mosport, New York, USA.
The C-50 cartridge from a gas mask (from Glendale Protecting Technologieε Inc. oodbury , New York, USA) may for example be adapted to hold a bed of reεin of granules of the present invention. Referring to figure 3, the cartridge 1 compriεeε an a hollow, open ended, thi-walled, tubular body of circular croεε εection. The wall 2 may for example be of nylon. The open endε of the cartridge are each blocked off by some suitable meεh like support material 3 (e.g. 10 micron polypropylene mesh) which is held in place in any suitable known manner such aε by glues, spring clip, etc. Referring to figure 4, the iodinated granular resin bed 4 occupies the entire space between the meεh supports 3 and 3 * ; although the granular resin is more or less tightly packed between the mesh εupportε 3 and 3 ' , there are εtill air spaces between the granules for the passage of air through the granular bed. The mesh supportε each have openingε εmall enough to retain the iodinated resin in place while allowing air to pass therethrough into the and through the supported resin bed 4. The cartridge as shown in figure 4 may include a downstream bed 5 of granules of activated carbon, catalyst, or iodine absorbent resins, to scavenge any iodine liberated from the iodinated resin 4. The activated carbon bed 5 iε held in place by a meεh support 3' and an additional mesh 6. The bed depth of the resin and carbon is shown as about 2.5 cm; wheras the bed diameter is about 8 cm. If the iodinated resin made in accordance with the procesε of the present invention is uεed the carbon bed may be omitted, i.e. only the iodinated resin bed 4 may be present in the cartridge as the active component (in the examples below, unless the contrary is indicated, the cartridgeε do not include any carbon bed) ; in thiε caεe the bed depth may, for example, be leεs 2.5 cm, e.g. 0.1 cm, 0.25 cm, 0.5 cm, 0.85 cm, 1.15 cm, etc.. Such a cartridge may be disposed in an air path as shown for example in figureε 5 and 6 which will be diεcuεεed below.
The reεin diεposed in the air path could of course take on any form other than granuleε εuch as blocks, plates, tubes etc.. The iodinated demand disinfectant resin for air treatment may be any (known) iodinated resin so long as the iodinated reεin iε capable of devitalizing airborne microorganisms (i.e. microorganismε tranεported by air) coming into contact therewith. It may, for example, be a reεin as proposed in U.S. patent nos. 3,923,665 and 4,238,477; in thiε caεe, however, it may be necessary to use the resin in conjunction with an iodine εcavenging material if the reεin gives up too much iodine to the air. The iodine scavenging material may be an activated carbon material or an un-iodinated strong baεe anion exchange reεin aε deεcribed herein.
Alternatively, as mentioned above, iodinated resin may advantageously be a resin made in accordance with the preεent invention; in thiε caεe the reεin need not be uεed in conjunction with an iodine εcavenging material εuch as a (known) exchange resin, activated carbon, catalyst, etc. , since an iodinated resin made in accordance with the procesε of the preεent invention may liberate iodine into the air in an amount below acceptable threεhold limits for breathing by human beings.
If desired the iodinated reεin for the treatment of air or water may be εome type of mixture of iodinated reεinε, e.g. a mixture of a known iodinated reεin and an iodinated reεin prepared in accordance herewith.
Aε mentioned above, the preεent invention in a further aεpect provides a combination which may act as a sterilization barrier with respect to microorganiεms. The sterilization combination may, for example, be incorporated into protective wearing apparel or be configured aε a εterilization dreεεing for leεions such as for example, wounds and burns; the εterilisation barrier combination can be configured to be or not to be air breathable.
A sterilization dressing of the present invention advantageously may take the form of a flexible porouε cellular polymeric foam εheet having a spongy aspect and having dispersed within the polymeric matrix thereof particles of a demand disinfectant comprising a (known) iodinated reεin or an iodinated resin as deεcribed herein. The εterilization εheet may be placed over a burn area to maintain the burn area in a εterilized εtate during the healing proceεε. The diεinfectant particleε are diεtributed throughout the polymeric matrix and have εurfaceε projecting into the open poreε of the εpongy matrix; the εpongy matrix acts as a sponge so that on the body side thereof it can soak up fluid εuch aε puε which exude from the burn leεion. Once within the body of the matrix any microorganisms in the fluid or pus can contact the diεinfectant reεin particleε and become devitalized aε a reεult. On the other hand, any microorganiεms on the opposite side of the sterilization barrier which attempt to pass through the barrier are also subject to being contacted with the diεinfectant and are also devitalised. A (flexible) phamaceutically acceptable hydrophilic foam matrix may be obtained by reacting water with HYPOL foamable hydrophilic polyurethane polymer; the HYPOL polymer starting material may be obtained from .R. Grace & Co. Lexintington Mass. U.S.A.. Water reacts to cross link the HYPOL polymer; if water is added quickly or at relatively high temperature foaming occurs and a foam product is obtained.
The carrier component may, as necessary, also be oil or fat loving, e.g. for dealing with individuals with high cholesterol levels.
If desired the iodinated resin for the steriliεation combination may be some type known iodinated resin, a resin prepared in accordance herewith, or a mixture of iodinated resins, e.g. a mixture of a known iodinated resin and an iodinated reεin prepared in accordance herewith.
Figureε 7 to 11 which illuεtrate a number of example embodiements of steriliεation barrier combinationε of the present invention will be discussed below; these combinations are also described in example 15 below.
Turning back to the procesε of the preεent invention, if commercially available materials are to be used to make the iodine/resin then, depending on the purity thereof, the εtarting materials may have to be treated to remove components which may interfer with the absorption of the halide into the resin. Water if present in the initial reaction mix should be free of interfering elements such as interfering ions. Distilled or ion free water is preferably used for washing.
The following materials may be used to prepare a triiodide reεin in accordance with the preεent invention:
a) Amberlite 401-S (from Rohm & Haεε) a strong base anion exchange reεin in granular form, having the following characteriεtics: support matrix - styrene/divinyl benzene polymer anion - chlorine denεity - 1.06 effective εize (diameter) - 0.52 mm total exchange capacity - 0.8 meq/ml working Ph range - 0 to 11 moisture content - 62% working temperature - 170° F or less
b) I2 (solid) - U.S.P. grade (from Fiεher Scientific)
c) Potaεεium iodide (KI) - U.S.P. grade (from Fiεher Scientific)
d) Water - ultra pure: obtained using double reverεe oεmoεiε (i.e. herein sometimes referred to simply aε R/O water) e) Ethanol - U.S.P. grade (from Fisher Scientific)
Uεing the above εubstances a resin cramed with triiodide (i.e. a triiodide jam-backed reεin) may be obtained as indicated in the following examples.
For the following exampleε, the following procedure for the evaluation of iodine (I2) and Iodide (I") , waε conducted according to "εtandard methodε for the examination of water and wastewater 17e Ed.":
Iodine method: mercuric chloride added to aqueous elemental iodine εolutions causes complete hydrolysis of iodine and the stoichiometric production of hypoiodouε acid. The compound 4, 4', 4" methylidynetriε (leuco crystal violet) reacts with the hypoiodous acid to form cryεtal violet dye. The maximum absorbance of the crystal violet dye εolution iε produced in the Ph range 3.5-4.0 and meaεured at a wavelength of 592 nm. The abεorbance follows beers' law over a wide range of iodine concentration. Iodine can be meaεured in the preεence of max. 50 PPM iodide ionε without interference.
Iodide method: iodide is selectively oxidized to iodine by the addition of potasεium peroxymonoεulfate. The iodine produced reactε inεtantaneously with the indicator reagent leuco crystal violet over the same conditions described previously for iodine methods. Total iodine + iodide results from this procedure and iodide is calculated from substraction of iodine concentration.
Readings were performed on a lkb spectrophotometer with a lightpath of 1 cm and selected at 592 nm.
EXAMPLE 1: STARTING MATERIALS PRETREATMENT:
i) Resin:
The resin is water waεhed to remove undeεirable elementε such as material in ionic form. Thuε, 100.00 grams of Amberlite 401 S and 200 ml of R/O water are placed in an erlenmyer of 1000 ml. The mixture is shaken for about 3 minuteε and the water iε then εeparated from the reεin by drip filtration uεing a wathman filter paper and funnel. The reεin iε water waεhed in the εame faεhion two more timeε. After the laεt water waεh the resin is drip dried (i.e. again using a wathman filter paper and funnel) for 15 minutes.
The εo recovered water washed resin is subjected to an alcohol wash to disεolve undeεirable organic material which may be stuck on the resin. Thuε, the water washed resin is immersed in 300.00 ml of ethanol. The reεin alcohol mixture iε εhaken in an ultrasonic bath (Crest ultrasonic:1000 Watts - 20 liter capacity) for 5 minuteε. The alcohol washed resin is drip dried, again using a wathman filter paper and funnel. The "fiεh" smell iε removed from the alcohol waεhed resin by a final water washing stage wherein the wash R/O water is preheated to 40 degreeε celεius. The alcohol washed resin is placed in an erlenmyer flaεk (1000 ml) and 250 ml of R/O water at 40 degreeε celεius is added thereto. The water-resin mixture is shaken in a shaking bath (Yamata shaking bath - 1 impulse per εecond/water at 32 degrees celsius) for 5 minutes; the water is then removed from the resin by drip drying aε mentioned above. The water wash is repeated once more and the resin is drip dried (for 1 hour) as mentioned above. The washed reεin iε now ready for use in example 2 hereinbelow.
ii) Iodine sludge containing water:
A mixture of iodine (I2) and potaεsium iodide (KI) iε prepared by mixing together, in an erlenmyer flaεk, 60.00 grams of iodine and 40.00 grams of potassium iodide (in both caseε on a dry weight baεiε) . Thereafter R/O water is admixed slowly drop by drop with the mixture until a metallic looking sludge iε obtained (e.g. with the addition of about 5.00 grams of water). The obtained iodine/potassium iodide sludge iε then ready for use in example 2 hereinbelow.
EXAMPLE 2: LOW TEMPERATURE/PRESSURE PREIMPREGNATION OF
RESIN WITH IODINE The aqueous iodine sludge, as obtained above, is placed in a 500.00 ml Erlenmyer flask and is slowly heated to, and maintained at 40 degrees celsius for a few minuteε. Once the temperature of the sludge reaches 40° C, the washed resin, obtained aε above, iε slowly admixed with the iodine sludge in 10.00 gram portions every 8 minutes until all of the washed resin is within the erlenmyer flask. The 500 ml Erlenmyer flask, containing the obtained starting mix (comprising the I2/KI mixture and the washed reεin - approximately 100 gramε of each of the starting materials) , is then sealed with a cork and is placed in a shaking water bath (Yamato BT:-25) for a period of 16 hourε. The temperature of the water in the shaking bath is maintained at about 20 degrees celsiuε during thiε time period. At the end of the time period, the Erlenmyer flaεk iε removed from the εhaking bath; at thiε point the removed flask contains an preimpregnation mix compriεing impregnated reεin and remaining I2/KI. The Erlenmyer flask is εized εuch that at the end of this (initial) impregnation step, it is only 50% filled with the in procesε resin, etc, i.e. there is a void volume above the impregnation mix.
NOTE: If procesεing of the treated reεin iε εtopped at thiε point and the obtained reεin iε suitably washed, a resin is obtained in accordance with the prior art i.e. U.S. patent no. 3,923,665.
EXAMPLE 3: ELEVATED PRESSURE/TEMPERATURE TREATMENT The cork of the Erlenmyer flaεk of EXAMPLE 2 removed from the εhaking bath and including the obtained impregnation mix comprising impregnated resin and remaining I2/KI, is changed for a cork having a εmall diameter perforation passing therethrough (i.e. of about 3 mm in diameter) . With the perforated cork in place, the Erlenmyer flask iε disposed within a (steam pressure) autoclave along with a suitable amount of water. With the autoclave (preεεure) εealed about the flaεk, the autoclave iε heated. Heating proceedε until an internal temperature and preεεure of 115 degreeε Celεiuε and 5 pεig reεpectively iε reached. Once thoεe parameterε have been reached, they are maintained for 15 minutes of processing time. Thereafter the autoclave is allowed to slowly cool for 50 minutes of cooling time
(until the internal pressure is equal to ambient preεεure) before removing the Erlenmyer flaεk containing a (raw) product reεin demand disinfectant in accordance with the present invention.
EXAMPLE 4: WASHING OF RAW PRODUCT RESIN
The (raw) disinfectant of Example 3 is removed from the autoclave Erlenmyer flask and placed in another 2000 ml Erlenmyer flaεk. 1400 ml of R/O water at 20 degreeε Celεius is admixed with the resin in the flask and the slurry is shaken manually for 3 minutes. The wash water is thereafter removed from the flask by decantation. This wash step is repeated 7 more timeε. The entire waεh cycle iε repeated twice (i.e. eight water washes per cycle) but using water at 45 degrees Celεius for the next wash cycle and then with water at 20 degrees Celsiuε for the last wash cycle. The washed iodine- resin iε then ready to use.
EXAMPLE 5: COMPARATIVE PHYSICAL DATA: The following resinε were examined with respect to certain physical characteristics:
Resin I-A :
Iodinated resin manufactured in accordance with the present invention i.e. as obtained from example 4 above.
Resin I-B :
Iodinated resin manufactured in accordance with teachings of the prior art (i.e. U.S. patent no. 3,923,665), namely as obtained from example 2 above after suitable washing to remove elutable iodine.
Resin I-C :
Iodinated resin manufactured by Water Technology Corporation in Minneapolis (a triiodide based disinfectant resin) . Resin I-D :
Iodinated resin manufactured by Water Technology Corporation in Minneapolis, sold under the Trademark: Pentapure.
In the exampleε which follow the above reεinε will be referred to uεing the above deεignations, i.e. I-D, Resin I- A, etc.
EXAMPLE 5.1: COMPARATIVE WET TAP DENSITY:
The reεinε were examined in a drip dried εtate, i.e. the reεinε were uεed after being drip dried uεing wathman filter paper and a funnel (for a 5 minute dry period) .
25 ml and 100 ml flaεkε were used for the study. The flaεkeε were weighed empty. The flaεkε were then filled with reεin and were then εubjected to a manual vibration εequence (approximately 2 impulεeε per εecond for two minuteε) in order to εettle the reεin, the volume of the settled resin was then noted. The density was obtained by weighing a filled flask and subtracting the weight of the empty flask so as to obtain the weight (gramε) per unit volume (ml) of the reεin. The reεults are shown in Table 1 below.
Table 1 Resin density I-A 1.720 gm/ml
I-B 1.480 gm/ml
I-D 1.600 gm/ml
EXAMPLE 5.2: COMPARATIVE DRY TAP DENSITY:
The same procedure aε deεcribed above for example 5.1 waε uεed except that the initial reεin materialε were dried εimultaneouεly for 12 hourε at 55 degreeε Celεius, and placed in desiccant for 2 hourε during cooling. The reεultε are εhown in Table 2 below.
Figure imgf000050_0001
EXAMPLE 5.3: IODINE CONTENT:
1.0 g of each of the different resins was boiled in 20 ml of water with a concentration of 5% by weight of εodium thioεulphate. Boiling waε conducted for 20 minuteε whereafter the water mixture waε set aside to air cool for 12 hours. The resin was then recovered and washed with 50 ml of a boiling water solution of εodium thioεulphate. Thereafter the reεin was dried in an oven for 12 hours at 105 degreeε. The iodine deεorbed reεin waε weighed in each caεe and the weight difference waε uεed to calculate the % by weight of the initial reεin repreεented by the active iodine removed. The reεultε are shown in Table 3 below.
Figure imgf000051_0001
NOTE: As may be seen from Table 3, the resin in accordance with the present invention (i.e resin I-A) has a εubεtantially higher iodine content than the commercially available resins or the resin prepared in accordance with the prior art
(i.e. resin I-B) .
EXAMPLE 5.4: COMPARATIVE IODINE CONTENT IN WATER DURING
STAGNATION: 100.00 gm of each reεin waε mixed with 125 ml of water in Erlenmyer flaεk which waε εealed airtight. The water mixture waε allowed to εtand 20 degreeε Celsius for 7 days. A water sample was then taken from each water mixture and subjected to a standard method for testing water for the presence of Iodine using the Leuco Cryεtal Violet lodometric Spectrophotometer Technique εo aε to obtain the "ppm" concentration of iodine in the water. The reεultε are εhown in Table 4 below. Table 4
Resin bleed iodine concentration (ppm)
I-A 1.7 ppm
I-D 2.5 ppm
NOTE: As may be seen from table 4, the resin of the present invention (reεin I-A) haε a εignificantly lower iodine bleed lose into water than the commercial product (resin I-D) .
EXAMPLE 5.5: RESIN SIZE STUDY:
Two grams of dry reεin waε examined with a microscope having a micrometer scale system and sized by eye. The reεultε are εhown in Table 5 below.
Table 5
Reεin Size (ie. approximate effective diameter size) - lowest to highest
AMBERLITE I 401 S 0.35 mm to 0.52 mm
I-A 0.60 mm to 1.20 mm
I-B 0.40 mm to 1.00 mm
EXAMPLE 6
Simultaneous teεtε were conducted to compare the antimicrobial activity of a diεinfectant reεin in accordance with the preεent invention (reεin I-A, above) and a prior art diεinfectant reεin (reεin I-D, above) . A series of batch solutionε waε prepared; each batch εolution contained a different microorganiεm. A batch εolution waε divided into test portions so that the comparative tests could be carried out against each of the resinε at the εame uεing a reεpective teεt portion of the batch εolution; the volume of the teεt portionε waε 150 literε. The same amount of each of the reεins was supported in a reεpective fixed bed configuration
(i.e. the reεinε were diεpoεed in a cylinder 1 cm high having an internal diameter of 3 cm) . The reεpective test solutionε were allowed to paεε downwardly through each of the resins in the same fashion and at the εame flow rate (i.e. the teεt conditionε were the same for each resin) . The testε were carried out at ambient conditionε of temperature and preεεure. The microorganiεmε and teεt reεultε were aε followε: a) A lyophilized εtrain of KLEBSIELLA TERRIGENA
(A.T.C.C. 33257) waε rehydrated in phoεphate-buffered εaline (PBS) and waε εubcultivated in order to obtain a broth with a bacterial denεity of 10° cfu/ml (cfu = colony forming unitε) . The broth waε treated to obtain media free monodiεperεed bacterial cells. The bacterial solution was then diluted in water to provide the teεt batch solution at an initial concentration of 4.8 X 107 cfu per 100 ml.
Microbiological monitoring of the test water was done throughout the experiment. Sampling of the filtered water was done at intervals prescribed by the: U.S.E.P.A. (protocol section 3.5.1 d 1(b)) with the membrane-filter technique for KLEBSIELLA deεcribed in: 17th edition of Standard Methodε for the examination of water and wastewater, pp. 9-97 to 9-99.
A test solution containing KLEBSIELLA TERRIGENA (A.T.C.C. 33257) at an initial concentration of 4.8 X 107 per 100 ml was pasεed through the fixed bed of each reεin at a flow rate of 125 ml/min to 200 ml/min. The treated volume of solution for each resin was 150 liters in total. Sampling of the effluent or treated εolution waε effected at intervalε correεponding with a predetermined percentage of the teεt portionε having paεεed through the reεinε. The reεults are shown in Table 6a below:
Table 6a
Total % of teεt Microorganiεm concentration in test solution pasεed effluent for each resin type (cfu/ml) through the reεin
Reεin I-D Reεin I-A
0%. ,0/0/0 .0/0/0 25% 0/0/0 0/0/0 50% 0/0/0 0/0/0 60% 0/0/0 0/0/0 75% .07070- 0/0/0 90% 0/0/0 0/0/0 100^ 0/0/0 0/0/0
As may be seen from table 6a the destruction of the bacteria was total in the case of each resin. b) Polioviruε 1 (A.T.C.C VR-59) waε obtained as a lypholized pellet, rehydrated in PBS, and grown on buffalo green monkey (BGM) kidney cells from the Armand Frappier Institute (IAF) in Laval Quebec. Standard cell culture and virological procedures were used to obtain a concentration of 3 x 107 of monodisperεed virion particleε per ml. Enough virus was added to a holding tank to obtain a concentration of about 1 X 107 pfu per liter for the test batch solution (pfu = plaque-forming units) .
The assay technique consiεted of inoculating healthy BGM cellε with a εmall amount of filtered water at regular intervalε. If a viruε particle were preεent, a plaque would be observed on the cellular bed thru the gellified maintenance media which contained a vital stain.
A test solution containing Poliovirus l (A.T.C.C VR-59) at an initial concentration of 1 X 107 pfu per liter waε paεεed through the fixed bed of each reεin at a flow rate of 125 ml/min to 200 ml/min. The treated volume of εolution for each reεin waε 150 literε in total. Sampling of the effluent or treated solution was effected at intervals corresponding with a predetermined percentage of the teεt portionε having passed through the resinε. The reεultε are εhown in Table 6b below:
Table 6b Total % of teεt Virus concentration in test effluent εolution paεεed for each resin type (pfu/1) through the reεin
Resin I-D Resin I-A
0% 0/0/0 0/0/0
25% 0/0/0 0/0/0
50% 0/0/0 0/0/0
60% 0/0/0 .0/0/0
75% 0/0/0 0/0/0
90% 0/0/0 0/0/0
100% 0/0/0 0/0/0
As may be εeen from table 6b the destruction of the Poliovirus waε total in the caεe of each resin.
c) Rotavirus (A.T.C.C VR-899) waε obtained , rehydrated in PBS, and grown on A-104 cellε obtained from IAF. The method uεed to obtain the diluted polioviruε above waε used with respect to the rotavirus. The yield for rotaviruε grown on MA-104 cellε waε 2xl06 pfu/ml. After dilution in the holding tank the concentration of the viruε waε 1 X 107 pfu per liter.
The aεεay techniqueε were εimilar to thoεe uεed for polioviruε, only the cell type and vital εtain changed εince they are εpecific for each type of virus. The same sampling strategy was applied.
A test solution containing Rotavirus (A.T.C.C VR-59) at an initial concentration of 1 X 107 per 100 ml was passed through the fixed bed of each resin at a flow rate of 125 ml/min to 200 ml/min. The treated volume of solution for each resin was 150 literε in total. Sampling of the effluent or treated εolution waε effected at intervalε correεponding with a predetermined percentage of the teεt portions having passed through the resins. The results are shown in Table 6c below:
Table 6c
Total % of test Viruε concentration in test effluent solution pasεed for each resin type (cfu/ml) through the reεin
Resin I-D Reεin I-A
0%. ,0/0/0 0/0/0 25% ,0/0/0 0/0/0 50% 0/0/0 0/0/0 60% 0/0/0 0/0/0 75% 0/0/0 0/0/0 90% 0/0/0 0/0/0 100 0/0/0 0/0/0
As may be seen from table 6c the destruction of the Rotavirus was total in the caεe of each reεin.
EXAMPLE 7
An iodine bleed teεt waε conducted on the Reεin I-A and Reεin I-D mentioned above. The tests were conducted as follows: A pressure syringe was filled with 20 gramε of resin (inner chamber of 3 cm x 13 cm) . Using a peristaltic pump 750 ml/min of R/O water (sterilized) waε pumped through the syringe; the resin being maintained in the syringe by suitable mesh means. The total water passed through the reεin waε 5 literε. The reεultε of the teεts are given in the graph shown in figure 1; i.e. ppm iodine in effluent vs total volume water pasεed through reεin. The bleed teεt reεultε aε εhown in the graph compareε iodine (I2) and iodide (I") in effluent of treated water after pasεing through each of the resins.
EXAMPLE 8
The bacteriocidal longevity of the Resin I-A and Resin I-D were determined for purposeε of compariεon. Two fixed resin bed devices were provided, one device loaded with one of the resins and the other device loaded with the other resin; each device was loaded with 75.00 grams of a respective resin. The tests for each resin bed were conducted simultaneously. For each resin bed, the εolution to be treated was passed therethrough at a flow rate of 2.0 litres per minute, with an initial concentration of Klebεiella Terrigena 1 X 107 cfu/100 ml. The effluent waε teεted at intervalε for the preεence of viable bacteria. As may be seen in the graph of figure 2, the volume of contaminated solution at which bacteria start to pasε through the prior art reεin (i.e. Reεin I-D) iε significantly less than the breakthrough volume for the resin of the preεent invention (i.e. Resin I-A) . From figure 2 it may be seen that the bacteriocidal activity of the disinfectant resin of the present invention (Reεin I-A) is superior to that of the known resin (Resin I-D), i.e. the Resin I-A has about a 16% εuperior antimicrobial activity in relation to the amount of water treatable by a given amount of disinfectant resin.
EXAMPLE 9: Preparation of Reεin I-A1 of the preεent invention
An iodinated reεin (Resin I-A') waε prepared following the procedureε of examples 1 to 4 except that for the resin, Amberlite IR-400 (OH") (waε uεed and for the procedure of example 3 the elevated temperature and preεεure conditionε were εet at 121° C and 15 pεig reεpectively. Reεin I-A1 waε uεed in the following exampleε.
EXAMPLE 10: COMPARATIVE IODINE CONTENT IN EFFLUENT AIR
Two cartridgeε aε illuεtrated in figures 3 and 4 were prepared. Each cartridge contained 50.0 grammes of dry (granular) resin (i.e. and no activated carbon bed) . One cartridge contained Resin I-A' and the other contained Reεin I-D.
The cartridgeε were each disposed in a syεtem as illustrated in figure 5 but which did not contain any atomizer indicated generally by the reference number 7. The system included a housing 8 for defining an air path and had an air inlet 9. The resin cartridge 1 waε disposed at the outlet of the air path. The air leaving the cartridge 1 was directed by appropriate tubing to a collector station 10. The syεtem included a vacuum pump 11 (but not the air sterilizer syεtem 12) for drawing air from inlet 9 through the εyεtem. In operation a cartridge 1 waε releasably placed in position
(e.g. snap fit, etc.) and the vacuum pump activated so as to draw outεide air (indicated by the arrow 13) into the houεing
8. The air paεεed through the cartridge 1 aε εhown by the arrowε 14. The air leaving the cartridge 1 waε then directed to the collector εtation 10. The air entering the collector εtation 10 impinged upon a iodine collector solution 15 (comprising double reverεe oεmoεiε water, i.e.
R/O water) in the collector εtation 10. Air leaving the collector station 10 thereafter pasεed through the pump 11 and waε exhauεted to the outside air.
Using the above described syεtem, each, cartridge was εubmitted to an air velocity therethrough of 0.7 Liter/per minute for a period of 50 minuteε. The collector εtation 10 included 50 ml purified R/O water (the water was then subjected to standard optical coloration techniqueε (i.e. the Leuco violet technique aε referred to in example 5.4 above), to determine the total iodine content) .
The reεults of the testε are εhown in table lOa:
Table 10a Reεin type total iodine (I2)
Resin I-A1 0.4 ppm Resin I-D 1.1 ppm
The reεults of the tests as εhown in table 9a meanε that each gramme of both of the reεin typeε will add a definite amount of iodine to the effluent air, namely aε indicated in table 10b.
Table 10b Resin type iodine (I2) release per gram resin
Resin I-A' 0.014 Mg/m3/gr
Reεin I-D 0.031 Mg/m3/gr
Thuε, for example, if a gas mask cartridge as discusεed above contained 50.0 gm of iodinated resin, the resinε would emit the level of iodine εet out in table 10c below
Table 10c Reεin type iodine (I2) release Resin I-A1 0.7 Mg/m3 (= 50 gr x 0.014 mg/m3/gr)
Reεin I-D 1.5 Mg/m3 (= 50 gr x 0.031 mg/m3/gr)
The "Committee of the American conference of governmental induεtrial hygieniεt." emitε the "threshold limit value" or T.L.V. for common chemicals. The iodine T.L.V. is 1.0 Mg/m3 for air analysis for human breathing during a period of 8 hrs.
Thuε, while the Resin I-D releaseε 50% more iodine than the maximum T.L.V. indicated above, the Reεin I-A' (of the preεent invention) releaεeε iodine at a level well below the T.L.V. The Resin I-A1 could thus be used without an iodine scavenger; thiε would, for example, simplify the construction of a gaε maεk cartridge. The known Reεin I-D on the other hand could also be used but it would require some sort of iodine scavenger (e.g. activated carbon) to obtain the necessary iodine T.V.L. level.
EXAMPLE 11: The Resin I-A1 was tested with different micro-organisms under different conditions for the sterilization of air.
EXAMPLE 11.1: Direct contact sterilization study
Reεin I-A' waε evaluated for itε biocidal capacity on direct contact with Klebεiella Terrigena in relation to a time reference and a humidity content variation; namely water content variationε of 110%, 50% & 0% (relative to the weight of dry reεin) and time variations of 2, 5, 10, and 15 secondε.
After preparing the three reεinε with their respective humidity content 25 glasε rodε were εterilized. A vial containing 25 ml of the inoculum (Klebεiella Terrigena: 10° x ml) waε alεo prepared.
The testing proceeded as follows with respect to the dry reεin. A glaεε rod waε immerεed in the inoculum and then immerεed in the dry reεin for 2 εeconds. The glasε rod was then washed in 100 ml phosphate buffer to wash out the microorganisms. Following the standard method for evaluation of water, the collected εample waε then plated and incubated. Thiε procedure waε then repeated for 5, 10 and 15 seconds.
The procedure was alεo repeated for the two other different humidity content batcheε of Reεin I-A1. The reεultε of the teεt are shown in table 11a.
Table 11a number of viable microorganisms per time period
2 sec. 5 sec. 10 sec. 15 sec % humidity
110% 16 0 0 0
50 % 23 1 0 0
0 % 67 15 0 0
As may be seen from table 11a, the Reεin I-A1 whether wet, humid or dry deεtroyε large quantitieε of reεiεtant bacteria in direct contact, and thiε deεtruction occurs on a relatively rapid time base as demonstrated above.
EXAMPLE 11.2: KLEBSIELLA TERRIGENA ERADICATION STUDY: AIR FLOW.
A study waε done to evaluate the biocidal effectiveness of dry Resin I-A1 versus Klebsiella Terrigena.
The system used was the εyεtem illustrated in figure 5. The system included an atomizer 7 (of known construction) diεpoεed in a houεing 8 provided with an air opening 9. The εystem had a vacuum pump 11 for the displacement of air through the system. The system included an air sterilizer 12 comprising a hollow houεing 10 inches high by about 2.5 inches in inner diameter and filled with about 1.5 kilograms of Resin I-A'; the sterilizer has an air inlet and outlet. The air path through the cartridge 1 is designated by teh arrows 14. The atomizer 7 contained an inoculum 16 (Klebεiella Terrigena: 107 x 100 ml) . For the teεt, the air flow at arrow 13 waε εet at 30 liters per minute and the air inflow at arrow 17 for the atomizer was set at 8 liters per minute; the atomizer 7 injected miεt or εpray 18 of inoculum into the air in the air path and the inoculated air then paεεed through cartridge 1 aε εhown by the arrows 14.
A cartridge 1 as illustrated in figures 3 and 4 was prepared using dry Resin I-A' (65.0 gm giving a bed depth of 1.15 cm) . The cartridge 1 was submitted to an injection of a total of 10 ml of inoculum over a time period of 15 minute. Sampling was done at 0 minutes, 7.5 minutes and at 15 minutes. The samples were collected in a standard impinger aε εhown in figure 5. After, proceεεing 100 ml of the water from the impinger on microbiological paper filter and incubation, the reεultε εhow total eradication of Klebεiella Terrigena.
EXAMPLE 11.3: BACILLUS PUMILUS ERADICATION: AIR CONTACT.
A εtudy waε carried out uεing the εyεtem εhown in figure 6. To the extent that members of the syεtem are the εame as those used in the system illustrated in figure 5, the same reference numerals are uεed to identify the same parts. The main difference between the syεtem of figure 5 and that of figure 6 iε that the εyεtem of figure 6 uεeε a microbiological filter paper 19 to collect the microorganiεmε leaving the cartridge 1; the filter paper iε maintained in place in any (known) εuitable faεhion.
An inoculum 20 of the thermophilic bacteria Bacillus Pumilus was prepared and injected at a concentration of 103/litre of influent air. A cartridge mask containing 65.00 gm of Reεin I-A1 waε prepared aε for the previouε example. The teεt ran for 30 minuteε.
All effluent (velocity at arrow 13 being 30 litreε per minute) waε collected on the microbiological filter paper 19 (from millepore) , then lain in a T.S.A. (trypticase Soy Agar) and incubated. the resultε εhowed total eradication of Bacilluε Pumiluε.
EXAMPLE 11.4: BACILLUS SUBTILIS STERILIZATION IN AIR FLOW.
This test was performed with Bacillus Subtilis in a mixture of 40% active bacteria / 60% sporeε. The εyεtem εhown in figure 6 was used with the cartridge comprising 50 grams of Resin I-A1 (giving a bed depth of .85 cm). The controlled concentration of processed air was 55 bacteriological units per litre. The air velocity was 23 litre per minute for 80 minutes.
Once the 80 minuteε ended, the millepore filter paper waε collected, lain on T.S.A. (after neutraliεation of potential iodine with εodium thioεulfate 5%) and incubated for 48 hours at 37 degree celsius. The resultε εhow a total eradication of micro-organiεmε.
EXAMPLE 11.5: BACILLUS SUBTILIS: Reεin I-A" versus glasε beadε in air flow.
In order to assess the retention factor of micro-organisms on inert materials thiε test was performed. Alεo, to evaluate the migration factor of the biological vector, a εequential incubation waε performed.
Two gaε cartridges were built in accordance with figures 3 and 4, namely:
a) Resin I-A' cartridge : 10 micron polypropylene upstream mesh (filter) ;
: 50.00 gm of Reεin I-A' giving a bed depth of .85 cm; : 10 Micron polypropylene downεtream mesh (filter) .
b) Glasε bead cartridge : 10 micron polypropylene upεtream mesh ( filter) ;
: 50.0 gm εterile glaεε beadε (from
Fiεher Scientific and having the εame εize aε the beads of Resin I- A1) giving a bed depth of .85 cm; and
: 10 Micron polypropylene downstream meεh (filter) .
The εyεtem aε εhown in figure 6 waε uεed for the teεts.
Simultaneously, the two cartridges were, once inεerted in their reεpective testing chamber, submitted to a velocity of 23 litre per minuteε for 40 minuteε with a microbiological load of 40 bacteria per litre in the influent.
Once the teεt period completed, the two cartridges were disεected in εterile conditions and the microbiological filter paper recovered. Each materials composing the masks were individually as well as the filter paper were incubated in T.S.A. for 48 hourε at 37 degree celεiuε. The results are shown in table lib.
Table lib
Resin I-A1 Glass beads
upstream mesh: 2 cfu tnc* cfu Resin\beads: 0 cfu tnc cfu
downεtream meεh: 0 cfu 220 cfu
microbiological filter paper: 0 cfu 86 cfu
tnc = microorganisms too numerous to count
As may be seen from table lib the Resin I-A' eradicated all bacteria and no living micro-organism can live in the resin bed.
The Glass beads on the other hand have a mechanical filtering capacity in regards to the biological vector but migration occurs rapidly thus obtaining "tnc" results (too numerous to count) on the upstream mesh and the beads themselves. The migration keeps on going through the filter until it reaches the microbiological paper filter in large number. Also, the glasε beads filter becomeε εeverely contaminated, cauεing a disposal problem.
EXAMPLE 11.6: BACILLUS SUBTILIS: Resin bed depth comparison This test was performed to establish the biocidal effectiveness of the Resin I-A' in regards to the microbiological eradication of Bacillus Subtiliε. The εyεtem of figure 6 waε used.
Two cartridgeε aε illustrated in figures 3 and 4 containing respectively 30.00 gm (giving a bed depth of 0.5 cm) and 50.00 Gr (giving a bed depth of 0.85 cm) of Resin I-A were submitted to 60 minutes of air pumping at a velocity of 27 litre per minutes. A total of 23 ml of inoculum at a concentration of 107 per ml were injected into the system.
A positive control yielded a concentration of 275 cfu/litre of air at the microbiological sampling site.
The results show total eradication for both cartridgeε.
EXAMPLE 11.7: BACILLUS SUBTILIS: LONGEVITY STUDY IN AIR
FLOW.
A cartridge of figure 3 and 4 containing 30.00 gr (bed depth: 0.5 cm) of Reεin I-A' waε εubmitted to an air flow velocity of 25 litre/ minute containing a concentration of Bacilluε Subtiliε of 112 cpu/litre (poεitive control for correlation) for a period of 3 hrs.
The test was done using the impinger technique (of figure 5) , with 300 ml of εterile water. Once the 3 hours completed the water from the impinger was filtered on a microbiological membrane as referred in standard method for analysis of water and waste water 17 th edition, pp.9-97 To 9-99. The growth media waε trypticaεe soy agar. The results after incubation for 48 hours at 37.5 degree celεiuε was total eradication. EXAMPLE 12: Studies of the fixation of iodine at different iodine concentrations
Reεin I-A1, Reεin I-B1, Reεin I-B" and Reεin I-A" were prepared aε followε:
Reεin I-A' waε prepared as described in example 9. Resin I-B' was prepared following the procedures of examples 1 and 2 except that for the resin, Amberlite IR-400 (OH") (from Rohm & Hasε) waε used. Reεin I-B" was prepared following the procedureε of exampleε 1 and 2 (uεing Amberlite 401-S) except that the amount of the I2/KI mixture waε adjuεted εo aε to provide a reεin compriεing about 30 percent iodine at the end of the procedure in example 2; the mixture obtained at the end of the procedure of example 2 waε divided into two equal partε and one part waε subjected to a wash to provide the iodinated resin obtained as at the end of the procedure in example 2; and Resin I-A" waε prepared by taking the remaining one half part of the intermediate mixture obtained in the preparation of Reεin I-B" (mentioned above) and εubjecting the mixture to the procedure of example 3 except that the elevated temperature and preεsure conditions were set at 121° C and 15 psig respectively.
The iodine content of the above iodinated reεinε was determined in accordance with the procedure outlined in example 5.3. The resinε were also subjected to an iodine bleed teεt aε outlined in example 7. The reεultε are εhown in table 12 below:
Table 12
Iodine leach
0.15 ppm 0.05 ppm
Resin I-B" 30.5 0.3 ppm
Resin I-A" 29.0 0.05 ppm
Aε may be εeen from table 12, εubjecting the reεin to a high temperature/preεεure treatment reεults in the iodine being more tenaciously fixed to the resin at different iodine concentrationε.
EXAMPLE 13: Air εtudy with I-B"
The procedure of example 11.6 waε followed uεing 30 grams of Resin I-B" and Bacillus Subtilis at a concentration of 275000 cfu per cubic meter. It was found that the Reεin I-B" eradicated only 7 to 10 % of the microorganiεmε. The reεultε of the teεt εhow that the Reεin I-B" iε not aε effective at eradicating microorganiεmε from air aε iε the Reεin I-A' ; it would be neceεεary to have εubεtantially more of Reεin I-B" in order to totally εterilize air aε compared with the Resin I-A' . EXAMPLE 14: Studieε of the fixation of iodine at different temperatures as well as at atmospheric and elevated pressureε
Reεin IA, Reεin 2B, Reεin 3A and Reεin 4B were prepared aε follows:
The starting resin waε Amberlite 402 (OH") from Rohm & Haεε. 1000 gramε of thiε reεin waε pretreated following the procedure outlined in example l(i). The obtained waεhed reεin waε divided into four 200 gram portionε. An iodine εludge (four portionε, one for each of the above mentioned 200 gm portionε of reεin) waε prepared aε outlined in example l(ii) but uεing twice the amount of materialε εuch aε the iodine and the potaεεium iodide. The 200 gm reεin portionε were each iodinated using a respective iodine sludge as follows:
Resin IA was prepared, using an above mentioned 200 gm resin portion and a respective iodine εludge, following the procedureε of exampleε 2 to 4 except that for the procedure of example 3 the elevated temperature and preεεure conditionε were set at 121° C and 15 psig respectively (while the reaction time at the elevated conditions remained at 15 minutes) ;
Resin 2B was prepared, using an above mentioned 200 gm resin portion and a respective iodine sludge, following the procedure of example 2 except that the temperature of the εhaking bath waε maintained at 40° C; Reεin 3A waε prepared, uεing an above mentioned 200 gm resin portion and a respective iodine sludge, following the procedures of examples 2 to 4 except that for the procedure of example 3 the elevated temperature and presεure conditionε were set at 121° C and 15 psig respectively while the reaction time at these elevated conditions waε set at 1.5 hours rather than at 15 minutes; and Reεin 4B waε prepared, uεing an above mentioned 200 gm reεin portion and a reεpective iodine εludge, following the procedure of example 2 except that the reaction mixture waε placed into a container having a looεe fitting cover; the container containing the reaction mixture waε placed into a heated water bath; the temperature of the reaction mixture was brought up to a boiling temperature of 100° C to 105° C over a period of 20 minutes and waε maintained at the boiling temperature og 100° C to 105° C for a period of 15 minutes; and thereafter the mixture was allowed to cool to room temperature over a period of about 1 hour (the reactor was not a preεεure εealed reactor but one wherein the loose fitting cover allowed gas\vapour to eεcape such that the reaction was carried out (eεεentially) at atmoεpheric preεεure - extra safety precautions had to be taken due to the violent sputtering of the reaction mixture and to the toxicity of the releaεed gaε\vapour) . The denεity of each of the obtained iodinated reεinε waε determined in accordance with the procedure outlined in example 5.1. The iodine content of the above iodinated reεinε waε determined in accordance with the procedure outlined in example 5.3. The reεinε were alεo subjected to an iodine bleed test as outlined in example 7. The resultε are shown in table 14 below:
Iodine leach Density
0.5 ppm 1.616 gm\ml 1.5 ppm 1.694 gm\ml 0.5 ppm 1.661 gm\ml
Figure imgf000074_0001
1.0 ppm 1.595 gm\ml
As may be seen from table 14, subjecting the starting iodine\resin mixture to a treatment at essentially atmospheric presεure and a temperature of 100° C to 105° C or lower (reεin 2B and 4B) doeε not reεult in the iodine being as tenaciouεly fixed to the reεin aε when uεing both a temperature above 100° C and a preεεure above atmospheric preεεure (reεinε IA and 3A) .
EXAMPLE 15: Steriliεation barrier combinationε for uεe aε wound (εteriliεation) dreεεingε
EXAMPLE 15.1 Preparation of εterilisation foam dressing The following εtarting materialε were uεed to prepare a sterilisation foam dresεing:
- a particulate iodinated reεin prepared in accordance with example 9 above; the reεin compriεing particleε or beadε of about 0.3 mm to about 0.7 mm;
- R/O water; and aε foam precurεor, HYPOL foamable hydrophilic polyurethane polymer, (code : # FHP2002) from W.R. Grace & Co. , Organic Chemicals Division, Lexington, Massachuεettε 02173.
The εteriliεation foam barrier waε prepared aε followε:
150 ml of R/O water was placed into a 300 ml beaker. The water was heated to 50° C. 10 cc of the HYPOL and 10 gm of the iodinated reεin were εimultaneouεly admixed with the heated water; mixing waε accompliεhed with a magnetic εtirring rod and waε carried out before and after the addition of the HYPOL and the reεin for the purpoεe of diεperεing the reεin particleε as homogeneously aε poεεible throughout the mixture. The obtained foam was set or cured in about 7 minutes; the resin particles were disperεed throughout the matrix of the foam which waε of porouε cellular εtructure (i.e. sponge like) . Once set the obtained flexible foam had a semi-sphere like form (see for example figure 9) ; εliceε of thiε foam material were taken so as to provide a foam dresεing having an eεεentially flat face for being applied against a wound. The obtained steriliεation foam waε flexible and sponge like in that it could absorb liquids εuch aε water, puε and the like.
EXAMPLE 15.2 Preparation of a band-aid like sterilisation dresεing
The following εtarting materialε were uεed to prepare a band- aid sterilisation dressing:
- a particulate iodinated resin prepared in accordance with example 4 above; the reεin compriεing particleε or beadε of about 0.3 mm to about 0.7 mm; and
- a strip of polymeric material having an adheεive on one face thereof (the εtrip waε Compeed) .
The εteriliεation strip barrier was prepared as follows:
An open ended ring funnel was dispoεed over a central area of the εtrip on the adhesive face thereof. Resin beadε were placed in the stem of the ring funnel εo aε to eεεentialy cover the central portion of the adheεive face defined by the ring; a plunger waε εhoved into the ring and a mild preεεure was applied to the resin beadε therein. The ring waε removed along with exceεε resin beads εo aε to leave behind a εingle layer of reεin beadε fixed to the adheεive face of the εtrip; the reεin beadε in the layer eεεentialy abutted each other. The εtrip barrier had a form as εhown in figure 8; if deεired the beads do not have to abut but could be spaced apart.
EXAMPLE 15.3 Animal infection study: cutε The foam type εteriliεation dreεεing obtained from example 15.1 waε teεted aε followε:
Eight male guinea pigs were shaved so as to expoεe eεsentially the same εkin area. The guinea pigε each weighed about 500 to 550 gm and were obtained from Charleε River, Quebec, Canada, a εub-diviεion of Bausch & Lomb; the guinea pigs were quarantined for a period of 48 hours before being prepared for and subjected to the teεtε.
The guinea pigs were prepared for the tests aε follows:
Esεentially the same area of skin of each of the guinea pigε waε aneεthetiεed uεing Carbocaine-V
(chlorhydrate of Mepivacaine USP 2%) ; thiε aneεthetic haε no known εterilisation qualities.
An inoculum compriεing a mixture of Staphillococuε
Aureus and Pseudomonaε Aeriginoεa waε prepared at
10° cfu/ml; the ratio of Staphillococuε Aureus to
Pεeudomonaε Aeriginoεa waε 1:1. 0.2 ml of the inoculum waε injected under the aneεthetiεed skin of each animal. A cruciform structured scalpel cut (#) waε made above the inoculum injection area of each of the animalε; i.e. the cuts were 1.0 to 4.0 cm long and 1.0 to 4.0 mm deep. Additional inoculum was dabbed onto the εurface cutε.
The animalε were divided into two groups of four animals each, one group to be used aε a control group and the other group aε a teεt group. A foam εteriliεation dressing was applied over the wound for each of the animals of the test group, i.e. the foam dresεing was placed in contact with the wounded skin area and maintained in place during the period of the test. The foam dreεεingε were maintained in place over the wound area by meanε of an adheεive εtrip which waε provided with an opening or window by meanε of which a portion of the foam dreεεing waε left uncovered and exposed to the air. No dresεing or εteriliεation material waε applied to the woundε of the animalε of the control group.
The four animals of the teεt group with dreεεingε developed no infection and the scaring process was initiated after 16 hourε. On the other hand the four control animalε developed infection and the infection waε εtill εpreading after 72 hourε.
The εtrip type εterilisation dressing obtained from example 15.2 was tested exactly as above for the foam dreεεing with exactly the εame reεultε.
EXAMPLE 15.4 Animal infection study: burns The same εtudieε aε deεcribed in example 15.3 were carried out except that the leεion waε a burn created with a 1.0 cm red hot rod; the hot rod waε firmly held againεt the εkin for about 3 to 4 seconds. The same Inoculum as in example 15.3 was injected beneath the burn area and alεo dabbed onto the εurface of the burned εkin. Exactly the same resultε were obtained for the two typeε of dreεsings as were obtained for the teεtε of example 15.3.
EXAMPLE 15.5 Animal infection εtudy: cutε with continual contact with infectiouε liquid The foam type εteriliεation dreεsing obtained from example 15.1 was teεted aε followε:
Four male guinea pigε were εhaved εo aε to expoεe eεεentially the εame εkin area. The guinea pigε each weighed about 500 to 550 gm and were obtained from Charleε River, Quebc, Canada; the guinea pigε were quarantined for a period of 48 hourε before being prepared for and εubjected to the teεtε.
The guinea pigε were prepared for the teεtε aε followε:
Essentially the same area of skin of each of the guinea pigε waε aneεthetiεed uεing Carbocaine-V
(chlorhydrate of Mepivacaine USP 2%) ; the area waε alεo εteriliεed uεing 70% isopropyl alcohol. A cruciform structured scalpel cut (#) was then made in the steriliεed area; i.e. the cutε were 1.0 to
4.0 cm long and 1.0 to 4.0 mm deep.
The animalε were divided into two groupε of two animalε each, one group to be uεed aε a control group and the other group aε a teεt group. A foam εterilisation dressing was applied over the wound for each of the animalε of the teεt group, i.e. the foam dreεεing waε placed in contact with the wounded skin area and maintained in place during the period of the test. The foam dreεsings were maintained in place over the wound area by meanε of an adhesive strip which was provided with an opening or window by means of which a portion of the foam dreεεing was left uncovered and exposed. No dresεing or εteriliεation material was applied to the wounds of the animalε of the control group.
An inoculum compriεing a mixture of Staphillococus Aureus and Pseudomonaε Aeriginoεa waε prepared at 107 cfu/ 100ml; the ratio of Staphillococuε Aureus to Pseudomonas Aeriginosa was 1:1. Sufficient inoculum waε prepared such that each of the animals of the test and control group could be bathed in the inoculum such that the bath liquid was in continual contact with the wound area, i.e. the bath liquid covered the dressingε. The animals of each group were kept in the bath inoculum for a period of 72 hours.
The two animals of the test group with dresεingε developed no infection and the εcaring proceεε waε in full process. On the other hand the two control animals each had developed infection.
EXAMPLE 15.6 Animal infection study: cuts contacted with aerosol borne infectious agents The same procedure as for example 15.5 was used except that instead of being maintained in a bath of inoculum, the inoculum waε applied uεing an atomiεer the same aε that used for example 11.2 for artificial creation of airborne infection of a wound; the inoculum used also had 10° cfu/ml rather than 107 cfu/100ml as in example 15.6. 4 ml of the inoculum waε sprayed directly on the wound of the control animals and on the dressing covering the wound of the test animals; the inoculum was so applied every hour for 8 hours with 72 hours of incubation. The same resultε aε in example 15.5 were obtained.
EXAMPLE 15.7 Skin reaction εtudy: iodine tincture
Three male guinea pigε were εhaved εo aε to expoεe eεεentially the same skin area. The guinea pigε each weighed about 500 to 550 gm and were obtained from Charleε River, Quebec, Canada; the guinea pigε were quarantined for a period of 48 hourε before being prepared for and εubjected to the teεtε.
The guinea pigε were prepared for the teεtε aε followε:
Eεεentially the same area of skin of each of the guinea pigε waε aneεthetiεed uεing Carbocaine-V (chlorhydrate of Mepivacaine USP 2%) ; the area waε alεo εteriliεed uεing &0& iεopropyl alcohol. A cruciform εtructured εcalpel cut (#) waε made in the εteriliεed area; i.e. the cuts were 1.0 to 4.0 cm long and 1.0 to 4.0 mm deep. An inoculum comprising a mixture of staphillococus Aureus and Pseudomonas Aeriginosa was prepared at 109 cfu/ml; the ratio of Staphillococuε Aureuε to Pseudomonas Aeriginosa waε 1:1.
The inoculum was only dabbed onto the surface of the wounds of each of the animals (no injection of inoculum under the skin) . It waε found that a 5% iodine tincture locally applied on the woundε would neutraliεe infection provided that the iodine tincture was applied at 0.1 ml directly after infection and every 2 hours thereafter for 10 hours; the iodine tincture was from Jean Coutu, Quebec, Canada - 5% iodine, 3.3% KI and 75% ethanol. However, it was noted that the skin in the periphery of the wound waε εeriouεly devitalised becauεe of the burning effect of the tincture i.e. of the iodine.
It waε also found that the iodine tincture did not stop infection from occurring if inoculum was injected under the skin.
EXAMPLE 15.8 Skin reaction study: sterilisation dresεingε
Three male guinea pigs were shaved so as to expoεe eεεentially the εame εkin area. The guinea pigs each weighed about 500 to 550 gm and were obtained from Charles River, Quebec, Canada; the guinea pigs were quarantined for a period of 48 hourε before being subjected to the testε.
A foam εteriliεation dressing of example 15.1 was applied over a εhave skin area of each of the animals, i.e. the foam dressing was placed in contact with the shaved εkin area and maintained in place during the period of the test. The foam dressings were maintained in place over the skin area by meanε of an adheεive εtrip which waε provided with an opening or window by meanε of which a portion of the foam dreεεing waε left uncovered and expoεed to the air. The dreεεing waε maintained in place for a period of 3 weekε. The covered skin area was examined every two dayε. No redness, rash, inflammation, or any other reaction waε noted; the covered εkin remained healthy.
The above procedure was also carried out uεing a strip sterilisation dresεing of example 15.2. However the dreεεing was maintained in place only for 7 dayε. Again, no redneεε, rash, inflammation, or any other reaction was noted; the covered εkin remained healthy.
Figureε 7 to 11 illustrate a number of example embodiements of steriliεation barrier combinationε of the preεent invention; εome of theεe combinationε are also described in example 15 above. Figure 7 showε a partially cut away perspective view of a sterilisation barrier dressing of tea-bag type construction wherein the iodinated resin particles or beads (one of which is designated by the reference numeral 30) are free flowing but are held together by being enveloped by a fluid (e.g. air-liquid) permeable envelope 31 of (known) pharmaceutically acceptable paper or gauze (e.g. a εuitable εterile gauze from Johnεon & Johnεon, Canada) . The paper or gauze iε permeable to fluidε εuch aε air and water but is able to hold onto the particles of iodinated resin enveloped thereby εince any holeε in the paper gauze are εized to be εmaller than the particleε of resin. This type of dressing may be made relatively small or relatively large keeping in mind the εize of the leεion that it iε intended to cover. The dreεεing may be made by providing a εheet of paper or gauze, placing the desired amount of resin particleε thereon and then folding one εide edge of the paper or gauze over the reεin particleε 30 εo as to overlay and abut the opposite side; these abuting side edgeε 32 and 33 aε well aε each of the reεpective εide edges of the two pairs of adjacent side edges indicated generally at 34 and 35 may be fixed together in any known manner, for example by compreεεion, εtitching or by the use of any known phamaceutically acceptable adhesive. The fixation of the sides is εuch that they will tend to maintain their integrity in the face of water , body fluidε or body exudateε (e.g. puε) . The embodiment εhown in figure 7 iε εhown may be considered as eεεentially having a plurality of resin bead layers; it could of course have only a single εuch layer.
Alternatively, the sterilisation barrier may take on a band- aid type aspect as shown in figure 8. The combination εhown haε a flexible carrier component 36. A central portion of one εide of the carrier component 36 haε fixed thereto a plurality of beads or particles (one of which is deεignated by the reference numeral 37) of demand disinfectant iodinated resin. The resin beadε 37 are fixed to the εurface by a εuitable adhesive which is phar acetically acceptable and which will maintain the beads on the carrier component even if exposed to water or body fluids or exudateε. The portion of the band surface 38 which surrounds the centrally dispoεed beadε 36 may alεo be provided with any (known) adhesive which may for example be able to releasably stick the combination to the skin (e.g. a latex based adheεive) . The carrier component 36 may, aε desired be permeable or impermeable to fluidε such as air, water, puε; prefereably, the carrier iε permeable to gaε such as air, water vapour, etc. at least in the region of the reεin beadε fixed thereto, i.e. thiε region iε air breathable. The carrier component 36 may be of any suitable pharmaceutically acceptable (plasticε) material (e.g. the carrier component may be a porouε hydrophobic material permeable to air and water vapour εuch aε deεcribed in U.S. patent nos. 3,953,566 and 4,194,041 - Gore-Tex) . The carrier component complete with an adheεive face may be obtained from Peco Marketing ltd. , Montreal, Quebec under the name "Compeed". Figureε 9, 10 and 11 εhow a number of further embodimentε of the sterilisation barrier combination.
Figure 9 εhowε a flexible sterilisation foam or εponge type dreεsing 39 for wounds. The dreεεing compriεeε a flexible pharmaceutically acceptable foam matrix 40 having iodinated resin particles (one of which iε deεignated with the reference numeral 41) dispersed therein. The foam matrix 40 has a porous open cell structure such that it is permeable to fluids such aε air and water and can absorb body liquidε in the manner of a εponge (e.g. the foam is hydrophilic and/or oil loving) ; the foam barrier is air breathable. The foam matrix 40 as shown has cells of relatively small εize εo aε to facilitate the abεorption of liquids such as puε. The reεin particles 41 making up the resin disinfectant component are distributed throughout and held or fixed in place by the polymeric matrix 40 εuch that εurface portionε of the reεin particles are exposed within the cells of the matrix 40. The exposed surfaceε of the reεin are available for contact with any microorganisms which may find their way into the cells of the body of the barrier combination; contact with the reεin devitaliεes the microorganismε.
The foam εteriliεation barrier or dreεεing 39 aε shown in figure 9 has a εemi-spherical like shape. The flat surface 42 may be applied to a wound or cut. The dresεing may be held in place by any εuitable meanε εuch aε for example any suitable strapping or by adheεive tape means. Preferably, the εterilisation foam dressing 39 is held in place such that at least a portion of it is exposed (e.g. exposed to the air) ; thus the means for holding the foam in place may be an adheεive εtrip which haε a central opening exposing at least a portion of the foam when the foam iε held in place. Once in place on the wound, the flexible foam εteriliεation barrier will εterilise the immediate area of the wound which it covers and also prevent other infectious microorganiεmε from contacting the wound from outside the body. Surpriεingly, however, it haε been found that the εterilisation barrier is also effective not only againεt microorganiεmε at the immediate εurface of a wound but also against thoεe deeper within the body in the area of a cut.
Figure 10 illuεtrateε another type of flexible foam εterilisation barrier 43. It differs from the steriliεation barrier shown in figure 9 in that the size of the cells (one of which iε deεignated with the reference numeral 44) is significantly larger than those for the foam shown in figure 9; this type of foam may be used aε a liner material for wearing apparel to provide the apparel with the ability to protect the wearer from (εkin) contact with viable microorganiεmε. The reεin beadε, εpheres or particles (one of which is deεignated with the reference numeral 45) are, aε in the caεe of the reεin spheres 41 for the foam barrier 39 of figure 9, dispersed in the foam matrix and are held or fixed in place thereby such that exposed surfaces of the resin are available for contact with any microorganiεmε which may find their way into the cellε of the body of the barrier combination; contact with the resin devitalises the microorganisms.
The foam matrix for the steriliεation barrierε of figures 9 and 10 may be made by admixing (known) starting reactants in (known) manner to make (known) foamε which are pharmaceutically acceptable. Known polyurethane foamε may for example be uεed. In order to make the εteriliεation barrier, the diεinfectant reεin particleε may be admixed with and diεperεed (e.g. more or leεε homogeneouεly) in the εtarting reactantε at the beginning of the foam producing reaction. The foam barrier may be set in molds or else cut to the deεired εhape. The foam εteriliεation barrier may take any deεired form such as sheetε, filmε, plugε, and the like; it may, for example, be molded εo aε to conform to the εhape of portion of the body to which it iε to be applied.
Aε mentioned above a (flexible) phamaceutically acceptable hydrophilic foam matrix may be obtained uεing water and HYPOL foamable hydrophilic polyurethane polymer εtarting material from W.R. Grace & Co. Lexintington Maεε. U.S.A..
The pore or cell εize of the foam barrier may be adjuεted in known manner; for example by altering the reaction temperature. For example in the caεe of HYPOL a temperature of about 50 to 70° C may be uεed to obtain small pore sizes and a lower temperature of about 35 to 45° C may be used to obtainer larger εized poreε.
Figure 11 εhowε a cross εectional portion of a εandwich type textile material 46 which incorporateε a flexible large cell εize sterilisation foam layer 47. The sandwich compriseε two outer flexible clothe type layerε 48 and 49 which are fixed to the central εteriliεation foam barrier 46 in any εuitable manner (e.g. by an adheεive, melt fuεion, etc.). The two outer layerε 48 and 49 may be of any desired material; they may be permeable or impermeable to fluids such aε air, water vapour, water and the like. They may for example be of cotton, polypropylene, etc.; or a Gore-tex type material mentioned above. A sheet of textile material as shown may cut into pieces of variouε εhapeε needed to form such protective wearing apparel as may be deεired, e.g. coatε, pantε, εockε, face masks (e.g. full face maskε or maεkε covering only the mouth and noεe) and the like.
The flexible foam layer 47 can be made in any known manner provided that diεinfectant resin particles are disperεed in the reaction mixture during the reaction εuch that the end product foam also has the reεin particleε diεperεed in the foam matrix and any microorganiεm able to penetrate into an interior cell of the foam may be able to contact a reεin particle expoεed into the cell and be devitalised thereby. The foam barrier as in the caεe of the foam dreεεingε mentioned may be configured to be permeable to fluids such aε air, water, etc.. The textile material 46 may be formed by first forming a sheet of the sterilisation foam; by providing sheetε of the desired outer layers; and then gluing the elements together such that the foam is sandwiched between the two other outer layerε. Alternatively, a mold may be used wherein opposed εurfaceε of the mold are provided with a reεpective outer layer; the foam εtarting materialε are introduced between the layers; and foaming activated such that the foam layer is produced in situ.
Although shown with two outer layers the combination of figure 11 may of course have only one εuch clothe like layer. Additionally if the outer layer or layers are permeable to fluids such as air, water, pus and the like, the wearing apparel made therefrom could as needed double as a kind of εteriliεation dressing; the textile may thus for example be air breathable.
Additionally although the foam sterilisation barrier has been described in relation to a flexible foam it may be a stiff foam depending upon the application; again the stiff foam matrix may be prepared in known manner.
An alternate embodiement of the εandwich type textile may be made wherein the foam matrix iε omitted; in thiε caεe the beadε may be placed between the outer layerε and the beads may be fixed in place for example by an adhesive or by melt fusion depending on the nature of the layers (e.g. melt fusion may be considered if the layers are of thermoplastics material; the textile may of course be so made aε to preεerve the flexibility of the combination.

Claims

I claim
1. A proceεε for preparing a demand diεinfectant reεin, said disinfectant resin being an iodinated strong base anion exchange reεin, the procesε compriεing a converεion εtep, the converεion εtep compriεing contacting a porouε εtrong baεe anion exchange reεin in a εalt form with a sufficient amount of an iodine-subεtance abεorbable by the anion exchange reεin εuch that the anion exchange reεin abεorbε εaid iodine-substance so aε to convert the anion exchange reεin to the demand disinfectant resin, said iodine- subεtance being εelected from the group compriεing I2 and polyiodide ionε having a valence of -1, characterized in that for the converεion εtep at leaεt a portion of the abεorption of iodine-εubεtance iε effected at elevated temperature and at elevated pressure, said elevated temperature being higher than 100° C, said elevated presεure being greater than atmoεpheric preεεure.
2. A proceεε aε defined in claim 1 wherein εaid elevated preεεure iε a pressure of 2 psig or greater.
3. A process as defined in claim 1 wherein said elevated presεure iε a preεεure of 5 pεig or greater.
4. A proceεε aε defined in claim 3 wherein εaid elevated preεεure is a presεure of up to 100 pεig.
5. A proceεε aε defined in claim 1 wherein εaid elevated pressure is a pressure of from 5 to 35 psig.
6. A procesε aε defined in claim 1 wherein εaid elevated preεεure iε a preεεure of from 5 to 20 pεig.
7. A process as defined in claim 1 wherein said elevated temperature is a temperature of 102° C or higher.
8. A procesε aε defined in claim 1 wherein εaid elevated temperature is a temperature of 115° C or higher.
9. A procesε aε defined in claim 1 wherein εaid elevated temperature is a temperature of from 115° C to 135° C.
10. A procesε as defined in claim 1 wherein εaid elevated temperature iε a temperature of 102° C or higher and εaid elevated preεεure is a pressure of 5 psig or greater.
11. A proceεε aε defined in claim 10 wherein said elevated temperature is a temperature of up to 210° C.
12. A proceεε as defined in claim 1 wherein said elevated temperature iε a temperature of 110° C or higher and εaid elevated preεεure iε a preεεure of 5 psig or greater.
13. A process as defined in claim 12 wherein said elevated temperature iε a temperature of up to 150° C.
14. A proceεε aε defined in claim 12 wherein εaid elevated temperature iε of from 115° C to 135° C.
15. A process as defined in claim 1 wherein said elevated temperature is a temperature of 115° C or higher and εaid elevated preεεure iε a pressure of from 5 to 35 psig.
16. A procesε as defined in claim 15 wherein said elevated temperature is a temperature of from 115° C to 135° C.
17. A proceεε for preparing a demand diεinfectant reεin, εaid diεinfectant resin being an iodinated strong base anion exchange resin, the process comprising a conversion step, the converεion εtep compriεing contacting a porouε εtrong base anion exchange reεin in a salt form other than the iodide form I", with a sufficient amount of an iodine-subεtance abεorbable by the anion exchange reεin such that the anion exchange reεin abεorbε εaid iodine-εubstance so aε to convert the anion exchange reεin to the demand diεinfectant resin, said iodine-εubεtance being εelected from the group compriεing polyiodide ionε having a valence of -1, characterized in that for the converεion step at least a portion of the absorption of iodine-subεtance iε effected at elevated temperature and at elevated preεεure, εaid elevated temperature being 100° C or higher, εaid elevated preεεure being greater than atmoεpheric preεεure.
18. A proceεε aε defined in claim 17 wherein εaid iodine- εubεtance compriεeε triiodide ionε of formula I3 ".
19. A proceεε aε defined in claim 17 wherein the anion exchange reεin iε in the chloride form Cl".
20. A proceεs aε defined in claim 17 wherein the anion exchange reεin iε in the hydroxyl form OH".
21. A process as defined in claim 17 wherein said elevated preεsure is a presεure of 2 psig or greater.
22. A process as defined in claim 17 wherein εaid elevated preεεure is a presεure of 5 pεig or greater.
23. A proceεε aε defined in claim 22 wherein εaid elevated pressure is a presεure of up to 100 psig.
24. A procesε aε defined in claim 18 wherein εaid elevated pressure is a presεure of from 5 to 35 pεig.
25. A proceεε aε defined in claim 18 wherein εaid elevated pressure is a preεεure of from 5 to 20 pεig.
26. A proceεε aε defined in claim 18 wherein εaid elevated temperature iε a temperature of 102° C or higher.
27. A proceεε aε defined in claim 18 wherein εaid elevated temperature is a temperature of 115° C or higher.
28. A procesε aε defined in claim 18 wherein εaid elevated temperature iε a temperature of from 115° C to 135° C.
29. A proceεε aε defined in claim 18 wherein εaid elevated temperature iε a temperature of 102° C or higher and εaid elevated preεεure iε a preεεure of 5 pεig or greater.
30. A proceεε aε defined in claim 29 wherein εaid elevated temperature iε a temperature of up to 210° C.
31. A proceεs as defined in claim 29 wherein the anion exchange resin is in the chloride form Cl".
32. A process as defined in claim 29 wherein the anion exchange resin is in the hydroxyl form OH".
33. A procesε aε defined in claim 18 wherein said elevated temperature is a temperature of 110° C or higher and said elevated preεεure iε a pressure of 5 psig or greater.
34. A proceεε aε defined in claim 33 wherein εaid elevated temperature iε a temperature of up to 150° C.
35. A proceεε as defined in claim 33 wherein said elevated temperature is of from 115° C to 135° C.
36. A proceεε aε defined in claim 18 wherein εaid elevated temperature iε a temperature of 115° C or higher and εaid elevated preεεure iε a preεεure of from 5 to 35 pεig.
37. A proceεε aε defined in claim 36 wherein εaid elevated temperature iε a temperature of from 115° C to 135° C.
38. A proceεε aε defined in claim 37 wherein the anion exchange reεin iε in the chloride form Cl".
39. A proceεε aε defined in claim 37 wherein the anion exchange reεin iε in the hydroxyl form OH".
40. A proceεε as defined in claim 18 wherein the anion exchange resin iε a quaternary ammonium anion exchange reεin.
41. A process as defined in claim 18 wherein the anion exchange resin iε contacted with a compoεition compriεing a mixture of KI, I2 and a minor amount of water, the mole ratio of KI to I2 initially being about 1.
42. A proceεε aε defined in claim 18 wherein said anion exchange reεin iε in the hydroxyl form OH", wherein the anion exchange reεin is contacted with a composition consisting of a mixture of KI, l2 and a minor amount of water, the mole ratio of KI to I2 initially being about 1, wherein said elevated temperature is a temperature of 102° C or higher and wherein said elevated presεure is a presεure of 2 pεig or greater .
43. A proceεs as defined in claim 42 wherein εaid elevated temperature iε a temperature of 115° C or higher and wherein εaid elevated preεεure iε a preεsure of from 5 to 35 psig.
44. A procesε for preparing a demand diεinfectant resin, said disinfectant reεin being an iodinated strong base anion exchange resin, the procesε compriεing a converεion εtep, the converεion εtep comprising contacting a porous strong base anion exchange resin in a salt form with a sufficient amount of an iodine-subεtance absorbable by the anion exchange resin such that the anion exchange resin abεorbε εaid iodine-substance so as to convert the anion exchange resin to the demand disinfectant resin, said iodine- subεtance being εelected from the group compriεing I2 and polyiodide ions having a valence of -1, characterized in that εaid converεion εtep compriεeε an initial converεion εtage followed by a second conversion εtage, in that εaid initial converεion stage compriseε contacting the anion exchange reεin with the iodine-εubεtance at a temperature of 100° C or lower εo aε to obtain an intermediate compoεition, εaid intermediate compoεition comprising residual absorbable iodine-εubεtance and an intermediate iodinated reεin, and in that εaid εecond converεion εtage comprises subjecting the intermediate composition to elevated temperature and elevated preεεure, εaid elevated temperature being higher than 100° C, εaid elevated preεεure being greater than atmoεpheric preεεure.
45. A proceεε aε defined in claim 44 wherein εaid elevated preεεure iε a presεure of 2 pεig or greater.
46. A proceεε aε defined in claim 44 wherein said elevated presεure iε a preεεure of 5 pεig or greater.
47. A proceεε aε defined in claim 46 wherein εaid elevated pressure is a presεure of up to 100 pεig.
48. A proceεε aε defined in claim 44 wherein said elevated pressure is a presεure of from 5 to 35 pεig.
49. A proceεε aε defined in claim 44 wherein εaid elevated pressure is a preεεure of from 5 to 20 pεig.
50. A proceεε aε defined in claim 44 wherein εaid initial converεion εtage compriεeε contacting the anion exchange reεin with the iodine-εubεtance at a preεεure of from 0 to leεε than 2 pεig.
51. A proceεε aε defined in claim 50 wherein εaid elevated preεεure iε a preεεure of 2 pεig or greater.
52. A proceεε as defined in claim 50 wherein said elevated presεure iε a preεεure of 5 pεig or greater.
53. A proceεε aε defined in claim 52 wherein εaid elevated preεεure iε a preεεure of up to 100 pεig.
54. A proceεε aε defined in claim 50 wherein εaid elevated preεεure iε a preεεure of from 5 to 35 pεig.
55. A proceεε aε defined in claim 50 wherein εaid elevated preεεure iε a pressure of from 5 to 20 psig.
56. A process as defined in claim 44 wherein said initial conversion stage compriεes contacting the anion exchange reεin with the iodine-substance at a temperature of from 20 to 40° C and at essentially ambient presεure.
57. A process as defined in claim 56 wherein said elevated preεεure iε a pressure of 2 psig or greater.
58. A procesε aε defined in claim 56 wherein εaid elevated pressure is a pressure of 5 psig or greater.
59. A procesε aε defined in claim 58 wherein εaid elevated preεεure is a pressure of up to 100 psig.
60. A proceεs as defined in claim 56 wherein said elevated pressure is a presεure of from 5 to 35 psig.
61. A proceεε aε defined in claim 56 wherein εaid elevated preεεure iε a preεεure of from 5 to 20 pεig.
62. A process as defined in claim 56 wherein said elevated temperature iε a temperature of 102° C or higher.
63. A proceεε as defined in claim 56 wherein said elevated temperature iε a temperature of 115° C or higher.
64. A proceεs as defined in claim 56 wherein εaid elevated temperature iε a temperature of from 115° C to 135° C.
65. A proceεε aε defined in claim 56 wherein εaid elevated temperature is a temperature of 102° C or higher and said elevated presεure iε a preεεure of 5 psig or greater.
66. A procesε aε defined in claim 65 wherein εaid elevated temperature iε a temperature of up to 210° C.
67. A proceεε aε defined in claim 56 wherein said elevated temperature is a temperature of 110° C or higher and said elevated preεεure is a presεure of 5 psig or greater.
68. A process as defined in claim 67 wherein εaid elevated temperature iε a temperature of up to 150° C.
69. A process as defined in claim 67 wherein said elevated temperature is of from 115° C to 135° C.
70. A procesε aε defined in claim 56 wherein εaid elevated temperature iε a temperature of 115° C or higher and εaid elevated pressure is a preεεure of from 5 to 35 psig.
71. A procesε aε defined in claim 70 wherein εaid elevated temperature iε a temperature of from 115° C to 135° C.
72. A proceεε aε defined in claim 44 wherein said first stage iε effected for a time period of 1 minute or more.
73. A proceεε aε defined in claim 56 wherein εaid firεt εtage iε effected for a time period of 1 minute or more.
74. A proceεε for preparing a demand diεinfectant reεin, εaid diεinfectant reεin being an iodinated εtrong base anion exchange resin, the procesε compriεing a converεion εtep, the converεion εtep comprising contacting a porous strong base anion exchange resin in a salt form other than the iodide form I", with a εufficient amount of an iodine-εubεtance abεorbable by the anion exchange reεin εuch that the anion exchange reεin abεorbε said iodine-substance so as to convert the anion exchange resin to the demand disinfectant reεin, εaid iodine-substance being selected from the group comprising polyiodide ions having a valence of -1, characterized in that said conversion εtep compriεes an initial conversion εtage followed by a εecond converεion εtage, in that εaid initial converεion stage comprises contacting the anion exchange resin with the iodine-subεtance the anion exchange reεin with the iodine-εubεtance at a temperature of 100° C or lower εo aε to obtain an intermediate compoεition, εaid intermediate compoεition compriεing reεidual abεorbable iodine-εubεtance and an intermediate iodinated reεin, and in that εaid second conversion stage compriseε εubjecting the intermediate compoεition to elevated temperature and elevated preεεure, εaid elevated temperature being 100° C or higher, εaid elevated preεεure being greater than atmoεpheric preεεure.
75. A proceεε aε defined in claim 74 wherein said iodine- εubstance compriseε triiodide ions of formula I3 ".
76. A procesε aε defined in claim 74 wherein the anion exchange reεin iε in the chloride form Cl".
77. A proceεε aε defined in claim 74 wherein the anion exchange reεin iε in the hydroxyl form OH".
78. A proceεε as defined in claim 74 wherein said elevated preεεure is a presεure of 2 pεig or greater.
79. A proceεε aε defined in claim 74 wherein εaid elevated pressure is a pressure of 5 psig or greater.
80. A proceεε as defined in claim 79 wherein said elevated presεure is a preεεure of up to 100 pεig.
81. A proceεε as defined in claim 74 wherein said elevated presεure iε a preεsure of from 5 to 35 psig.
82. A proceεs as defined in claim 74 wherein said elevated presεure is a preεεure of from 5 to 20 psig.
83. A proceεε as defined in claim 75 wherein said initial conversion stage compriseε contacting the anion exchange resin with the iodine-subεtance at a pressure of from 0 to lesε than 2 pεig.
84. A proceεε aε defined in claim 83 wherein said elevated pressure iε a preεεure of 2 pεig or greater.
85. A process as defined in claim 83 wherein εaid elevated pressure is a presεure of 5 pεig or greater.
86. A proceεs as defined in claim 85 wherein said elevated preεεure iε a preεεure of up to 100 pεig.
87. A procesε aε defined in claim 83 wherein εaid elevated preεεure iε a preεsure of from 5 to 35 psig.
88. A proceεε aε defined in claim 83 wherein εaid elevated preεεure iε a pressure of from 5 to 20 psig.
89. A process as defined in claim 75 wherein said initia converεion stage comprises contacting the anion exchang resin with the iodine-substance at a temperature of from 2 to 40° C and at esεentially ambient presεure (i.e. a preεsur of less than 1 psig to 0 (zero) psig; 0 pεig reflectin barometric or atmospheric presεure) .
90. A proceεε as defined in claim 89 wherein said elevate presεure iε a preεsure of 2 pεig or greater.
91. A proceεε aε defined in claim 89 wherein said elevate pressure is a presεure of 5 psig or greater.
92. A proceεε aε defined in claim 91 wherein εaid elevate preεsure is a preεεure of up to 100 pεig.
93. A process as defined in claim 89 wherein said elevate pressure is a pressure of from 5 to 35 psig.
94. A process as defined in claim 89 wherein εaid elevate preεsure is a pressure of from 5 to 20 psig.
95. A process as defined in claim 89 wherein said elevate temperature is a temperature of 102° C or higher.
96. A proceεε aε defined in claim 89 wherein said elevate temperature is a temperature of 115° C or higher.
97. A proceεε aε defined in claim 89 wherein εaid elevated temperature is a temperature of from 115° C to 135° C.
98. A process as defined in claim 89 wherein said elevated temperature is a temperature of 102° C or higher and εaid elevated preεεure iε a preεεure of 5 pεig or greater.
99. A proceεε aε defined in claim 98 wherein εaid elevated temperature iε a temperature of up to 210° C.
100. A proceεε aε defined in claim 89 wherein εaid elevated temperature iε a temperature of 110° C or higher and εaid elevated preεεure iε a preεεure of 5 pεig or greater.
101. A proceεε as defined in claim 100 wherein said elevated temperature iε a temperature of up to 150° C.
102. A proceεε as defined in claim 100 wherein said elevated temperature is of from 115° C to 135° C.
103. A procesε aε defined in claim 89 wherein εaid elevated temperature iε a temperature of 115° C or higher and εaid elevated pressure iε a preεεure of from 5 to 35 psig.
104. A procesε aε defined in claim 103 wherein εaid elevated temperature iε a temperature of from 115° C to 135° C.
105. A procesε aε defined in claim 74 wherein εaid firεt stage is effected for a time period of 1 minute or more.
106. A process as defined in claim 89 wherein said firεt εtage iε effected for a time period of 1 minute or more.
107. A proceεε aε defined in claim 104 wherein the anion exchange reεin is in the chloride form Cl".
108. A procesε aε defined in claim 104 wherein the anion exchange reεin is in the hydroxyl form OH".
109. A process as defined in claim 75 wherein the anion exchange reεin iε a quaternary ammonium anion exchange reεin.
110. A proceεε aε defined in claim 75 wherein the anion exchange reεin is contacted with a composition comprising a mixture of KI, I2 and a minor amount of water, the mole ratio of KI to I2 initially being about 1.
111. A process as defined in claim 75 wherein said anion exchange resin is in the hydroxyl form OH", wherein the anion exchange reεin iε contacted with a composition conεiεting of a mixture of KI, I2 and a minor amount of water, the mole ratio of KI to I2 initially being about 1 and wherein εaid elevated temperature iε a temperature of 102° C or higher, and wherein εaid elevated preεεure is a preεsure of 2 psig or greater.
112. A process as defined in claim 111 wherein said elevated pressure is a preεεure of from 2 to 35 pεig.
113. A process as defined in claim 111 wherein εaid first stage iε effected for a time period of from 1 minute to 24 hourε.
114. A demand disinfectant resin, εaid diεinfectant resin being an iodinated strong baεe anion exchange reεin which iε the same aε an iodinated εtrong baεe anion exchange reεin prepared in accordance with a proceεε aε defined in claim 1.
115. A demand disinfectant resin, εaid diεinfectant reεin being an iodinated εtrong baεe anion exchange reεin whenever prepared in accordance with a proceεε aε defined in claim 1.
116. A demand diεinfectant reεin, εaid diεinfectant reεin being an iodinated εtrong base anion exchange resin which iε the same as an iodinated strong base anion exchange reεin prepared in accordance with a proceεε aε defined in claim 112.
117. A demand diεinfectant reεin, εaid diεinfectant resin being an iodinated strong baεe anion exchange reεin whenever prepared in accordance with a proceεε aε defined in claim 112.
118. A method for disinfecting air containing airborne
SUBSTITUTE SHEET microorganiεms, said method comprising pasεing εaid air over a demand diεinfectant reεin εuch that airborne microorganiεmε contact said reεin and are devitalized thereby, said demand disinfectant resin comprising an iodinated εtrong baεe anion exchange reεin.
119. A method for diεinfecting air aε defined in claim 118 wherein εaid iodinated εtrong baεe anion exchange resin comprises a strong base anion exchange resin component which represents from 25 to 90 percent by weight of the total weight of the iodinated resin.
120. A method for disinfecting air as defined in claim 118 wherein εaid iodinated εtrong baεe anion exchange reεin compriεes a strong baεe anion exchange reεin component which repreεentε from 45 to 65 percent by weight of the total weight of the iodinated reεin.
121. A method for diεinfecting air aε defined in claim 118 wherein εaid iodinated εtrong baεe anion exchange resin is an iodinated strong baεe anion exchange reεin prepared in accordance with a proceεs as defined in claim 1.
122. A method for disinfecting air as defined in claim 118 wherein said iodinated strong base anion exchange resin is an iodinated strong base anion exchange resin prepared in accordance with a process as defined in claim 112.
123. A syεtem for diεinfecting air containing airborne microorganiεmε, said syεtem compriεing meanε for providing an air path for the movement of air therethroug , and a demand diεinfectant reεin disposed in said air path such that airborne microorganiεmε in air paεεing through εaid air path are able to be brought into contact with εaid reεin and be devitalized thereby, εaid demand diεinfectant reεin compriεing an iodinated strong base anion exchange resin.
124. A syεtem for disinfecting air as defined in claim 123 wherein said iodinated strong base anion exchange resin compriseε a strong base anion exchange reεin component which repreεentε from 25 to 90 percent by weight of the total weight of the iodinated reεin.
125. A εystem for disinfecting air aε defined in claim 123 wherein said iodinated strong baεe anion exchange reεin comprises a strong base anion exchange resin component which repreεentε from 45 to 65 percent by weight of the total weight of the iodinated reεin.
126. A εyεtem for diεinfecting air aε defined in claim 123 wherein εaid iodinated εtrong base anion exchange reεin iε an iodinated εtrong baεe anion exchange reεin prepared in accordance with a proceεs as defined in claim 1.
127. A syεtem for diεinfecting air aε defined in claim 123 wherein εaid iodinated εtrong base anion exchange resin is an iodinated εtrong base anion exchange resin prepared in accordance with a proceεs aε defined in claim 112.
128. A εyεtem for diεinfecting air aε defined in claim 123, εaid εyεtem including meanε for urging the air through said air path.
129. A syεtem for disinfecting air as defined in claim 123, εaid εyεtem including meanε disposed in said air path for εcavenging iodine liberated from the disinfectant resin.
130. A method for disinfecting a liquid containing microorganismε, said method comprising paεεing εaid liquid over a demand diεinfectant reεin such that microorganismε therein contact εaid reεin and are devitalized thereby, εaid diεinfectant reεin being an iodinated strong base anion exchange resin which is the same aε an iodinated εtrong base anion exchange resin prepared in accordance with a procesε aε defined in claim 1.
131. A method for diεinfecting a liquid containing microorganiεms, said method compriεing paεεing εaid liquid over a demand disinfectant resin such that microorganiεmε therein contact εaid reεin and are devitalized thereby, said disinfectant reεin being an iodinated εtrong base anion exchange resin whenever prepared in accordance with a process as defined in claim 1.
132. A method for diεinfecting a liquid containing microorganiεmε, εaid method compriεing paεεing εaid liquid over a demand disinfectant resin such that microorganisms therein contact said resin and are devitalized thereby, εaid diεinfectant reεin being an iodinated εtrong baεe anion exchange reεin which iε the εame aε an iodinated εtrong baεe anion exchange reεin prepared in accordance with a proceεε aε defined in claim 112.
133. A method for diεinfecting a liquid containing microorganiεmε, εaid method compriεing paεεing εaid liquid over a demand diεinfectant reεin εuch that microorganiεmε therein contact εaid reεin and are devitalized thereby, said disinfectant reεin being an iodinated εtrong baεe anion exchange reεin whenever prepared in accordance with a proceεs as defined in claim 112.
134. A combination comprising a demand disinfectant component and a carrier component, εaid demand disinfectant component comprising particleε of an iodinated strong base anion exchange reεin, εaid particleε of εaid demand disinfectant component being held to said carrier component.
135. A combination as defined in claim 134 wherein said particles of said demand disinfectant component are fixed to said carrier component, wherein said carrrier component compriεeε a flexible polymeric matrix and wherein particleε of εaid demand diεinfectant are diεperεed in εaid polymeric matrix.
136. A combination aε defined in claim 135 wherein εaid flexible polymeric matrix iε a porous cellular polymeric matrix.
137. A combination as defined in claim 134 wherein εaid iodinated εtrong baεe anion exchange reεin compriεeε a strong base anion exchange reεin component which repreεentε from 25 to 90 percent by weight of the total weight of the iodinated reεin.
138. A combination aε defined in claim 134 wherein said iodinated strong base anion exchange resin compriεeε a strong base anion exchange reεin component which represents from 45 to 65 percent by weight of the total weight of the iodinated resin.
139. A combination aε defined in claim 134 wherein εaid iodinated εtrong baεe anion exchange reεin iε an iodinated strong base anion exchange resin prepared in accordance with a procesε aε defined in claim 1.
140. A combination aε defined in claim 136 wherein εaid iodinated εtrong baεe anion exchange reεin iε an iodinated εtrong baεe anion exchange reεin prepared in accordance with a process as defined in claim 112.
141. A sterilisation dresεing, for being applied to a leεion, said dresεing compriεing a demand diεinfectant component and a carrier component, εaid demand diεinfectant component compriεing particles of an iodinated strong baεe anion exchange reεin, said carrier component being configured so as to hold onto particleε of said demand diεinfectant component εuch that microorganiεmε are able to be brought into contact with εaid particleε and be devitaliεed thereby, εaid carrier component being of a pharmaceutically acceptable material.
142. A dressing as defined in claim 141 wherein εaid carrier component is flexible and has an outer εurface and wherein particles of said demand disinfectant are fixed to at least a portion of said outer εurface.
143. A dreεεing aε defined in claim 141 wherein εaid carrier component iε flexible and compriεes a porous cellular polymeric matrix, wherein particles of εaid demand diεinfectant are dispersed in said polymeric matrix.
144. A dreεεing as defined in claim 141 wherein εaid iodinated εtrong base anion exchange resin compriseε a εtrong base anion exchange resin component which represents from 25 to 90 percent by weight of the total weight of the iodinated resin.
145. A dresεing as defined in claim 141 wherein εaid iodinated strong base anion exchange resin compriseε a εtrong baεe anion exchange reεin component which repreεentε from 45 to 65 percent by weight of the total weight of the iodinated reεin.
146. A dreεεing aε defined in claim 141 wherein εaid iodinated εtrong baεe anion exchange reεin iε an iodinated εtrong baεe anion exchange resin prepared in accordance with a process as defined in claim 1.
147. A dresεing aε defined in claim 141 wherein said iodinated strong baεe anion exchange reεin iε an iodinated strong base anion exchange resin prepared in accordance with a procesε as defined in claim 112.
148. A dreεsing as defined in claim 143 wherein εaid iodinated εtrong baεe anion exchange reεin iε an iodinated strong base anion exchange reεin prepared in accordance with a process as defined in claim 112.
149. A method for disinfecting air containing airborne microorganiεmε, εaid method compriεing paεεing said air over a disinfectant resin such that airborne microorganismε contact εaid reεin and are devitalized thereby, εaid diεinfectant reεin compriεing a diεinfectant iodinated reεin.
150. A εyεtem for diεinfecting air containing airborne microorganiεmε, said syεtem compriεing meanε for providing an air path for the movement of air therethrough, and a diεinfectant reεin diεpoεed in εaid air path εuch that airborne microorganiεmε in air paεεing through said air path are able to be brought into contact with said resin and be devitalized thereby, εaid diεinfectant reεin compriεing a diεinfectant iodinated reεin.
151. A combination compriεing a diεinfectant component and a carrier component, εaid diεinfectant component compriεing particleε of an iodinated reεin, εaid particleε of εaid diεinfectant component being held to εaid carrier component.
152. A εteriliεation dreεsing, for being applied to a lesion, said dressing comprising a disinfectant component and a carrier component, said diεinfectant component compriεing particles of an iodinated resin, said carrier component being configured so as to hold onto particles of εaid disinfectant component such that microorganisms are able to be brought into contact with said particles and be devitaliεed thereby, εaid carrier component being of a pharmaceutically acceptable material.
PCT/CA1993/000378 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof WO1994006296A1 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
DE69320483T DE69320483T2 (en) 1992-09-16 1993-09-15 DISINFECTING IODINE RESIN AND METHOD FOR THE PRODUCTION THEREOF
KR1020007014954A KR100316166B1 (en) 1992-09-16 1993-09-15 Method For Disinfecting A Liquid Containing Microorganisms
KR1019950701017A KR100306886B1 (en) 1992-09-16 1993-09-15 Iodine / resin disinfectant and its manufacturing method
AU49401/93A AU688276B2 (en) 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof
JP50762894A JP3289831B2 (en) 1992-09-16 1993-09-15 Iodine / resin fungicide and method for producing the same
DK93918858T DK0660668T3 (en) 1992-09-16 1993-09-15 Iodine / resin disinfectant and a process for their preparation
DK97108792T DK0797917T3 (en) 1992-09-16 1993-09-15 Method for disinfecting air with iodine / resin-based disinfectant and systems for disinfecting airborne microorganisms
EP93918858A EP0660668B1 (en) 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof
CA002140639A CA2140639C (en) 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof
KR1020007014953A KR100316165B1 (en) 1992-09-16 1993-09-15 Method For Disinfection Air Containing Airborne Microorganisms And System
KR1020007014955A KR100316167B1 (en) 1992-09-16 1993-09-15 A Combination Comprising A Demand Disinfectant Component And A Carrier Component And Dressing
KR1020007014956A KR100316168B1 (en) 1992-09-16 1993-09-15 A Sterilisation Dressing for Being Applied To A Lesion
US08/256,425 US5639452A (en) 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof
US08/803,869 US6045820A (en) 1992-09-16 1997-02-24 Iodine/resin disinfectant a procedure for the preparation thereof
HK98112325A HK1011259A1 (en) 1992-09-16 1998-11-26 Iodine/resin disinfectant and a procedure for the preparation thereof
US09/267,056 US6680050B1 (en) 1992-09-16 1999-03-12 Iodine/resin disinfectant and a procedure for the preparation thereof
US09/735,125 US20010009661A1 (en) 1992-09-16 2001-02-15 Method for disinfecting body fluids
US10/161,102 US6899868B2 (en) 1992-09-16 2002-05-31 Iodine/resin disinfectant and a procedure for the preparation thereof
US10/166,465 US6696055B2 (en) 1992-09-16 2002-06-10 Method and system for treating air with an iodinated resin
US10/238,758 US7261879B2 (en) 1992-09-16 2002-09-10 Iodinated anion exchange resin and process for preparing same
AU2002302053A AU2002302053B2 (en) 1992-09-16 2002-11-19 Iodinated Anion Exchange Resin and Process for Preparing same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US95730792A 1992-09-16 1992-09-16
US4753593A 1993-04-19 1993-04-19
US07/957,307 1993-04-19
US08/047,535 1993-04-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US4753593A Continuation-In-Part 1992-09-16 1993-04-19

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US08256425 A-371-Of-International 1993-09-15
US08/256,425 A-371-Of-International US5639452A (en) 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof
US08/256,425 Continuation US5639452A (en) 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof
US08/803,869 Division US6045820A (en) 1992-09-16 1997-02-24 Iodine/resin disinfectant a procedure for the preparation thereof

Publications (1)

Publication Number Publication Date
WO1994006296A1 true WO1994006296A1 (en) 1994-03-31

Family

ID=26725146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1993/000378 WO1994006296A1 (en) 1992-09-16 1993-09-15 Iodine/resin disinfectant and a procedure for the preparation thereof

Country Status (14)

Country Link
US (6) US5639452A (en)
EP (3) EP0797917B1 (en)
JP (6) JP3289831B2 (en)
KR (5) KR100316166B1 (en)
AT (3) ATE347807T1 (en)
AU (2) AU688276B2 (en)
CA (1) CA2140639C (en)
DE (3) DE69334082T2 (en)
DK (2) DK0797917T3 (en)
ES (1) ES2124320T3 (en)
HK (1) HK1011259A1 (en)
NZ (1) NZ255299A (en)
SG (1) SG47367A1 (en)
WO (1) WO1994006296A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0721024A1 (en) 1994-12-23 1996-07-10 Gentex Corporation Laminated biocidal fabric and method and apparatus for making the same
WO1997048422A1 (en) * 1996-06-21 1997-12-24 Edward Shanbrom Iodinated gel filtration media for disinfecting protein solutions
EP0910460A1 (en) * 1996-06-21 1999-04-28 American Red Cross Iodinated matrices for disinfecting biological fluids
DE19931371A1 (en) * 1999-07-08 2001-01-11 Mhb Filtration Gmbh & Co Kg Filter material for gas filtration with biocidal properties
WO2001010219A1 (en) * 1999-08-05 2001-02-15 Pierre Jean Messier Topical antiseptic composition
WO2001010208A1 (en) * 1999-08-05 2001-02-15 Hemo-Biotech, Inc. Deactivation of toxic biological agents in biological fluids such as blood
WO2003085126A1 (en) * 2002-04-05 2003-10-16 Sharp Kabushiki Kaisha Method of estimating elimination of microorganisms and apparatus for estimating elimination of microorganisms
US6680050B1 (en) * 1992-09-16 2004-01-20 Triosyn Holdings, Inc. Iodine/resin disinfectant and a procedure for the preparation thereof
WO2010124130A2 (en) * 2009-04-22 2010-10-28 Triosyn Holding Inc. Method for coating an elastomeric material with a layer of antitoxic material
WO2021191294A1 (en) * 2020-03-24 2021-09-30 Mecadi GmbH - Chemicals/ Processing Use and method for reducing the viral, bacterial and fungal spore load or other biological contaminants in gases
DE102020125922B4 (en) 2020-10-04 2022-06-02 Elke Münch Mobile device for cleaning and disinfecting room air

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47367A1 (en) * 1992-09-16 1998-04-17 Pierre Jean Messier Iodine-resin disinfectant and a procedure for the preparation thereof
US7261879B2 (en) * 1992-09-16 2007-08-28 Triosyn Holding Inc. Iodinated anion exchange resin and process for preparing same
DE69626313T2 (en) * 1995-10-26 2003-11-27 Purepulse Technologies Inc DISABLING ORGANIC WITH POLYCHROMATIC HIGH INTENSITY PULSE LIGHT
GB9706713D0 (en) * 1997-04-02 1997-05-21 Reckitt & Colman Inc Improvements in or relating to organic compositions
US6562885B1 (en) * 1998-03-19 2003-05-13 Battelle Memorial Institute Composition for deactivating chemically and biologically active agents and method of making the same
US6565803B1 (en) 1998-05-13 2003-05-20 Calgon Carbon Corporation Method for the inactivation of cryptosporidium parvum using ultraviolet light
AU4699799A (en) 1998-06-19 2000-01-05 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
US6106773A (en) * 1998-09-24 2000-08-22 American National Red Cross Pathogen inactivating compositions for disinfecting biological fluids
US6224655B1 (en) 1998-11-03 2001-05-01 Pierre Messier Biostatic air filter
JP4003333B2 (en) * 1999-02-02 2007-11-07 三菱電機株式会社 Storage, fan device
US6727400B2 (en) 1999-06-08 2004-04-27 Triosyn Holdings, Inc. Deactivation of toxic chemical agents
JP2001205023A (en) * 2000-01-21 2001-07-31 Ricoh Elemex Corp Air filter
JP3275000B2 (en) * 2000-03-07 2002-04-15 國新産業株式会社 Method of forming a breathable film
US6506737B1 (en) 2000-04-05 2003-01-14 Ecolab, Inc. Antimicrobial phosphonium and sulfonium polyhalide compositions
US8034092B2 (en) 2000-09-15 2011-10-11 Bruder Healthcare Company Wound and therapy compress and dressing
WO2002022060A1 (en) 2000-09-15 2002-03-21 Bruder Healthcare Company Wound and therapy compress and dressing
US10105259B2 (en) 2000-09-15 2018-10-23 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
US9925087B2 (en) 2000-09-15 2018-03-27 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
WO2002083046A1 (en) 2001-04-16 2002-10-24 Pamela Howard Wound dressing system
US6770250B2 (en) * 2001-09-24 2004-08-03 Cooper Environmental Services Apparatus and methods for removing mercury from fluid streams
US20030075047A1 (en) * 2001-10-22 2003-04-24 Normand Bolduc Bactericidal after-filter device
KR20040091072A (en) * 2002-02-25 2004-10-27 젠텍스 코오포레이숀 Muti-fucntional protective textiles and methods for decontamination
KR20110055576A (en) * 2002-09-16 2011-05-25 트리오신 홀딩 아이엔씨 Electrostatically charged filter media incorporating an active agent
US20040122387A1 (en) * 2002-12-23 2004-06-24 Kimberly-Clark Worldwide, Inc. Absorbent articles that include a stretchable substrate having odor control properties
US20040121682A1 (en) * 2002-12-23 2004-06-24 Kimberly-Clark Worldwide, Inc. Antimicrobial fibrous substrates
US20040121681A1 (en) * 2002-12-23 2004-06-24 Kimberly-Clark Worldwide, Inc. Absorbent articles containing an activated carbon substrate
US20040121688A1 (en) * 2002-12-23 2004-06-24 Kimberly-Clark Worldwide, Inc. Flexible activated carbon substrates
WO2005012552A2 (en) * 2003-07-30 2005-02-10 Triosyn Holding, Inc. Method and system for control of microorganisms in metalworking fluid
WO2005036125A2 (en) * 2003-09-10 2005-04-21 Triosyn Holding, Inc. System, method and apparatus for purifying biological fluids such as blood and constituents thereof
GB2414474A (en) * 2004-05-24 2005-11-30 Bw Technologies Ltd Device for purifying fluids, in particular water
US7329385B1 (en) * 2004-07-08 2008-02-12 Radicone Michael C Device and method for air stream, fluid and vessel decontamination
US8097343B2 (en) * 2004-08-31 2012-01-17 Triton Systems, Inc. Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
WO2006135406A2 (en) * 2004-08-31 2006-12-21 Triton Systems, Inc. Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
KR100664879B1 (en) 2005-02-18 2007-01-04 신호상 Apparatus Produce Iodine Disinfectant Water
US20060266731A1 (en) * 2005-05-31 2006-11-30 Yu Steven Y Etchant rinse method
US20060282028A1 (en) * 2005-06-10 2006-12-14 Howard Pamela A Wound Management System
US8834687B2 (en) 2005-09-30 2014-09-16 Teledyne Licensing, Llc Multilayer self-decontaminating coatings
US9266733B2 (en) * 2005-09-30 2016-02-23 Teledyne Scientific & Imaging, Llc Multilayer self-decontaminating coatings
JP2006239687A (en) * 2006-03-29 2006-09-14 Ricoh Elemex Corp Air filter
JP2006247403A (en) * 2006-03-29 2006-09-21 Ricoh Elemex Corp Air filter
JP2006289078A (en) * 2006-03-29 2006-10-26 Ricoh Elemex Corp Mask
BRPI0621568A2 (en) * 2006-04-20 2011-12-13 Water Security Corp fluid purification compositions and methods
US20080011662A1 (en) * 2006-04-20 2008-01-17 Emil Milosavljevic Compositions and methods for fluid purification
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US20080045440A1 (en) * 2006-08-16 2008-02-21 Conopco, Inc. D/B/A Unilever Anti-Malodour Composition
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
US7520923B2 (en) * 2007-03-22 2009-04-21 Mvp Textiles & Apparel, Inc. Antimicrobial filtration article
WO2009076611A1 (en) * 2007-12-12 2009-06-18 Engle George M Delivery of iodine gas
MX2010011581A (en) * 2008-04-23 2010-12-14 Water Security Corp Improved halogenated resin beds.
JP2011528610A (en) * 2008-06-30 2011-11-24 スリーエム イノベイティブ プロパティズ カンパニー Method for in situ formation of metal nanoclusters in a porous substrate field
US20100006505A1 (en) * 2008-07-10 2010-01-14 Terryll Riley Smith Filter with iodinated resin and filter life indicator
BRPI0918827A2 (en) * 2008-09-22 2015-12-08 Triosyn Holding Inc iodine resin product and manufacturing process
WO2010047827A1 (en) * 2008-10-23 2010-04-29 Triosyn Holding Inc. Rapid and safe technique for performing pcr amplifications
US20100133194A1 (en) * 2008-11-05 2010-06-03 Water Security Corporation Water treatment systems with dual purpose ion exchange resin
US20120042427A1 (en) * 2010-03-22 2012-02-23 Triomed Innovations Corp. Coatings for Elastomeric Products
FR2962348B1 (en) * 2010-07-12 2012-09-07 Ind Du Ponant L MICROBICIDAL FILTER AND FILTER CARTRIDGE INCORPORATING SUCH A FILTER
CN103221462A (en) * 2010-08-02 2013-07-24 特莱奥美德创新公司 Polymer films with embedded iodinated resin and methods of manufacturing same
LT5802B (en) 2011-05-20 2012-01-25 Kauno technologijos universitetas, , Cationic starch-triiodide bactericide
JP2015528520A (en) 2012-08-13 2015-09-28 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド Preparation method of trihalide anion exchange resin, reversible adsorption reaction and chlorination method using ion exchange resin
EP2908870B1 (en) 2012-10-16 2018-05-23 SurModics, Inc. Wound packing device and methods
US20140154297A1 (en) * 2012-10-30 2014-06-05 Baxter Healthcare S.A. Antimicrobial substrates and methods for processing the same
WO2014143139A1 (en) 2013-03-15 2014-09-18 Bruder Healthcare Company Wound and therapy compress and dressing
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
KR101974633B1 (en) * 2016-07-28 2019-05-02 스마트비젼(주) Block-type cross sterilizing and deodorizing device
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
KR102041516B1 (en) 2018-06-22 2019-11-06 경상대학교 산학협력단 Manufacturing Method of Triiodide resin using starch

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113851A (en) * 1976-04-15 1978-09-12 Leveen Harry H Microbiocidal composition and articles prepared therefrom
US4187183A (en) * 1975-03-28 1980-02-05 Aqua-Chem, Inc. Mixed-form polyhalide resins for disinfecting water
US4238477A (en) * 1979-04-20 1980-12-09 Kansas State University Research Foundation Process of preparing homogeneous resin-polyiodide disinfectants
US4343765A (en) * 1980-12-11 1982-08-10 Georgia Tech Research Institute Method for deodorizing and disinfecting air
US4381380A (en) * 1980-11-03 1983-04-26 Leveen Harry H Thermoplastic polyurethane article treated with iodine for antibacterial use
EP0402865A1 (en) * 1989-06-13 1990-12-19 Kansas State University Research Foundation Preparation of I5-polyiodide disinfectant resins
US5051256A (en) * 1988-02-16 1991-09-24 Barnes Carl E Biocidal complex and dressing formed therefrom

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB853566A (en) * 1958-09-15 1960-11-09 Vickers Electrical Co Ltd Improvements relating to the stress-relief of large metal vessels by electrical heating
US3316173A (en) * 1963-05-27 1967-04-25 Dow Chemical Co Process for treating water with bromine
US3462363A (en) * 1967-07-14 1969-08-19 Dow Chemical Co Control of microorganisms with polyhalide resins
US3817860A (en) * 1969-12-03 1974-06-18 Univ Kansas State Method of disinfecting water and demand bactericide for use therein
US3923665A (en) * 1969-12-03 1975-12-02 Univ Kansas State Demand bactericide for disinfecting water and process of preparation
GB1331648A (en) * 1969-12-03 1973-09-26 Univ Kansas State Method of disinfecting water and ion exchange resin compounds for use therein
US3715972A (en) * 1971-05-28 1973-02-13 Integrated Air Syst Inc Clean work station
US4190529A (en) * 1975-03-28 1980-02-26 Aqua-Chem, Inc. Mixed-form polyhalide resins for disinfecting water
US3987038A (en) * 1975-05-21 1976-10-19 Warner-Lambert Company Process for the preparation of {1-[5-(4-hydroxy-2H-1,2-benzothiazin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}ethanone S,S-dioxide
US4076622A (en) * 1976-06-22 1978-02-28 Rohm And Haas Company Microbiocidal macroreticular ion exchange resins, their method of preparation and use
BE863566A (en) * 1977-02-03 1978-08-02 Ciba Geigy MIXTURE OF DITHIOPHOSPHORIC OR TRITHIOPHOSPHORIC DIESTERS FOR USE AS LUBRICANT STABILIZER.
BE853566A (en) * 1977-04-13 1977-08-01 Hoeschler Frank A DISINFECTION PROCESS AND APPARATUS FOR THE TREATMENT OF WATER
US4298475A (en) * 1980-07-18 1981-11-03 Gartner William J Water purification system
US4420590A (en) * 1981-04-06 1983-12-13 Halex, Inc. Bacteriocidal resins and disinfection of water therewith
DE3200959A1 (en) * 1982-01-14 1983-07-21 Hasso von 4000 Düsseldorf Blücher Textile two-dimensional filter
DE3211322A1 (en) * 1982-03-27 1983-09-29 Hasso von 4000 Düsseldorf Blücher AREA FILTER AND METHOD FOR THE PRODUCTION THEREOF
DE3304349C3 (en) * 1983-02-09 1995-10-26 Bluecher Hubert Surface filter and process for its manufacture
US4469826A (en) * 1983-06-02 1984-09-04 Sun Chemical Corporation Process for the production of dispersions of polymers in non-aqueous vehicles
US4483771A (en) * 1983-08-08 1984-11-20 Elizabeth Koch Multi-layer filter
US4526751A (en) * 1983-12-09 1985-07-02 Gartner William J Germicidal solutions effective for solid surface disinfection
JPS60243003A (en) * 1984-05-18 1985-12-03 Tokyo Organ Chem Ind Ltd Method for controlling injurious organism of surface coating composition
JPS6365923A (en) * 1986-09-05 1988-03-24 Ebara Corp Precoating type filtration
US4749484A (en) * 1986-10-07 1988-06-07 Shapiro/Devine Home water filter
US4891227A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US5856245A (en) * 1988-03-14 1999-01-05 Nextec Applications, Inc. Articles of barrier webs
US5019062A (en) * 1988-06-23 1991-05-28 The Procter & Gamble Company Bicomponent material
US4925517A (en) * 1988-06-27 1990-05-15 Minnesota Mining And Manufacturing Company Method of forming fragrance releasing pull-apart sheets
US5626820A (en) * 1988-12-12 1997-05-06 Kinkead; Devon A. Clean room air filtering
DE68927320T2 (en) * 1988-12-30 1997-02-20 Purotech Ltd Water purification system
US5156843A (en) * 1989-03-20 1992-10-20 Advanced Polymer Systems, Inc. Fabric impregnated with functional substances for controlled release
DE3918561C2 (en) * 1989-06-07 1997-09-11 Brita Wasserfilter Water treatment device
US4988557A (en) * 1989-12-08 1991-01-29 Minnesota Mining And Manufacturing Company Fragrance sampling device
US4978449A (en) * 1990-02-12 1990-12-18 Devine Frank M Water purifier with air-passing retainer above water inlet
US4995976A (en) * 1990-05-31 1991-02-26 Water Technologies Corporation Water purification straw
AU8626991A (en) * 1990-09-25 1992-04-15 Allergan, Inc. Apparatus and method for disinfecting a contact lens and detecting the presence of an oxidative disinfectant
TW200394B (en) * 1991-01-25 1993-02-21 Kao Corp
FR2672790B1 (en) * 1991-02-19 1994-10-28 Elysees Balzac Financiere CLEANING COMBINATION AND MANUFACTURING METHODS.
US5176836A (en) * 1991-03-18 1993-01-05 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Regenerable biocide delivery unit
AU2554892A (en) * 1991-09-09 1993-04-05 Novapharm Research (Australia) Pty. Limited Antibacterial treatment of bulk water
WO1993006911A1 (en) * 1991-10-08 1993-04-15 Isp Investments Inc. Method of treating blood
US5383236A (en) * 1991-11-25 1995-01-24 Als Enterprises, Inc. Odor absorbing clothing
DE4243232A1 (en) * 1992-02-25 1994-06-23 Hasso Von Bluecher Protective material
IL101109A (en) * 1992-02-28 1996-12-05 Purotech Ltd Disinfecting resin
IT1257251B (en) * 1992-07-03 1996-01-10 Gianfranco Palumbo THIN STRATIFIED ABSORBENT STRUCTURE, ABSORBENT ITEM INCLUDING SUCH STRUCTURE AND RELATED MANUFACTURING PROCEDURE
DE4310110A1 (en) * 1992-07-07 1994-01-13 Kaercher Gmbh & Co Alfred Multi-layer, textile, gas-permeable filter material against chemical pollutants
SG47367A1 (en) * 1992-09-16 1998-04-17 Pierre Jean Messier Iodine-resin disinfectant and a procedure for the preparation thereof
US6680050B1 (en) * 1992-09-16 2004-01-20 Triosyn Holdings, Inc. Iodine/resin disinfectant and a procedure for the preparation thereof
AU762071B2 (en) * 1992-09-16 2003-06-19 Triosyn Holding Inc. Use of iodinated resins to disinfect body fluids and liquids containing microorganisms
GR1002550B (en) * 1992-10-09 1997-01-28 Mcneil-Ppc Inc. Catamenial device with odor control.
US5370534A (en) * 1992-11-09 1994-12-06 Time Motion Systems Company Water purification system for dental instrument
ZA941727B (en) * 1993-03-12 1994-10-26 Univ Auburn Polymeric cyclic N-halamine biocidal compounds.
US6294185B1 (en) * 1993-03-12 2001-09-25 Auburn University Monomeric and polymeric cyclic amine and N-halamine compounds
US5431908A (en) * 1993-03-17 1995-07-11 Recovery Engineering, Inc. Method for preparing polyhalide resin disinfectants
US5350625A (en) * 1993-07-09 1994-09-27 E. I. Du Pont De Nemours And Company Absorbent acrylic spunlaced fabric
US5772738A (en) * 1993-11-30 1998-06-30 Purex Co., Ltd. Multifunctional air filter and air-circulating clean unit with the same incorporated therein
US5474451A (en) * 1994-02-02 1995-12-12 Regents Of The University Of Minnesota Dental water and air purification equipment
DE4410920C1 (en) * 1994-03-29 1995-08-24 Sandler Helmut Helsa Werke Flexible sheet filter material esp. for protective clothing
US5662991A (en) * 1994-12-23 1997-09-02 Gentex Corporation Laminated biocidal fabric
US5614301A (en) * 1995-04-15 1997-03-25 The United States Of America As Represented By The Secretary Of The Army Chemical protective fabric
DE19649237A1 (en) * 1996-11-28 1998-06-04 Bluecher Gmbh Agent with antiseptic activity, which produces iodine vapour
JPH10317529A (en) * 1997-05-16 1998-12-02 Suzuki Sakan Tairukouten:Kk Sterilization wall material

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187183A (en) * 1975-03-28 1980-02-05 Aqua-Chem, Inc. Mixed-form polyhalide resins for disinfecting water
US4113851A (en) * 1976-04-15 1978-09-12 Leveen Harry H Microbiocidal composition and articles prepared therefrom
US4238477A (en) * 1979-04-20 1980-12-09 Kansas State University Research Foundation Process of preparing homogeneous resin-polyiodide disinfectants
EP0048286A1 (en) * 1979-04-20 1982-03-31 Kansas State University Research Foundation Process of preparing homogeneous resin-polyiodide disinfectants
US4381380A (en) * 1980-11-03 1983-04-26 Leveen Harry H Thermoplastic polyurethane article treated with iodine for antibacterial use
US4343765A (en) * 1980-12-11 1982-08-10 Georgia Tech Research Institute Method for deodorizing and disinfecting air
US5051256A (en) * 1988-02-16 1991-09-24 Barnes Carl E Biocidal complex and dressing formed therefrom
EP0402865A1 (en) * 1989-06-13 1990-12-19 Kansas State University Research Foundation Preparation of I5-polyiodide disinfectant resins

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680050B1 (en) * 1992-09-16 2004-01-20 Triosyn Holdings, Inc. Iodine/resin disinfectant and a procedure for the preparation thereof
EP0721024A1 (en) 1994-12-23 1996-07-10 Gentex Corporation Laminated biocidal fabric and method and apparatus for making the same
WO1997048422A1 (en) * 1996-06-21 1997-12-24 Edward Shanbrom Iodinated gel filtration media for disinfecting protein solutions
EP0910460A1 (en) * 1996-06-21 1999-04-28 American Red Cross Iodinated matrices for disinfecting biological fluids
EP0910460A4 (en) * 1996-06-21 1999-09-15 American Nat Red Cross Iodinated matrices for disinfecting biological fluids
US6589321B2 (en) 1999-07-08 2003-07-08 Jost Kames Filter material useful for gas filtration and having biocidal properties
WO2001003801A1 (en) * 1999-07-08 2001-01-18 Mhb Filtration Gmbh + Co. Kg Filter material used in gas filtration and having biocidal properties
DE19931371A1 (en) * 1999-07-08 2001-01-11 Mhb Filtration Gmbh & Co Kg Filter material for gas filtration with biocidal properties
WO2001010219A1 (en) * 1999-08-05 2001-02-15 Pierre Jean Messier Topical antiseptic composition
WO2001010208A1 (en) * 1999-08-05 2001-02-15 Hemo-Biotech, Inc. Deactivation of toxic biological agents in biological fluids such as blood
WO2003085126A1 (en) * 2002-04-05 2003-10-16 Sharp Kabushiki Kaisha Method of estimating elimination of microorganisms and apparatus for estimating elimination of microorganisms
KR100738174B1 (en) * 2002-04-05 2007-07-10 샤프 가부시키가이샤 Method of Estimating Elimination of Microorganisms and Apparatus for Estimating Elimination of Microorganisms
US8828714B2 (en) 2002-04-05 2014-09-09 Sharp Kabushiki Kaisha Method of evaluating elimination of microoganisms and apparatus for evaluating elimination of microorganisms
WO2010124130A2 (en) * 2009-04-22 2010-10-28 Triosyn Holding Inc. Method for coating an elastomeric material with a layer of antitoxic material
WO2010124130A3 (en) * 2009-04-22 2012-08-30 Triomed Innovations Corp. Method for coating an elastomeric material with a layer of antitoxic material
WO2021191294A1 (en) * 2020-03-24 2021-09-30 Mecadi GmbH - Chemicals/ Processing Use and method for reducing the viral, bacterial and fungal spore load or other biological contaminants in gases
DE102020125922B4 (en) 2020-10-04 2022-06-02 Elke Münch Mobile device for cleaning and disinfecting room air

Also Published As

Publication number Publication date
KR950703368A (en) 1995-09-20
US5639452A (en) 1997-06-17
DE69320483T2 (en) 1999-04-22
ATE169798T1 (en) 1998-09-15
KR100316167B1 (en) 2001-12-12
ATE345045T1 (en) 2006-12-15
JP3696818B2 (en) 2005-09-21
DK0660668T3 (en) 1999-05-25
JP3737726B2 (en) 2006-01-25
US20030099606A1 (en) 2003-05-29
AU4940193A (en) 1994-04-12
JP3577019B2 (en) 2004-10-13
DE69320483D1 (en) 1998-09-24
JP2002165827A (en) 2002-06-11
ATE347807T1 (en) 2007-01-15
KR100316166B1 (en) 2001-12-12
US20010009661A1 (en) 2001-07-26
JP2002153548A (en) 2002-05-28
JP2002173430A (en) 2002-06-21
CA2140639C (en) 1999-05-18
DE69334082T2 (en) 2007-05-31
JPH08501300A (en) 1996-02-13
KR100316168B1 (en) 2001-12-12
KR100316165B1 (en) 2001-12-12
JP2002173431A (en) 2002-06-21
KR100306886B1 (en) 2002-12-06
US6045820A (en) 2000-04-04
US6696055B2 (en) 2004-02-24
US20030037673A1 (en) 2003-02-27
SG47367A1 (en) 1998-04-17
EP0660668B1 (en) 1998-08-19
DE69334096D1 (en) 2007-01-25
NZ255299A (en) 1996-12-20
JP3708852B2 (en) 2005-10-19
AU688276B2 (en) 1998-03-12
ES2124320T3 (en) 1999-02-01
EP0660668A1 (en) 1995-07-05
HK1011259A1 (en) 1999-07-09
CA2140639A1 (en) 1994-03-31
JP2002187805A (en) 2002-07-05
DE69334096T2 (en) 2007-06-21
JP3682008B2 (en) 2005-08-10
EP0797917B1 (en) 2006-12-13
EP0804876A1 (en) 1997-11-05
DE69334082D1 (en) 2006-12-28
DK0797917T3 (en) 2007-04-23
EP0797917A1 (en) 1997-10-01
JP3706320B2 (en) 2005-10-12
JP2002143860A (en) 2002-05-21
US6899868B2 (en) 2005-05-31
US5980827A (en) 1999-11-09
AU2002302053B2 (en) 2005-04-07
JP3289831B2 (en) 2002-06-10
EP0804876B1 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
WO1994006296A1 (en) Iodine/resin disinfectant and a procedure for the preparation thereof
US7699906B2 (en) Iodinated anion exchange resin and process for preparing same
US6680050B1 (en) Iodine/resin disinfectant and a procedure for the preparation thereof
AU762071B2 (en) Use of iodinated resins to disinfect body fluids and liquids containing microorganisms
AU719355B2 (en) Use of iodinated resins to disinfect air and liquids containing microorganisms
NZ299531A (en) Disinfecting a liquid ontaining microorganisms by passing over an iodinated strong base anion exchange resin
JP3737726B6 (en) Disinfectant using iodine / resin disinfectant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 08256425

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2140639

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 255299

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1019950701017

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1993918858

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1993918858

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1993918858

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020007014953

Country of ref document: KR

Ref document number: 1020007014955

Country of ref document: KR

Ref document number: 1020007014954

Country of ref document: KR

Ref document number: 1020007014956

Country of ref document: KR